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ABSTRACT 
In Xenopus oocytes, 5S ribosomal RNA (5S RNA) is synthesised prior to 
other ribosomal components, and stored in the cytoplasm in ribonucleoprotein 
particles (RNPs). At vitellogenesis, when ribosome assembly begins, 5S RNA is 
imported into the nucleus and targeted to the amplified nucleoli for assembly into the 
60S ribosomal subunit. In this thesis, I have investigated some of the steps of this 
pathway taken by 5S RNA. 
In vivo assays using a series of mutant 5S RNAs revealed that only one 
mutant, with base substitutions in loop A, was defective for binding the 7S RNP 
storage protein, TFIIIA. All mutants were capable of binding to ribosomal protein 
L5, a precursor to ribosome assembly. Four of the mutants tested were defective for 
incorporation into 60S subunits, possibly due to a loss of recognition sites for 
interactions with other ribosomal proteins. Nucleolar localisation studies showed that 
the defective ribosome incorporation of these mutants was not due to defective 
nucleolar targeting. Taken together, these results reveal that different structural 
features of 5S RNA and different oocyte factors are required for different steps in the 
pathway taken by 5S RNA. 
Nucleolar localisation studies also revealed that a large proportion of oocyte-
type 5S RNA and L5 in the nucleus are not associated with nucleoli. In contrast, 
somatic-type 5S RNA was predominantly asssociated with nucleoli, suggesting that 
nuclear factors directly recognise the sequence differences between the two types of 
5S RNA. These could be nucleolar components, which have a higher affinity for 
somatic-type, or nucleoplasmic factors which have a higher affinity for oocyte-type. 
Finally, the mechanism by which 7S RNPs are sequestered in the cytoplasm 
of previtellogenic oocytes was investigated. The results show that neither cytoskeletal 
or membrane structures are responsible for cytoplasmic retention. Other possibilities 
for cytoplasmic retention are discussed. 
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GENERAL INTRODUCTION 
The tenn ribosome was first coined in 1958, to describe 20 to l00S 
ribonucleoprotein particles (RNPs), by R. H. Roberts, who wrote: "this seems a very 
satisfactory name, and it has a pleasant sound" (as quoted in Nomura, 1990). 
Subsequently, ribosomes were shown to be directly responsible for protein synthesis 
in all animal, plant and bacterial cells. Functional ribosomes are made up of two 
subunits, in prokaryotes the 30S and 50S subunits, and in eukaryotes the 40S and 
60S subunits, which each have different protein and RNA components. As shown in 
Figure 1-1, the 60S subunit consists of three ribosomal RNAs (rRNAs): the 
28S rRNA, 5.8S rRNA and 5S rRNA, as well as approximately 49 ribosomal 
proteins. The 40S subunit contains the 18S rRNA and approximately 33 ribosomal 
proteins (reviewed in Hadjiolov, 1985). 
The two ribosomal subunits are made and present in the cell in equimolar 
amounts. Thus, the biogenesis of ribosomes requires the co-ordinate synthesis of four 
rRNAs and 80 proteins. A fundamental challenge in cellular and molecular biology is 
understanding how the co-ordinate expression and subsequent assembly of so many 
molecules is achieved. One approach to studying such a complex structure as the 
ribosome is to investigate the synthesis and structure of individual ribosomal 
components. One such component is 5S rRNA and specific RNPs which it fonns. 
The focus of this study is the pathway taken by 5S rRNA, from synthesis to 
ribosome incorporation, in oocytes of the African Clawed Frog, Xenopus laevis. 
2 
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Figure 1-1 Schematic representation of the components of the eukaryotic 
ribosome. 
1.1 THE RIBOSOMAL RNAS 
The equimolar synthesis of the 18S, 28S and 5.8S rRNAs is ensured by their 
placement within a single transcription unit, which is transcribed as a single 
pre-rRNA molecule by RNA polymerase 1. The rRNA genes are highly repeated, 
being present in 102 to 103 copies per haploid genome, and are usually grouped in 
one or several clusters located at specific sites on one or a few chromosomes 
(reviewed in Hadjiolov, 1985). They are usually looped off the main chromosomal 
3 
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fibre masses as highly extended threads. These ribosomal DNA (rDNA) loops 
coalesce with specific proteins to form nucleoli. The rDNA repeat sequences are 
therefore known as nucleolus organiser regions (NORs). The nucleolus is a non-
membrane bound, intranuclear organelle, which is the site of rRNA transcription and 
processing, and ribosomal subunit assembly (reviewed in Hadjiolov, 1985). 
The fourth rRNA, 5S rRNA (referred to hereafter as 5S RNA), is transcribed 
from another set of tandemly arranged genes which are under the control of RNA 
polymerase III, and are found on chromosomes that are not nucleolar associated 
(Hadjiolov, 1985). Initiation of 5S RNA transcription depends on the 5S RNA gene-
specific transcription factor IlIA (TFIIIA), which binds tightly to nucleotides 50-84 
of the 5S RNA gene (Engelke et al., 1980), as well as two general transcription 
factors, TFIIIB and TFIIIC (reviewed in Wolffe and Brown, 1988). 5S RNA is a 
small molecule of 120 nucleotides and is conserved from bacteria to higher 
eukaryotes (reviewed in Garrett et al., 1981; Specht et al., 1990). 
4 
After transcription in somatic cells, 5S RNA transiently associates with the 
La protein (Steitz et al., 1988), which is thought to be involved in the termination of 
transcription of polymerase III transcripts (Gottlieb and Steitz, 1989). 5S RNA is 
then targeted to the nucleolus and incorporated into the 60S ribosomal subunit. 
Although it is an essential component of the ribosome, a specific function for 
5S RNA has yet to be elucidated (reviewed in Garrett et al., 1981). 
When mammalian ribosomes or 60S subunits are treated with EDTA 
(ethylene dinitrilo tetraacetic acid), a complex of 5S RNA bound to ribosomal protein 
L5 is released (Blobel, 1971). A similar complex is also released from yeast 
ribosomes, where the bound protein is called Ll or YL3 (Nazar, 1979). In 
Escherichia coli, the complex released by similar treatment contains 5S RNA and 
three ribosomal proteins, L5, L18 and L25 (Yu and Wittmann, 1973). Subsequently, 
these 5S RNA complexes were shown to be precursors to ribosome assembly in 
HeLa cells (Steitz et aI., 1988), Xenopus oocytes (Allison et aI., 1991) and embryos 
(Wormington, 1989), yeast (Deshmukh et al., 1993) and E. coli (Yu and Wittmann, 
1973). In the following text, this group of ribosomal proteins will be referred to as 
the 5S RNA-binding proteins, as distinguishable from other ribosomal proteins which 
may interact with 5S RNA in the ribosome, but do not remain associated with 
5S RNA after dissociation with EDTA, and do not form precursor RNPs with 5S RNA. 
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1.2 OOGENESIS IN XENOPUS LAEVIS 
After fertilisation, the Xenopus embryo undergoes twelve very rapid and 
. almost synchronous cleavage divisions, characterised by short interphase periods 
during which DNA synthesis occurs at a very accelerated rate. During this time there 
is no detectable RNA transcription, so the egg relies solely on factors which have 
been stockpiled during oogenesis. These include approximately 1012 ribosomes, yolk, 
maternal messenger RNAs (mRNAs) that are translated in early development, and 
many proteins (reviewed in Hausen and Riebesell, 1991). The oocyte, therefore, is a 
highly productive cell, with many specialised mechanisms to allow the synthesis of 
huge amounts of maternal factors. 
Oogenesis in Xenopus is a continuous, asynchronous process, and oocytes in 
all stages .of development are present in the ovary at all times during adult life. These 
oocytes are arrested in the first meiotic prophase, until hormonal stimulation results 
in the resumption of meiosis and the development of the mature egg (reviewed in 
Bement and Capco, 1990). Oogenesis has been divided up into six stages based on 
the anatomy of the developing oocyte (Dumont, 1972). The massive synthesis of 
ribosomes, together with the large size of the fully grown oocyte (greater than one 
millimetre) and the accessibility of the oocytes renders them an excellent model 
system for studying ribosome biogenesis. 
Ribosomes are synthesised at a rate 1000 times faster in oocytes than in 
somatic cells (reviewed in Wormington and Baum, 1986). To accomplish this, the 
genes encoding the rRNA primary transcript are selectively amplified l00-1000-fold 
over somatic cells (Brown and Dawid, 1968; Gall, 1968). The amplified DNA forms 
large numbers of extrachromosomal nucleoli, which each contain one to twenty 
tandemly arranged rRNA genes (Brown and Dawid, 1968). Transcription from these 
amplified rRNA genes provides enough 188,288 and S.88 rRNAs for the huge 
amounts of ribosomes that are synthesised in oocytes. However, S8 RNA must also 
be synthesised at a higher rate, to match that of the other rRNAs. The frog oocyte 
accomplishes this by having two sets of genes encoding S8 RNA. One encodes the 
S8 RNA found in somatic cells, and is present in 400 copies (Peterson et al., 1980). 
The other encodes S8 RNA which is specifically found in oocytes, and is present in 
Chapter 1 
20 000 copies (Peterson et al., 1980). In somatic cells, the somatic-type 5S RNA 
genes are expressed, while the oocyte-type genes are repressed (reviewed in Wolffe, 
1994). In the oocyte, the oocyte-type and somatic-type genes are both switched on, 
allowing 50 times more 5S RNA synthesis for ribosome stockpiling. The 5S RNA 
produced from the somatic-type and oocyte-type set of genes differs by six 
nucleotides (Ford and Southern, 1973). 
1.3 PATHWAY TAKEN BY 5S RNA IN XENOPUS OOCYTES 
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Although the oocyte-type 5S RNA genes are switched on in oocytes, this only 
provides 50 times·more templates for transcription, as compared with the 100-1000 
times amplification of the DNA encoding the other rRNAs. Another mechanism is 
. thus utilis.ed in oocytes to provide necessary quantities of 5S RNA. This results in a 
pathway taken by 5S RNA that is more complicated in oocytes than the route taken 
in somatic cells. This pathway is described below, and is diagrammed in Figure 1-2. 
Most ribosome assembly and stockpiling takes place during the vitellogenic 
stage of oogenesis. However, 5S RNA is synthesised before the other rRNAs and 
ribosomal proteins (Ford, 1971). In early oogenesis, 5S RNA is synthesised in fifteen 
to twenty-fold molar excess over the rRNAs, although this ratio decreases to three to 
four fold molar excess at later stages (Ford, 1971). In previtellogenic oocytes, this 
excess of 5S RNA is stored in the cytoplasm in two RNP particles, which sediment 
at 42S and 7S. 
The basic unit of the 42S RNP consists of 5S RNA bound to a non-ribosomal 
protein, p43, transfer RNA (tRNA), and another non-ribosomal protein, p48, in a 
ratio of 1:1:3:2 (Ford, 1971; Picard et al., 1980). The 42S RNP is a tetramer of this 
basic unit (Picard et al., 1980). 42S RNPs are predominant in stages I and II of 
oogenesis, but are not detectable by stage VI (Dixon and Ford, 1982a,b; Viel et al., 
1990). 
Chapter 1 
60S subunit 
5S RNP 1 
LS 
cytoplasm 
Figure 1-2 Pathway taken by 5S RNA in Xenopus oocytes. 
The remaining 50% of 5S RNA is complexed in a one to one ratio with the 
protein TFIIIA (Picard and Wegnez, 1979; Honda and Roeder, 1980; Pelham and 
Brown, 1980). Thus, in oocytes, TFllA has the ability to bind both the 5S RNA 
gene and 5S RNA itself. TFllA is present in a constant amount (60 ng!oocyte) 
throughout the early stages of oogenesis, but declines twenty-fold by the end of 
oogenesis (Shastry et al., 1984). Immunocytochemistry and immunoprecipitation 
assays have shown that both 42S and 7S RNPs are exclusively localised in the 
cytoplasm of oocytes (Mattaj et al., 1983; Viel et al., 1990; Allison et al., 1991). 
7 
5S RNA is stored in 7S and 42S RNPs until vitellogenesis, when the other 
rRNAs and ribosomal proteins are synthesised. At this time 5S RNA is released from 
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the storage particles, and binds to ribosomal protein L5, forming 5S RNPs (Allison 
et al., 1991). Synthesis of L5 is maximal during vitellogenesis, coinciding with 
synthesis of the rRNAs and other ribosomal proteins and ribosome assembly 
(Wormington, 1989). Since 5S RNPs were immunoprecipitated from both 
cytoplasmic and nuclear fractions of oocytes, L5 was implicated in the mobilisation 
of stored 5S RNA for import into the nucleus (Allison et al., 1991). Once in the 
nucleus, 5S RNA is targeted to the amplified nucleoli, where it becomes incolporated 
into the 60S ribosomal subunit (Allison et al., 1993). The fmal step of the 5S RNA 
pathway in oocytes is export from the nucleus to the cytoplasm as part of the 
60S ribosomal subunit and storage in 80S mono somes for use in embryogenesis. 
Although somatic-type 5S RNA is synthesised in oocytes (Ford and Southern, 
1973), it was not detected in long term storage particles or ribosomes from 
vitellogenic oocytes (Denis and Wegnez, 1977). More recently, oocyte-type and 
somatic-type 5S RNAs were shown to have different behaviours after microinjection 
into the oocyte cytoplasm (Allison et aI., 1995). Oocyte-type 5S RNA predominantly 
associated with TFIIIA, forming 7S RNP storage particles, whereas somatic-type 
5S RNA preferentially associated with ribosomal protein L5. In addition, somatic-
type 5S RNA was imported into the nucleus at a faster rate and to a larger extent, 
and more was incOtporated into 60S ribosomal subunits (Allison et al., 1995). These 
results further support the hypothesis that L5 mobilises 5S RNA for import into the 
nucleus and incolporation into ribosomal subunits. 
The pathway taken by newly synthesised 5S RNA in late stage oocytes has 
also been investigated. (Guddat et al., 1990). When genes encoding 5S RNA were 
microinjected into oocyte nuclei, the transcribed RNA transiently associated with the 
La antigen (Guddat et al., 1990). The La protein was then replaced by either TFilIA 
or L5, and these RNPs exported to the cytoplasm. 5S RNA molecules impaired in 
their ability to bind L5 and mllA were retained in the nucleus (Guddat et al., 
1990). 
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1.4 THE PRESENT STUDY 
The pathway taken by 5S RNA in oocytes of Xenopus laevis involves 
multiple RNA-protein interactions, bi-directional nuclear transport, and nucleolar 
targeting. Although the overall pathway is known, the molecular interactions and 
mechanisms of regulation for each step remain to be elucidated. In the present study, 
I have investigated some of the steps taken in this pathway in detail. including 
storage of 5S RNA as a 7S RNP in the cytoplasm of previtellogenic oocytes, 
targeting of 5S RNA to the nucleolus, and incorporation into the 60S ribosomal 
subunit. 
Chapter 2 presents the methods used in this investigation. Chapter 3 describes 
experiments in which the specific sequence and structural requirements of 5S RNA 
for protein associations in the cytoplasm and for ribosomal incorporation were 
investigated, using a series of mutant 5S RNA molecules. Chapter 4 describes 
experiments in which the intranuclear distribution of endogenous and exogenous 
mutant 5S RNA molecules was examined to determine the requirements of 5S RNA 
for nucleolar localisation. Chapter 5 addresses the possible mechanisms for the 
retention of 7S RNPs in the cytoplasm of previtellogenic oocytes, in particular, the 
role of cytoskeletal and intracellular membrane structures. 
CHAPTER 2 
MATERIALS AND METHODS 
2.1 MATERIALS 
Chemicals used in this study were purchased from BDH (BDH Chemicals 
New Zealand Ltd., Palmerston North, New Zealand), unless otherwise specified. 
Restriction enzymes were purchased from Boehringer Mannheim N. Z. Ltd. 
(Auckland, New Zealand). All solutions were made using ultrafiltered ~O from a 
Barnstead Nanopure Ultrapure water system. Xenopus laevis were either bred in the 
Department of Zoology at the University of Canterbury, or were purchased from 
Xenopus I (Ann Arbor, Michigan, USA). 
I. Plasmids 
DNA templates for the synthesis of wild-type and mutant 5S RNA molecules 
were a generous gift from P. J. Romaniuk (University of Victoria, Victoria, British 
Columbia, Canada). Plasmids contain one copy of a 5S RNA gene, constructed from 
a series of synthetic oligonucleotides which were subsequently annealed and ligated 
into the vector pUC18 (Romaniuk et al., 1987a). Some of these clones were 
subsequently inserted into M13mp18 (Baudin and Romaniuk, 1989). The 5S RNA 
10 
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genes were constructed so that digestion with DraI and transcription with T7 RNA 
polymerase yields a 121 nucleotide molecule with identical 5' and 3' termini to those 
found in naturally occurring 5S RNA molecules. The U1 snRNA template (Hamm 
et al., 1987) was provided by D. S. Goldfarb (University of Rochester, Rochester, 
New York, USA). After linearisation with Bam HI and transcription with 17 RNA 
polymerase, this synthetic U1 snRNA contains three additional G residues at the 
5' end and four additional nucleotides (GATC) at the 3' end (Hamm et al., 1987). 
The U3snoRNA gene template (pXlU3A'; Savino et al., 1992) was provided by 
S. A. Gerbi (Brown University, Providence, Rhode Island, USA). The template used 
for transcription of U3 snoRNA was produced by M. Ezrokhi (Brown University), 
using PCR as described in Terns and Dahlberg (1994). The template contains a 
T7 promoter and produces U3 snoRNA with 5 extra nucleotides at the 3' end 
(3'-UUUUA), which enhances the in vivo stability of the transcript. 
pSP6-L5b containing the Xenopus ribosomal protein L5 cDNA clone 
(Wormington, 1989) was provided by W. M. Wormington (University of Virginia, 
Charlottesville, Virginia, USA). 
Plasmid pXl08G contains one repeat unit of oocyte-type 5S DNA from pXl08 
subcloned into pGEM4 (Allison et al., 1991). Transcription of pXl08 linearised with 
SmaI with 17 RNA polymerase yields a transcript of 714nucleotides containing an 
antisense 5S RNA sequence. Plasmid pSP72-Vg1 was a generous gift from 
D. A. Melton (Harvard University, Cambridge, Massachusetts, USA). This plasmid 
contains a fragment of Xenopus V gl cloned into the SmaI site of pSP72. Digestion 
with Eco RI and transcription with SP6 RNA polymerase produces a transcript 
containing an antisense Vg1 sequence. Plasmid pX1r101A was a gift from 
A. H. Bakken (University of Washington, Seattle, Washington, USA), and contains a 
full repeating unit of the Xenopus ribosomal DNA (rDNA) cloned into the Hind III 
site of pBR322 (Bakken et ai., 1982). 
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ll. Antisera 
Anti-TFIlIA and anti-60S ribosomal subunit antisera were generously 
provided by M. Ie Maire (CEA et CNRS, Gif-sur-Yvette, France). These antisera are 
described and characterised in Viel et al. (1990) and Allison et al. (1993). Anti-
N038 (No-185; Schmidt-Zachmann et al., 1987) was generously donated by 
M. S. Schmidt-Zachmann (German Cancer Research Centre, Heidelberg, Germany). 
Anti-Artemia L5 was provided by N. Kenmochi (Niigata University School of 
Medicine, Niigata, Japan), and is described in Kenmochi and Ogata (1989). 
2.2 IN VITRO TRANSCRIPTION OF RNA 
I. 32P.labelled SS RNAs 
32P-Iabelled wild-type or mutant 5S RNAs were produced from gene templates 
linearlsed with DraI, using one of the following two methods. 
i. Method A 
A final transcription reaction volume of 20 pi contained 40 mM Tris-HCI, 
pH 8.1 @ 37°C, 15 mM MgC12, 5 mM dithiothreitol (DTT), 0.1 mg/ml Bovine 
Serum Albumin (BSA; Boehringer Mannheim), 1 mM spermidine, 40 U RNasin 
(Promega: Pacific Diagnostics, Pty. Ltd., Auckland, New Zealand), 1 mM each of 
ATP, CTP, and UTP, and 0.025 mM GTP (Boehringer Mannheim), 1 pg linearised 
template DNA, 50-100 pei [a_32P]GTP (3000 Ci/mmol; Amersham Australia Pty. 
Ltd., Auckland, New Zealand) and 20 U T7 RNA polymerase (Boehringer 
Mannheim). The reaction was incubated at 37°C for 1.5 hr. The DNA template was 
removed by treatment with 1 U RNase-free DNase I (Boehringer Mannheim) for 
15 min at 37°C. 
Samples were extracted once with an equal volume each of phenol (saturated 
in TE [10 mM Tris-HCI, 1 mM EDTA], pH 8.0) and chloroform:isoamyl alcohol 
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(24:1; hereafter referred to as "chlorofonn"), and then once with an equal volume of 
chlorofonn. RNA was precipitated two times, each with 2.5 M ammonium acetate 
and 2 volumes of 100% ethanol. RNA pellets were resuspended in TE pH 7.6, 
aliquoted and stored at -80°C. 
RNA was quantified using DNA Dipstick (Invitrogen Corp., San Diego, 
California, USA). Typical yields were between 50-100 ng of RNA. 
ii. Method B 
Transcription reactions contained T7 transcription buffer (Epicentre 
Technologies: Intenned Scientific Ltd., Auckland, New Zealand), 10 mM DTT, 
40 U RNasin, 200 pM CTP, ATP, and UTP, 40 pM GTP, 1 pg linearised template 
DNA, 50-100 pCi [a_32P]GTP (3000 Ci/mmol; DuPont NEN: Life Technologies Ltd., 
Auckland, New Zealand) and 50 U T7 RNA polymerase (Epicentre). The 
20 pI mixture was incubated at 37°C for 1 hr followed by treatment with 1 U RNase-
free DNase. One hundred and twenty-eight microlitres of UB Blue (175 mM NaCI, 
5 mM Tris-HCI, pH 7.4,5 mM EDTA, 0.5% sodium dodecyl sulphate [SDS], 
0.05% methylene blue, 7 M urea) and 20 pg glycogen (Boehringer Mannheim) were 
added, and the sample extracted once with an equal volume of phenoVchlorofonn and 
once with an equal volume of chlorofonn. The RNA was precipitated with 2 volumes 
of 100% ethanol on ice for 15 min, and again with 2.5 M ammonium acetate and 
2 volumes of 100% ethanol on ice for 15 min. The RNA was resuspended in TE, 
pH 7.6 and stored at -80°C. 
RNA was quantified using DNA Quik STRIP (Eastman Chemical Co., New 
Haven, Connecticut, USA). Typical yields were approximately 300 ng. 32P-Iabelled 
RNA was also counted in a Quick-Count QC-2000 benchtop radioisotope counter 
(Bioscan Inc., Washington, D. C., USA) to allow comparable dilutions of the 
different RNAs. 
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II. 32P-Iabelled Ul snRNA and U3 snoRNA 
Reactions were perfonned as described in Method B for 5S RNA, containing 
1 pg of Ul or U3 template, with the addition of 0.4 mM m7G cap (New England 
Biolabs) to the reaction mixture. The RNAs were purified as in Method B above and 
stored at -SO°C. 
In. 33P-Iabelled RNAs 
For in situ localisation assays, RNAs were synthesised containing [33p]UTP, 
as this isotope has five-fold weaker B-emissions than 32p, allowing higher 
autoradiographic resolution. RNAs were synthesised in a reaction containing 200 pM 
CTP, ATP, and GTP, 40 pM UTP and 50 pCi [a_33p]UTP (1000-3000 Ci/mmol~ 
Amersham) and purified as described in Method B above. 
IV. DIG-labelled Antisense RNA Probes 
For northern hybridisation, digoxigenin (DIG)-labelled antisense RNAs were 
synthesised from pXloSG and pSP72-Vg1. DIG-labelled sense-strand 5S RNA probes 
were synthesised using the pXlo-wt template. Twenty microlitre reaction mixtures 
contained 40 mM Tris-HCI, pH S.O, 6 mM MgCI2, 10 mM NaCI, 10 mM DTT, 
2 mM spennidine, 40 U RNasin, 1 mM each of ATP, GTP and CTP, 0.65 mM UTP, 
0.35 mM DIG-II-UTP (Boehringer Mannheim), 1 pg template DNA and 40 U 
T7 RNA polymerase (for antisense and sense-strand 5S RNA; Epicentre) or SP6 
RNA polymerase (for antisense Vgl; Boehringer Mannheim). Reactions were 
incubated for 1.5 hr at 37°C, and the DNA digested with DNase. RNA was purified 
as described in Method A above, dissolved in TE, pH 7.6, and stored at -SO°C. 
The yield of DIG-labelled RNA was estimated by spotting serial dilutions of 
transcripts onto a nylon membrane followed by visualisation using DIG 
chemiluminescent detection (see section 2.1O.N) and comparison with DIG-labelled 
Chapter 2 15 
RNA standards (Boehringer Mannheim). Typical transcription yields were estimated 
to be 10-20 }lg RNA. 
2.3 IN VITRO SYNTHESIS OF 35S-LABELLED LS 
35S-labelled ribosomal protein L5 was synthesised in vitro using a rabbit 
reticulocyte coupled transcription-translation system for templates with SP6 
promoters (Promega). Reactions were performed following the manufacturer's 
instructions, with 1 }lg of non-linearised pSP6-L5b, containing 50 }lei 
[35S]methionine (>1000 Ci/mmol; DuPont NEN), and incubated at 30°C for 1.5 hr. 
Reaction mixtures· were then filtered through a 0.22 }lm filtration unit (Millipore: 
BioLab Scientific, Christchurch, New Zealand) to remove large aggregates before 
microinjection. Labelled protein was aliquoted and stored at -80°C. 
2.4 OOCYTE ISOLATION AND PREPARATION 
Mature Xenopus laevis females were anaesthetised on ice, and lobes of ovary 
surgically removed through a small abdominal incision, which was then sutured. 
Ovarian tissue was rinsed three times in 0.15 M NaCI, 0.05 M Tris-HCI, pH 8.0, and 
1 mM EDTA to remove the blood, then rinsed twice in phosphate buffered saline 
(PBS; 68 mM NaCI, 1.3 mM KCI, 4.0 mM N~HP04' 0.7 mM KHZP04, 0.35 mM 
CaClz, 0.25 mM MgCIJ to remove the EDTA. The tissue was then digested with 
1 mg/ml collagenase (Type II, Sigma, St. Louis, Missouri, USA) diluted in 0.1 M 
sodium phosphate pH 7.4, at room temperature with end over end rotation for 
20-30 min. Oocytes were then rinsed twice with PBS and twice with O-R2 (82.5 mM 
NaCl, 2.5 mM KCI, 1 mM CaClz, 1 mM MgClz, 1.0 mM NaJIP04' 3.8 mM NaOH, 
5.0 mM HEPES [N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid], pH 7.8; 
Wallace et al., 1973), and incubated in O-R2 at 18°C. All procedures ;used were 
approved by the University of Canterbury Animal Ethics Committee. 
Oocytes were separated into stages according to Dumont (1972) using the 
following criteria: stage I, transparent, 50-300 }lm; stage n, white/opaque, 
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300-400 pm; stage ITI, light brown/tan, 450-600 pm; stage IV, animal and vegetal 
hemispheres differentiated, animal pole dark brown, 600-1000 pm; stage V, animal 
pole brown/beige colour, 1000-1200 pm; stage VI, unpigmented equatorial band, 
1200-1300 pm. 
2.5 MICRO INJECTION 
I. Equipment 
A PW-6 microelectrode puller (Narashige, Tokyo, Japan) was used to pull 
16 
1 mm O. D. glass needles (Clark Electromedical Instruments, Reading, England). The 
microinjection equipment consisted of a micromanipulator and PV 830 Pneumatic 
PicoPump (World Precision Instruments, Inc., New Haven, Connecticut, USA), a 
Schott KL1500 cold light source, and a Heerbrugg stereo-microscope. Vacuum was 
provided by a Gast oil-less diaphragm vacuum pump, and pressure by a tank of N2 
gas. Microinjection dishes were made by gluing Nitex 900 pm mesh to culture dishes 
with chlorofonn. 
II. Procedure 
Microinjection needles were pulled and ground to a 20 pm tip. Solutions to be 
injected were loaded into the needle using approximately 25 mm Hg vacuum. The 
injected volume was calibrated using the drop diameter and adjusted by reguladng 
the pulse time. Healthy stage V oocytes were transferred to microinjection dishes in 
O-R2 media, and injections were perfonned into the vegetal hemisphere. After 
injection, oocytes were placed on ice for 30 min to aid wound healing, and then 
incubated at 18°C for specified lengths of time. 
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2.6 IMMUNOPRECIPITATION ASSAYS 
To analyse the incorporation of wild-type and mutant SS RNAs into oocyte 
RNPs, immunoprecipitation assays were performed on either whole oocytes or 
nuclear fractions using antibodies specific for these RNPs~ This technique utilises the 
high affinity of protein A for immunoglobulins, which, when attached to a solid 
matrix allows the purification of antibody-antigen complexes. 
I. Whole Oocytes 
Forty to eighty nanolitres of 32P-Iabelled wild-type or mutant SS RNAs (0.2 to 
O.S ng RNA), synthesised using Method A, were injected into the cytoplasm of 
oocytes which were then incubated for 48 hr. Protein A-Sepharose (CL-4B; 
Pharmacia LKB Biotechnology, Auckland, New Zealand) was swollen in Ipp1S0 
(SO mM Tris-HCl, pH 7.4, ISO mM NaCI, O.OS% NP-40 [nonidet P40D at S mg/ml 
for IS min, then SOO pI aliquots were incubated for 2 hr with end over end rotation 
with 10 pI anti-TFIIIA or anti-60S ribosomal subunit antisera to allow binding of 
antibodies to protein A. The resin was then pelleted for lOs in a microfuge and 
resuspended in 1 ml of Ipp1S0. This wash was repeated three times to remove all 
unbound antibody. 
Whole oocytes were homogenised in Ipp1S0 containing 0.1 mM 
phenylmethylsulphonyl fluoride (PMSF) and 10 Vlml RNasin using a Gilson p1000 
Pipetman, and cleared of yolk and pigment by centrifugation at 10 000 rpm for 
10 min at 4°C. Supernatants were divided into SOO pI samples (20 oocyte 
equivalents) and aliquoted onto protein A-Sepharose-antibody pellets, and incubated 
for 1 hr at 4°C with end over end rotation. The resin was then pelleted and the 
immunosupernatants kept. Pellets were washed four times with Ipp1S0 to remove 
unbound cellular material. After the fmal wash, 300 pI of Ipp1S0 was added to each 
pellet, followed by 2 pg of carrier yeast tRNA (Gibco BRL: Life Technologies), 
30 pI of 10% SDS and an equal volume of phenoVchloroform. RNA was also 
extracted from immunosupernatants by adding SO pI of 10% SDS and an equal 
volume of phenoVchloroform. The samples were vortexed and incubated for IS min 
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at 37°C with frequent mixing. The aqueous phase was recovered after centrifugation, 
and the RNA precipitated with 0.4 M sodium acetate and ethanol. RNA pellets were 
dissolved in 10-20 pi of formam ide-dye loading buffer (95% deionised formamide, 
0.05% xylene cyanol, 0.05% bromophenol blue), and denatured by boiling for 3 min. 
Samples were resolved by denaturing electrophoresis on 8% polyacrylamide/ 
8 M urea gels in TBE running buffer (89 mM Tris, 89 mM boric acid, 2.7 mM 
EDTA) for 1 hr at 650 V (0.75 mm x 20 cm gels). Gels were dried for two hours at 
80°C in a BioRad model 583 gel dryer (BioRad Laboratories Pty. Ltd., Auckland, 
New Zealand) with vacuum supplied by water pressure. Dried gels were exposed to 
X-ray film (Hyperfilm-MP, Amersham) with intensifying screens at -80°C for 
overnight (immunosupernatants) or 3 weeks (immunoprecipitates). Films were 
developed in AGFA G150 developer for 3 min and fixed in llford Hypam rapid fixer 
for 4 min. 
For characterisation of antisera, endogenous oocyte RNA was labelled by 
microinjection of 40 nl of 10 mCi/ml [3Zp]GTP (DuPont NEN) into the cytoplasm of 
oocytes which were incubated overnight. Homogenates of 20 oocytes were prepared 
as above for immunoprecipitation. For control experiments, oocyte homogenates 
(containing no PMSF) were treated with 200 pg/ml proteinase K (Boehringer 
Mannheim) for 1 hr at 37°C. This reaction was stopped with the addition of 
10 mM EDTA. Immunoprecipitations were then performed as described above. 
ll. Nuclear Fractions 
For immunoprecipitation of oocyte nuclei, oocytes were cytoplasmically 
injected with 20 nl of 3zP-Iabelled 5S RNA (synthesised using Method B) and 
incubated for 18 hr. Nuclei were dissected using watchmaker's forceps in nucleus 
isolation buffer (25 mM Tris-HCI, pH 8.0, 10% glycerol, 5 mM MgClz, 2 mM DTI; 
McKnight et aZ., 1980). Immunoprecipitation assays were performed as described 
above, with the following modifications: Assays were performed in Ipp300 (50 mM 
Tris-HCl, pH 7.4, 300 mM NaCI, 0.05% NP-40), using 20 pI of anti-TFIIIA, anti-L5 
or anti-60S subunit antisera. As a control, immunoprecipitations were performed 
using 20 pI of normal rabbit serum (Sigma). For sequential immunoprecipitations, 
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immunosupematants from the ftrst precipitation were added to a second protein 
A-Sepharose-antibody pellet and incubated a further hour at 4°C with end over end 
rotation. To prevent degradation, fresh PMSF and RNasin were added to the second 
immunoprecipitation reaction. The RNA was extracted from immunoprecipitates and 
immunosupematants and analysed as described for whole oocytes. 
2.7 NON-DENATURING GEL ELECTROPHORESIS ASSAYS 
For non-denaturing gel electrophoresis assays of mutant 5S RNAs, oocytes 
were cytoplasmically injected with 20-40 nl 32P-Iabelled RNA, synthesised using 
Method A, and incubated for 48 hr. Three to ftve oocytes were homogenised with a 
Gilson p20 Pipetman in 20 pi RNP homogenisation buffer (20 mM Tris-HCl, pH 7.6, 
100 mM Kel, 1.5 mm MgCl2, 2 mM DTI, 0.1 mM PMSF, 10 U/ml RNasin) and 
centrifuged for 5 min at 10 000 rpm at 4°C to remove yolk: and pigment. One-tenth 
volume of 10 X glycerol dye loading buffer (200 mM EDT A, 50% glycerol, 
0.25% bromophenol blue, 0.25% xylene cyanol) was added to supernatants, which 
were then resolved on 6% polyacrylamide gels containing 0.1 % Triton X-loo, in 
TBE running buffer containing 0.1 % Triton X-loo, for 1.5 hr at 300 V 
(0.75 mm x 20 cm gel). Gels were dried for 30 min at 80°C under vacuum, and 
exposed to X-ray fIlm at -80°C for 1-20 days. 
For analysis of nuclear fractions, 20 nuclei were dissected in RNP 
homogenisation buffer without PMSF and RNasin, and then homogenised and 
analysed as described above. Nuclear fractions treated with proteinase K were 
incubated at 37°C for 30 min with 50 pg/ml proteinase K. For EDT A treatment, 
nuclei were dissected and homogenised in RNP homogenisation buffer containing 
25 mMEDTA. 
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2.8 NUCLEOLAR LOCALISATION ASSAYS 
For analysis of the nucleolar localisation of 5S RNA mutants, 20 n1 of either 
32p_ or 33P-labelled RNA (0.1 to 1 ng RNA) was microinjected into the cytoplasm of 
oocytes, which were incubated overnight. For nucleolar localisation of 35S-labelled 
ribosomal protein L5, 50 nl of filtered L5 lysate reaction mixture was injected into 
oocytes which were incubated overnight in O-R2 containing 100 pg/ml 
cycloheximide to prevent incorporation of excess [35S]methionine into oocyte 
proteins. Nucleolar localisation was analysed by the following two methods. 
I. Biochemical Fractionation 
Nucleoli were isolated using the method of Peculis and Gall (1992). Nuclei 
were dissected from stage V oocytes in Nucleolar Isolation Buffer (83 mM KCI, 
17 mM NaCl, 6.5 mM N~HP04' 10 mM MgCI2, 1 mM EDTA, 1 mM DTT) using 
watchmaker's forceps, and collected in microfuge tubes. Isolated nuclei were 
sonicated in approximately 50 pI Nucleolar Isolation Buffer in a Branson bath 
sonicator (Bransonic 2) for 20 s in ice-water. Samples were centrifuged for 20 min at 
13 000 rpm in a bench top microfuge to pellet nucleoli. Mter drawing off the 
supernatant (nucleoplasmic fraction), nucleolar pellets were washed by adding 200 pI 
Nucleolar Isolation Buffer, centrifuging for 5 min and discarding the supernatant. 
i. RNA extraction and analysis 
RNA was extracted from oocyte fractions using a procedure modified from 
Peppel and Baglioni (1990). Fractions were homogenised in 500 pI of Solution 1 
(2% SDS, 200 mM Tris-HCl, pH 7.5, 1 mM EDTA) and vortexed for 5 s at high 
speed. One hundred and fifty microlitres of cold Solution 2 (42.9 g potassium 
acetate, 11.2 ml acetic acid and water to 100 ml) was added, and mixed by vortexing 
at medium speed for 10 s. Proteins and DNA were precipitated by placing on ice for 
2 min and centrifuging 5 min at 13 000 rpm. Supernatants were extracted twice with 
300 pI of chloroform, and the RNA precipitated with 650 pi of isopropanol. 
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Samples were resuspended in 10 pI fonnamide-dye loading buffer and 
denatured by boiling for analysis by S M urea/S% polyacrylamide gel electrophoresis 
(PAGE) and autoradiography. A Zeineh analytical hand-held scanning densitometer 
and Biomed Image Analysis software (Advanced American Biotechnology, Fullerton, 
California, USA) were used to quantify the intensity of bands on suitable exposures 
of autoradiograms (within the linear range of signal intensity of the film). 
Alternatively, samples were resuspended in 50 pI of TE, pH 7.6 and added to 2 ml of 
Biodegradable Counting Scintillant (BCS j ; Amersham) for direct counting of samples 
in a scintillation counter (Beckman LS 2SOO). 
ii. Protein extraction and analysis 
Nucleolar pellets were dissolved directly in 10 pI SDS-PAGE sample buffer 
(2% SDS, 100 mM DIT, 60 mM Tris-HCI, pH 6.S, 0.01% bromophenol blue). 
Nucleoplasmic proteins were precipitated with 5 volumes of acetone overnight at 
-20°C, centrifuged at 13 000 rpm for 10 min, and resuspended in 20 pI SDS-PAGE 
sample buffer. Samples were boiled for 10 min and placed on ice prior to 
electrophoresis. Proteins were separated on discontinuous 12% polyacrylamide gels 
containing 0.1 % SDS in SDS running buffer (25 mM Tris, 192 mM glycine, 
0.1% SDS) for 4 hr at 200 V (0.75 mm x 20 cm gel). Mter electrophoresis, gels 
were fixed for 30 min in 25% isopropanol, 10% acetic acid and 3% glycerol, 
followed by soaking in Amplify (Amersham) for 30 min. Gels were air dried on 
perspex gel drying frames with a cellophane cover (Tut's Tomb, Idea Scientific Co.), 
then exposed to X-ray film at -SO°C for 2 weeks. 
II. In Situ Localisation 
i. Preparation of sections 
Oocytes were fixed for 24 hr in 5% acetic acid, 2% formaldehyde, 250 mM 
NaCI, after which an equal volume of 95% ethanol was added dropwise with mixing 
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over 15 min, followed by a further 15 min incubation (Allison et al., 1991). The 
oocytes were dehydrated further in 70% ethanol for 30 min, 90% ethanol for 30 min, 
and 2 changes of 100% ethanol for 15 min each. They were then incubated in 
Cedarwood oil (Gurr) for 2-6 hr with gentle rotation for clearing. Oocytes were 
. infiltrated with paraffm wax by incubating in three changes of molten wax at 65°C 
under vacuum for 5 min each. The oocytes were embedded in paraffin wax in watch 
glasses. The wax was hardened overnight, and the blocks trimmed to trapezoids, and 
sectioned using a Beck microtome at 4-7 pm. 
Slides were prepared by soaking in 1 N HCI overnight, rinsing with tapwater 
and distilled water and then air dried. Subbing solution was prepared by dissolving 
0.1 % gelatin (Sigma) by heating, then adding 0.01 % chromic potassium sulphate and 
filtering through a 45 pm pore membrane. Slides were dipped into subbing solution, 
drained and baked at 65°C overnight. Sections were adhered onto subbed slides by 
floating in· sterile H20, which was heated to approximately 45°C to decompress the 
sections. The H20 was gently drawn off and the slides dried overnight at 37°C. 
ii. Autoradiography and staining 
Paraffin was removed from sections by two changes of xylene for 3 min each, 
followed by a rinse in 1: 1 xylene:ethanol, then 100% ethanol for 3 min. The slides 
were then air dried. 
LM-1 emulsion (Amersham) was melted in the dark at 43°C for 15 min, then 
diluted 1:1 with sterile distilled ~O, also at 43°C. Slides were slowly dipped into 
diluted emulsion for 5 s, drained and air dried for 2 hr, sealed in light-proof racks 
containing silica crystals and exposed at 4°C for 4 days to 4 weeks. 
Before developing, slides were warmed to room temperature for 2 hr to 
prevent condensation forming. Slides were developed at 18°C in D19 developer 
(Kodak) for 5 min, washed for 30 s in 0.5% acetic acid, fixed for 10 min in Ilford 
Hypam fixative, and rinsed for 15 min in running tapwater and twice in distilled 
H20. Giemsa stain was prepared by adding 2 ml of Giemsa stock (Gurr: BDH; 
0.5 g Giemsa dissolved in 33 ml glycerol and 33 ml methanol) to 200 m! of 
3.35 mM Na2HP04 and 3.35 mM KH2P04• Sections were stained for 10 min at room 
temperature, thoroughly rinsed with distilled H20 and air dried. Slides were viewed 
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under brightfield microscopy using an Olympus BH-2 microscope and photographed 
with either Agfacolor Optima 125 print film using neutral density and blue filters, or 
with Fujichrome 64T slide ftlm using a neutral density filter. 
2.9 WESTERN ANALYSIS 
I. Preparation of Samples 
Total oocyte proteins were prepared by homogenising a mixture of 10 mature 
and 20 immature oocytes in cold 100 mM NaCI, 20 mM Tris-HCI, pH 7.6 and 
0.1 mM PMSF, and centrifuging at 4°C for 10 min at 10 000 rpm. Supernatants were 
diluted with 2 X SDS-P AGE sample buffer for electrophoresis. 
5S RNPs were purified from EDTA-treated ribosomes isolated from ovaries 
of mature Xenopus females by L. A. Allison as previously described (Allison et al., 
1991). For western analysis, 2 pI of purified sample was diluted with SDS-PAGE 
sample buffer. 
7S RNPs were prepared using a modified protocol of Blanco et al. (1989). 
Ovaries were removed from five immature Xenopus females (containing stage I-III 
oocytes) and washed three times in 0.15 M NaCI, 0.05 M Tris-HCI, pH 8.0, 
1 mM EDTA and twice in homogenisation buffer (60 mM ~CI, 7 mM MgCI2, 
10 mM HEPES, pH 7.5,25 mM DIT, 0.1 mM PMSF). Tissue was homogenised in 
3 ml cold homogenisation buffer with a glass homogeniser and centrifuged at 2°C in 
a Sorvall SS-34 rotor at 12000 x g for 10 min. The supernatant was recovered and 
loaded onto a DEAE-Sepharose (CL-6B; Sigma) column pre-equilibrated with Buffer 
A (20 mM HEPES, pH 7.5,0.1 mM EDTA, 5 mM MgCI2, 10% glycerol, 100 mM 
KCI, 0.5 mM DTT). The column was then washed with 5 column volumes of buffer 
A containing 150 mM KCl. 7S RNPs were eluted with 5 ml buffer A containing 
320 mM KCl, and stored at -80°C. For western analysis, 8 pI of the 7S RNP 
preparation was diluted with SDS-PAGE sample buffer. 
For western analysis of endogenous nucleolar and nucleoplasmic proteins, 
nuclei from 50 stage V oocytes were separated into nucleolar and nucleoplasmic 
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fractions as described in section 2.8.!. Nucleolar pellets were dissolved directly in 
SDS-PAGE sample buffer. Nucleoplasmic fractions were precipitated with 5 volumes 
of cold acetone on ice for 10 min and centrifuged for 5 min at 5000 rpm to pellet the 
proteins. Pellets were dissolved in SDS-PAGE sample buffer. 
IL Electrophoresis and Transfer 
Prior to electrophoresis, samples were boiled for 10 min and placed 
immediately on ice. Proteins were separated on discontinuous 12% polyacrylamide 
gels containing 0.1 % SDS in SDS running buffer at 200 V for 1 hr (1 mm x 7 cm 
mini gel). Proteins were transferred to nitrocellulose membrane (Hybond-C, 
Amersham) using a BioRad Mini-Trans Blot electrophoretic transfer apparatus in 
25 mM Tris, 190 mM glycine and 20% methanol for 18 hr at 30 V (approximately 
48 rnA) at 4°C, according to the manufacturer's instructions. After transfer, 
membranes were stained with 0.2% Ponceau S (from a 2% stock dissolved in 
3% trichloroacetic acid [TCA] and 3% sulphosalicylic acid) for 5-10 min to confmn 
transfer and to stain high molecular weight protein standards (BioRad). 
ill. Immunodetection 
Immunodetection was performed using a protocol from Harlow and Lane 
(1988) for antibodies conjugated to horseradish peroxidase (POD). Membranes were 
thoroughly rinsed in PBS (l37 mM NaCl, 2.7 mM KCI, 10.1 mM NaJIP04' 1.8 mM 
KH2P04, pH 7.2) to remove Ponceau S stain. Membranes were blocked for 2 hr at 
room temperature in 3% BSA (fraction V; Boehringer Mannheim) in PBS 
(BSA/PBS) followed by two 5 min rinses in PBS. Primary antibodies (Artemia anti-
L5 or anti-N038) were diluted l:lO00 in 3% BSA/PBS before incubation for 1 hr, 
followed by four 5 min washes in PBS. Membranes were then incubated in either 
anti-rabbit (for L5 detection; Boehringer Mannheim) or anti-mouse (for N038 
detection; Vector Laboratories) IgG-POD secondary antibodies diluted 1:2000 in 
3% BSAlPBS for 1 hr, followed by four washes for 5 min in PBS. For detection of 
proteins, a 30 mg/ml stock solution of the POD substrate, 4-chlorq-1-naphthol 
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(dissolved in ethanol; Sigma) was diluted 1:100 in 50 mM Tris-HCI, pH 7.6 and 
filtered through Whatmann No.1 filter paper. Membranes were incubated in 10 ml of 
this chloronaphthol solution containing 10 p.1 of 30% hydrogen peroxide until bands 
were suitably dark (5-30 min). The reaction was stopped by rinsing with PBS. 
2.10 NORTHERN ANALYSIS 
I. Preparation of Samples 
For the analysis of nucleolar localisation of endogenous 5S RNA and other 
rRNAs, RNA was extracted from nucleolar and nucleoplasmic fractions from 
40 nuclei as described in section 2.8.1. 
RNA samples from oocytes fractionated into cytoskeletal and membrane 
fractions were prepared as described in sections 2.11 and 2.12, respectively. 
Samples were resuspended for electrophoresis in TBE with 14% formaldehyde 
and denatured at 65°C for 15 min. After heating, samples were placed immediately 
on ice and 0.1 volume~ each of 10 X glycerol-dye loading buffer and of a 1 mg/ml 
solution of ethidium bromide were added. 
II. Electrophoresis and Transfer 
RNA samples were separated on either 1.8% agarose (for analysis of 5S RNA 
and Vgl) or 1% agarose (for analysis of rRNAs) gels (without formaldehyde; Liu 
and Chou, 1990) in TBE for 2-3 hrs at 60-80 V. RNA was transferred by capillary 
transfer to positively charged nylon membrane (Boehringer Mannheim) in 20 X SSC 
(3 M NaCI, 0.3 M sodium citrate) overnight as described in Sambrook et al. (1989). 
Mter transfer, membranes were soaked in 6 X SSC for 5 min, then placed between 
two pieces of 3 MM paper (Whatmann). RNA was immobilised on filters by 
exposure to ultraviolet irradiation for 3 min. 
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ID. Hybridisation 
i. Antisense RNA probes 
DIG-labelled antisense 5S RNA and V gl RNA probes were synthesised as 
described in section 2.2.N. Membranes were prehybridised 2-4 hr at 68°e in 
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20-40 ml hybridisation buffer (50% formamide, 5 X sse, 2% blocking solution [see 
section N; Boehringer Mannheim], 0.1 % sarkosyl, 0.02% SDS). This solution was 
then removed and replaced with 10 ml fresh hybridisation buffer preheated to 68°e 
containing 50-200 ng/ml DIG-labelled RNA probe which had been denatured by 
heating in hybridisation buffer at 68°e for 15 min. Membranes were hybridised 
overnight at 68°e with agitation. Subsequently, membranes were washed twice in 
2 X sse and 0.1 % SDS at room temperature for 5 min each, and twice in 
0.1 X sse and 0.1 % SDS at 68°e for 15 min each, with agitation. 
ii. DNA probes 
DIG-labelled rDNA probes were synthesised from 2 llg of denatured 
pXlr101A digested with Hind TIl using a random priming reaction containing 
100 D/ml Klenow enzyme, hexanuc1eotide mixture and dNTP labelling mixture, at 
37°e overnight, according to the manufacturer's instructions (Boehringer Mannheim). 
Reactions were stopped with the addition of 20 mM EDTA and the DNA was 
precipitated with 0.4 M LiCl and 3 volumes of ethanol. After centrifugation, DNA 
pellets were dissolved in TE, pH 8.0 and stored at -20oe. The yield of DIG-labelled 
probe was estimated by spotting serial dilutions onto a nylon membrane, followed by 
visualisation using DIG chemiluminescent detection (see section N) and comparison 
with DIG-labelled control DNA (Boehringer Mannheim). Total yields of DIG-
labelled DNA were estimated to be 1 llg. 
Membranes were prehybridised for 4 hr at 500 e in 20-40 ml SDS 
hybridisation buffer (50% formamide, 5 X sse, 2% blocking solution [see section 
IV; Boehringer Mannheim], 50 mM sodium phosphate, pH 7.0, 7% SDS, 
0.1 % sarkosyl, 50 llg/ml yeast tRNA). The prehybridisation solution was then 
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removed, and replaced with 10 ml fresh SDS hybridisation buffer preheated to 50°C, 
containing 5 ng/ml DIG DNA probe denatured by boiling. Membranes were 
hybridised overnight at 50°C with agitation. Subsequently, membranes were washed 
as described for RNA probes (section ill.i). 
IV. DIG Chemiluminescent Detection 
DIG detection was performed using reagents purchased from Boehringer 
Mannheim, following the manufacturer's instructions. All steps were performed at 
room temperature unless otherwise indicated, and with agitation. Membranes were 
initially washed 5 min in 0.3% Tween 20 in Buffer 1 (0.1 M maleic acid, 
0.15 M NaCI, pH with NaOH to 7.5) then incubated for 30 min in 1% blocking 
solution (Blocking reagent dissolved in Buffer 1). Membranes were then incubated 
with anti-digoxigenin Fab fragments conjugated to alkaline phosphatase, diluted 1: 10 
000 in 1 % blocking solution for 30 min, followed by two washes in 0.3% Tween 20 
in Buffer 1 for 15 min each. Membranes were then equilibrated for 5 min in Buffer 3 
(0.1 M Tris-HCI, pH 9.5, 0.1 M NaCl), then incubated for 5 min in substrate solution 
(AMPPD or Lumigen PPD) diluted 1:100 in Buffer 3. Membranes were blotted for a 
few seconds on 3 MM paper, sealed in Glad Wrap and incubated for 15 min at 37°C 
before exposure to X-ray fIlm at room temperature for 1 min to 2 hr. 
2.11 CYTOSKELETON PREPARATION 
Cytoskeletal fractions of oocytes were prepared using four different extraction 
buffers, each of which is described below. The first was the method of Yisraeli et al. 
(1990), which was designed to isolate the oocyte cytoskeleton free of yolk proteins. 
The other three procedures were designed to enrich specific components of the 
cytoskeleton. 
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I. General Procedure 
Ten mature (stage V) or 20 immatnre (stages I and IT) oocytes were 
homogenised in 500 pI of Triton X-l00 extraction buffer (0.5% Triton X-l00, 
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10 mM Pipes [1,4-Piperazine-diethanesulphonic acid], pH 6.8, 0.3 M KCl, 10 mM 
MgOAc, 0.5 mM EGTA [ethylenebis oxyethylenenitrilo tetraacetic acid], 20 pg/ml 
yeast tRNA, 10 D/ml RNasin, 0.1 mM PMSF) using a Gilson pl000 Pipetman, and 
incubated at room temperature for 5-10 min. The samples were then centrifuged at 
13 000 rpm for 5 min, and the supernatant (soluble fraction) removed to a new tube. 
Cytoskeletal pellets were then washed by adding 500 pI of Triton X-l00 extraction 
buffer and re-centrifuging for 5 min. 
i. Total RNA extraction 
Cytoskeletal pellets were resuspended in 400 pI Extraction Solution A 
(50 mM Tris-HCI, pH 7.5,0.1 M NaCI, 10 mM EDTA, 0.5% SDS, 25 pg/ml yeast 
tRNA, 400 pg/ml proteinase K), and digested at 45°C for 1 hr. Soluble fractions were 
diluted 1:4 with Solution A and also digested for 1 hr at 45°C. The RNA was 
extracted twice with phenol/chloroform (1:1) and precipitated with 0.1 volume of 
3 M sodium acetate and 2.5 volumes of 100% ethanol. RNA pellets were dissolved 
in TBE containing 14% formaldehyde for denatnring agarose gel electrophoresis and 
northern analysis as described in section 2.10. 
ii. Immunoprecipitation 
For immunoprecipitation assays of cytoskeletal fractions, cytoskeletal pellets 
were resuspended in 500 pI Ipp 150, and soluble fractions were diluted with 1 ml 
(1:2) Ipp150. Fractions were then added to protein A-Sepharose bound with 10 pI 
anti-TFIIIA antiserum as described in section 2.6.1. Immunoprecipitation assays and 
subsequent RNA extraction were performed as described in section 2.6.I, after which 
RNA pellets were resuspended in TBE containing 14% formaldehyde for northern 
analysis as described in section 2.10. 
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II. Enrichment of Microtubules 
To enrich oocyte microtubules, oocytes were fractionated essentially as 
described in section I, with the addition of 300 mM sucrose to the Triton X -100 
extraction buffer. RNA was extracted and analysed as described above. 
Ill. Enrichment of Intermediate Filaments 
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To enrich oocyte intennediate filaments, oocytes were fractionated using the 
procedure of Pondel and King (1988). Oocytes were homogenised in 500 pI of buffer 
containing 1% Triton X-100, 10 mM Pipes, pH 6.8, either 0.5 or 1.5 M KCI, 5 mM 
MgOAc, 1 mM EGTA, 300 mM sucrose, 20 pg/ml yeast tRNA, 10 Dlml RNasin, 
and 0.1 mM PMSF. Samples were incubated for 10 min at room temperature and 
centrifuged at 13 000 rpm for 5 min. RNA from each fraction was analysed as 
described in section L 
IV. Enrichment of Microfllaments 
To enrich oocyte microfllaments, oocytes were fractionated using a low salt 
extraction buffer following a modified procedure from Capco and Bement (1991). 
Five hundred microlitres of low salt extraction buffer (92.5 mM KCl, 6.2 mM NaCI, 
5 mM EGTA, 2 mM MgC~, 12 mM HEPES, pH 7.4, 1% Triton X-1oo, 20 mg/ml 
yeast tRNA, 10 Dlml RNasin, 0.1 mM PMSF) was added to oocytes in a microfuge 
tube, and incubated with rotation for 15 min at room temperature. The oocytes were 
then homogenised in the same buffer, and incubated a further 10 min at room 
temperature with rotation. Lysates were centrifuged for 5 min at 13 000 rpm, and 
pellet and supernatant fractions recovered The RNA from the two fractions was 
analysed as described in section I. 
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2.12 ISOLATION OF INTRACELLULAR MEMBRANES 
Oocyte membrane fractions were prepared as described in Colman (1984). 
Twenty mature (stage V) or immature (stages I and II) oocytes were homogenised in 
500 )ll ice-cold homogenisation buffer (0.15 M NaCI, 10 mM MgOAc, 20 mM Tris-
HCI, pH 7.6, 10% sucrose, 10 Vlml RNasin, 1 mM PMSF) using a Gilson plooo 
Pipetman, layered onto 1 ml of sucrose buffer (20% sucrose, 50 mM NaCI, 10 mM 
MgOAc, 20 mM Tris-HCI, pH 7.6, 10 Vlml RNasin, 1 mM PMSF) and centrifuged 
in a Sorvall SS-34 rotor at 11 500 rpm (15 000 x g) at 4°C for 30 min. After 
centrifugation the uppermost 500 )ll (10% sucrose layer containing cytosolic 
components) was removed to a new tube. Pellets (containing membranes, yolk and 
pigment) were resuspended in 50 )ll of homogenisation buffer and centrifuged for 
1 min in a bench top microfuge at 10000 rpm to pellet the yolk and pigment. 
Supernatants (containing membranes) were removed to new tubes. 
I. Total RNA Extraction 
RNA was extracted from membrane and cytosol fractions using the procedure 
of Peppel and Baglioni (1990). Membrane fractions were homogenised in 500 )ll 
Solution 1 (2% SDS, 200 mM Tris-HCI, pH 7.5, 1 mM EDT A). Three cytosol 
fractions, of 166 )ll each, were aliquoted into tubes and diluted with 334 )ll (1:2) 
Solution 1. Each tube was then treated as described in section 2.8.I.i for extraction of 
RNA. Mter resuspension in TBE with 14% formaldehyde, cytosol fractions were 
recombined for gel electrophoresis and northern analysis. 
II. Immunoprecipitation 
For immunoprecipitation with anti-TFIIIA antiserum, membrane fractions 
were diluted with 450 )ll Ipp150, and cytosol fractions were diluted with 500 )ll 
Ipp150, before their addition to protein A-Sepharose bound to anti-TFIIIA antiserum. 
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Assays were subsequently perfonned as described in section 2.6, after which RNA 
pellets were resuspended in TBE with 14% fonnaldehyde for northern analysis. 
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CHAPTER 3 
SEQUENCE AND STRUCTURAL 
REQIDREMENTS OF 5S RNA FOR PROTEIN 
ASSOCIATIONS AND RIBOSOME ASSEMBLY IN 
XENOPUS OOCYTES 
3.1 INTRODUCTION 
In living cells, RNA is usually complexed with proteins, to fonn 
ribonucleoprotein particles (RNPs). RNPs range in size from complexes of one RNA 
and one protein (for example, 7S RNPs), to large multicomponent complexes such as 
spliceosomes and ribosomes. The features of RNA that are involved in RNA-protein 
interactions are just beginning to be elucidated. Because RNA has so many diverse 
functions, but only consists of chains of four basic nucleotide subunits, a range of 
confonnational flexibility is required, perhaps more analogous to that of protein 
structure than DNA structure. This versatility is achieved by the fonnation of RNA 
secondary and tertiary structures. 
Secondary structures in RNA are fonned by complementary regions within 
the molecule which fonn Watson-Crick base pairs. These base paired regions fonn 
right handed A-fonn double helices, which differ from the canonical B-fonn DNA 
helices in the distance of a complete helical turn and in the angle of the tilt that the 
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base pairs make with the helical axis (reviewed in Wyatt et al., 1989), The 
consequence of these differences is manifested in the size and shape of the major and 
minor grooves. In B-form DNA the major groove is wide enough to accommodate 
protein structures such as an a-helix or an antiparallel B-ribbon, and the functional 
groups on the exposed edges of the base pairs can be directly contacted by side 
chains of proteins (reviewed in Steitz, 1993). The minor groove is deep and narrow, 
and so is less accessible to secondary structures such as a-helices; however, it is the 
major groove that contains a richer array of hydrogen bond acceptors and donors. 
A-form RNA helices contain a wide, shallow minor groove, and a major groove that 
is deep and narrow. The hydrogen bond acceptors and donors contained within the 
major groove are therefore largely inaccessible for protein interactions (reviewed in 
Steitz, 1993). However, most naturally occurring RNA molecules contain only 
relatively short duplex regions, which are interrupted by mismatches, bulges or loops. 
These features are thought to provide either sequence-specific contacts and/or 
conformational structures recognised by proteins (reviewed in Draper, 1989; Wyatt 
et al., 1989; Wyatt and Tinoco, 1993; Draper, 1995) 
As outlined in the General Introduction, 5S RNA associates with a number of 
proteins on its journey from synthesis to assembly in the ribosome in Xenopus laevis 
oocytes. In this chapter, I investigate the sequence and structural requirements of 
5S RNA for binding to TFIIlA and ribosomal protein L5, and for assembly into the 
60S ribosomal subunit. Results from this study have been published (Allison et al., 
1993). A copy of this publication is included in Appendix m. 
I. Secondary and Tertiary Structure of 5S RNA 
5S RNA is a small molecule of 120 nucleotides which shows sequence 
conservation throughout evolution (for compilation of sequences, see Specht et al., 
1990). Universal secondary structures have been proposed for both prokaryotic and 
eukaryotic 5S RNAs (reviewed in Garrett et al., 1981). As shown in Figure 3-1A, the 
secondary structure of eukaryotic 5S RNA consists of five regions of Watson-Crick 
base pairing, referred to as helices I to V, which are connected by five single 
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stranded loops, designated A to E. Nucleotides are numbered from 1 to 120, in the 
direction 5' to 3'. 
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Analysis of the general consensus model of eukaryotic 5S RNA has indicated 
that the most highly conserved regions occur within the single stranded loops 
(Romaniuk:, 1989). The structure of the asymmetric loop E has been the subject of 
many studies. Chemical and enzymatic probing, and nuclear magnetic resonance 
spectroscopy have suggested that loop E folds into an unusual secondary structure, 
containing non-canonical (non-Watson-Crick) base pairing, of the types A'A, U-U 
and A' G (Andersen et al., 1984a; Romaniuk: et al., 1988; Wimberly et al., 1993). 
The model for Xenopus loop E proposed by Wimberly et al. (1993) is shown in 
Figure 3-1B. Other features of the secondary structure of 5S RNA include four 
nucleotides which are bulged out of helical regions, which in Xenopus 5S RNA are at 
positions 49, 50, 63 and 83 . 
. A model for the tertiary structure of Xenopus 5S RNA has been proposed, 
using computer graphic modelling (Westhof et al., 1989). In this model, shown in 
Figure 3-1 C, the 5S RNA molecule adopts a distorted Y -shape structure, the stalk of 
which consists of helix I and the two arms consisting of helices IT and ill and IV and 
V. Helices n and V are proposed to be almost colinear, and there are thought to be 
no long range tertiary interactions between loop C and loops D or E (Westhof et al., 
1989). Although other tertiary structure models have been proposed for 5S RNA 
which do incorporate long range tertiary interactions (for example, Pieler and 
Erdmann, 1982; Nazar, 1991), the above model has some experimental support. 
Mutagenesis studies showed that mutations in either loops B, C, D or E induced 
conformational changes restricted only to the mutated regions (BruneI et al., 1990; 
Leal de Stevenson et al., 1991). In addition, the tertiary structure of 5S RNA has 
been probed with bis (phen-anthroline )(phenanthrenequinone diimine) rhodium (ITI) 
(Rh[phenh[phi]3+), which cleaves RNA preferentially at sites of tertiary interaction 
that provide an accessible major groove. The results of cleavage of wild-type 
5S RNA as well as of mutated and truncated 5S RNA molecules indicate that the 
domains of 5S RNA are independently organised, and support the Y-model structure 
(Chow et al., 1992). 
Figure 3-1 Secondary and tertiary structure of Xenopus laevis oocyte-type 5S RNA. (A) Secondary 
structure of oocyte-type 5S RNA after Romaniuk el aI. (1988). Double helix regions are nwnbered I to 
V. and single stranded loop regions are designated A to E. Loop E is depicted as single stranded. 
(8) Structure of loop E as proposed by Wimberly et al. (1993). Non-Watson-Crick base pairs are 
indicated by open circles. (C) Stereoscopic view of the three-dimensional model for the tertiary 
structure of Xenopus 5S RNA as proposed by Westhof el aI. (1989), showing a V-shape consisting of 
three independent domains. Reprinted with pennission from B. Ehresmann. 
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II. TFIIIA Binding 
There have been many studies on the characterisation of the 7S RNP complex 
from Xenopus oocytes (reviewed in Romby et al., 1990). Enzyme and chemical 
nuclease probing have shown that TFITIA protects a substantial portion of 5S RNA 
from cleavage, including helix lI/loop B and helix IV /loop Elhelix V (Andersen 
et al., 1984b; Romaniuk, 1985; Huber and Wool, 1986a; Christiansen et ai., 1987; 
Darsillo and Huber, 1991; McBryant et al., 1995). Deletion mutagenesis of 5S RNA 
showed that nucleotides 11-108 provide the necessary sequence and conformational 
information for TFIIIA binding (Romaniuk et al., 1987a). In addition, a series of 
5S RNA mutants has been characterised for their in vitro binding affmity to TFITIA 
(Baudin and Romaniuk, 1989; Romaniuk, 1989; You and Romaniuk, 1990; Baudin 
et ai., 1991). The affinity binding data of these mutants is shown in Appendix 1. The 
main conclusion to be drawn from these studies was that TFllIA appears to recognise 
essentially secondary structures of 5S RNA, predominantly the helical structure 
formed by the near colinear stacking of helices IT and V. 
Despite extensive studies in vitro, there is very little information regarding 
requirements for 7S RNP formation in vivo. I was therefore interested in 
determining the requirements of 5S RNA for binding TFllIA within the oocyte, and 
to compare this with the previously accumulated in vitro binding data. To this end, 
the series of mutant 5S RNA molecules previously analysed for their in vitro binding 
affinity to TFIIIA was tested for their in vivo binding ability to TFllIA after 
microinjection into the oocyte cytoplasm. TFIIIA binding was assessed by 
immunoprecipitation with an anti-TFIIIA antibody, and by non-denaturing gel 
electrophoresis. 
III. L5 Binding 
Since binding of 5S RNA to ribosomal protein L5 (YL3 or Ll in yeast; L5, 
L18 and L25 in E. coli) seems to be a precursor to assembly into the large ribosomal 
subunit in bacteria, yeast, amphibians and mammals (Yu and Wittmann, 1973; Steitz 
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et aI., 1988; Allison et ai., 1991; Deshmukh et ai., 1993), then an obvious 
prerequisite for ribosome incorporation of 5S RNA is binding to L5. 
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The 5S RNA-binding protein(s)-5S RNA complex has been most extensively 
studied in E. coli. Nuclease protection assays showed that the three E. coli 5S RNA-
binding proteins each bind a different site on 5S RNA, with L18 having the highest 
affinity and aiding the subsequent binding of L5 (Pieler and Erdmann, 1982; Huber 
and Wool, 1984; Egebjerg et al., 1989). More detailed studies of L18 binding 
revealed the importance of a bulged adenosine residue at position 66 in helix II 
(Peattie et ai., 1981; Christiansen et ai., 1985; Egebjerg et al., 1989). The position of 
this bulged nucleotide is invariant within helix II in 5S RNA from different species, 
although its identity varies with major phylogenetic divisions (Peattie et al., 1981). 
Binding studies of yeast ribosomal protein L1 to 5S RNA have shown that 
helices I, II, and IV are important for this interaction (Nazar, 1979; Nazar and 
Wildeman, 1983). In rat liver; helices II, IV and V of 5S RNA were protected by L5 
binding from the cytotoxic nuclease, a-sarcin (Huber and Wool, 1986b). These 
studies reveal that the site of ribosomal protein binding on 5S RNA is conserved in 
different organisms, and that the binding site of rat L5 and yeast L1 approximates 
that of the combined binding sites of the three E. coli 5S RNA-binding proteins 
(Nazar and Wildeman, 1983; Huber and Wool, 1986b; reviewed in Nazar et al., 
1982). 
The mutant 5S RNAs used in the present study have also been previously 
analysed for their in vitro binding affmity to Xenopus L5 (Q. You, W. Q. Zang, and 
P. I. Romaniuk, in prep.). This data is shown in Appendix I. Surprisingly, most of 
the 5S RNA mutants tested were not significantly affected in their binding to L5, 
including deletion of the bulged cytidine residue in helix II. Mutations which altered 
the binding affinity of L5 the most were located in helix m. Slightly differing results 
were recently obtained by another group, also investigating the binding of Xenopus 
5S RNA to L5 (Scripture and Huber, 1995). In this study, 5S RNA mutants were 
identified which significantly altered the binding affinity of L5. These results were 
similar to the above results in that the mutations most defective for L5 binding were 
confined to the helix III/loop C region of 5S RNA. The reason for the discrepancy 
between the two sets of data is not known, but may be due to the different assays 
used by each group to determine L5 binding. In order to test the ability of the 
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5S RNA mutants to bind L5 in vivo, I perfonned non-denaturing gel electrophoresis 
on oocyte homogenates after microinjection of mutant 5S RNAs into the oocyte 
cytoplasm. 
IV. 5S RNA within the Ribosome: Structure and Function 
Ribosomal RNA is thought to perfonn more than just a structural role within 
the ribosome. Evidence indicates that rRNA may have a role in all steps of protein 
synthesis, including messenger RNA (mRNA) binding, subunit association, transfer 
RNA (tRNA) binding and peptidyltransferase activity (reviewed in Dahlberg, 1989; 
Noller, 1993). The function of 5S RNA is still unknown, but its universal presence 
and high degree of conservation suggest it has an important role. Prokaryotic 
ribosomes reconstituted in vitro lacking 5S RNA show greatly reduced activities, 
including peptidyltransferase, tRNA binding, elongation factor-dependent binding of 
GTP and chain tennination (Dohme and Nierhaus, 1976; Erdmann, 1976). 
Complexes fonned in vitro between 5S RNA and 18S rRNA have led to the 
hypothesis that this interaction may be important for the association of the 
60S subunit with the 40S subunit (Azad and Lane, 1973). Subsequent analyses have 
delineated the binding sites of this interaction to be at the 3' end of both RNAs in 
Neurospora (Kelly and Cox, 1982), and to a 5' region and a 3' region in mouse 
5S RNA (Sarge and Maxwell, 1991). Another proposed function of 5S RNA in the 
ribosome is in binding to aminoacyl-tRNAs via base pairing of the conserved tRNA 
GTvC sequence with the conserved GAAC sequence (loop C) of bacterial 5S RNA 
(Erdmann, 1976). However, 50S ribosomal subunits containing 5S RNA with 
deletions of this and surrounding sequences retained their ability to carry out 
poly(A)-directed synthesis of polyphenylalanine and to translate a natural phage 
mRNA in vitro, ruling out this interaction being an obligatory step for protein 
synthesis (Pace et al., 1982; Zagorska et al., 1984). Yet another postulated function 
of 5S RNA is as a binding site for eukaryotic elongation factor 2 and associated 
GTPase activity (Grummt et al., 1974; NygArd and Nilsson, 1987; Holmberg et al., 
1992), 
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Possible functions of 5S RNA can also be sunnised from its topographical 
position within the ribosome. The morphologies of prokaryotic and eukaryotic 
ribosomes have been established by three-dimensional electron microscopy (reviewed 
in Frank et al., 1990). Ribosomes from the two kingdoms show a marked degree of 
morphological resemblance. Common features of the large ribosomal subunit include 
the central protuberance, the interface canyon, and stalk and ridge structures 
(Fig. 3-2). The peptidyltransferase centre is thought to lie in the vicinity of the 
interface canyon, at the base of the central protuberance (reviewed in Frank et al., 
1990). To date, most analyses of ribosomal structure have used prokaryotic species. 
The structures of the E. coli 30S and 50S ribosomal subunits have been fairly well 
mapped with regard to protein placement using immunoelectron microscopy and 
protein-protein crosslinking (Walleczek et al., 1988; reviewed in Brimacombe et al., 
1990; Oakes et al., 1990; Staffler-Meilicke and Staffler, 1990). 
The three E. coli 5S RNA-binding proteins, L5, L18 and L25, have been 
localised near the top of the central protuberance of the 50S subunit (Fig. 3-2; 
Walleczek et al., 1988). Immunoelectron microscopy has placed the 3'-5' terminal 
stem of 5S RNA on the surface of the 50S subunit, on the outward side of the central 
protuberance (Shatsky et ai., 1980; Staffler-Meilicke et al., 1981; Clark and Lake, 
1984), whereas loop C was mapped to the interface side of the central protuberance 
(Evstafieva et al., 1985). In addition, crosslinking studies have suggested that loop D 
lies close to the peptidyltransferase centre, and a model was proposed such that 5S 
RNA is constrained into a bent Y shape within the E. coli ribosome (Fig. 3-2; 
Dontsova et al., 1994). 
The placement of ribosomal proteins within the eukaryotic 60S subunit has 
not been established. However, crosslinking studies on rat liver 80S ribosomes 
showed protein L5 crosslinked with two 40S subunit proteins, S4 and S25, indicating 
L5 lies somewhere near the subunit interface (Uchiumi et al., 1986). In addition, L5 
was also identified as being located at the peptidyl-tRNA binding site (Fabijanski and 
Pellegrini, 1981), 
Although the above data are by no means definitive, it appears that in both 
prokaryotic and eukaryotic ribosomes, 5S RNA and binding protein(s) occupy a 
similar and functionally significant position. There is, however, very little 
information concerning the actual sequence andlor conformational structures of 
Chapter 3 
L7/L12 stalk 
Ll Iidse 
Figure 3·2 Diagram of prokaryotic 508 large ribosomal subunit, showing proposed location 
of 58 RNA and binding proteins. The figure shows the "crown projection" of the large 
subunit, with the interface side facing the viewer. Pre, peptidyltransferase centre; 58 5' and 
58 3', 5' and 3' termini of 58 RNA. Location of proteins (indicated by shaded circles and 
numbers) and protein-protein crosslinks are from Walleczek et al. (1988). The location of 
the three arms of 58 RNA (I, helix I; II, helices II and III; IV, helices IV and V) are 
derived from data from Shatsky et al. (1980), SWffier-Meilicke et al. (1981). Clark and 
Lake (1984). Evstafieva et al. (1985) and Dontsova et al. (1994). 
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5S RNA that are required for integration into ribosomal subunits. To determine these 
requirements in Xenopus, I have analysed the ability of a series of mutant 5S RNA 
molecules to be incorporated into 60S ribosomal subunits after microinjection into 
the oocyte cytoplasm. This was assayed by immunoprecipitation using an anti-60S 
ribosomal subunit antibody. 
v. Description of 5S RNA Mutants used in this Study 
A summary of the 5S RNA mutants used in this study is shown in Figure 3-3. 
To test the importance of the highly conserved single stranded loops of 5S RNA, a 
series of mutant molecules were used which contained block substitutions in each of 
the loop regions. These substitutions maintain the single stranded secondary structure, 
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but with a different nucleotide sequence (Romaniuk, 1989). Mutants are designated 
by the nucleotides which have been substituted, for example, in mutant 10-13, 
nucleotides at positions 10 to 13 (CACA) have been substituted with the sequence 
UGCG. Another loop mutation, 96-101, has three nucleotide substitutions in the loop 
E region designed to increase the amount of Watson-Crick base pairs, to test the 
importance of the unusual conformation in this region of the molecule (Romaniuk, 
1989). 
A second group of mutant 5S RNA molecules contains mutations in the 
helical stem regions. These mutants also consist of block substitutions, on either side 
of a double helix, resulting in mismatches and the formation of single stranded 
regions. Double mutants contain compensating substitutions on both sides of the 
helix, thus restoring the helical stem structure, but with a different nucleotide 
sequence (You and Romaniuk, 1990). This allowed the importance of both the helical 
structure· and sequence to be tested for protein interactions. 
To test the importance of the bulged nucleotides for protein associations, 
mutants were tested in which the bulged nucleotides at position 49 and 50, 63 or 83 
were deleted (Baudin and Romaniuk, 1989). These mutants are referred to as A49,50, 
A63 and A83, respectively. 
Nucleotides at the junction of helices I, IT and V are highly conserved, and 
have been proposed to control the colinearity of helices IT and V (Romaniuk, 1989; 
Baudin et al., 1991). Two further 5S RNA mutants were therefore tested, in which 
nucleotides G66 and U109 were replaced with a cytidine and guanosine, respectively 
(Baudin et al., 1991), 
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Figure 3-3 Secondary structure of Xenopus laevis oocyte-type 5S RNA showing mutant nucleotide substitutions and deletions. (A) Single strand substitutions. Boxed 
nucleotides were replaced with the indicated nucleotides. The bulged nucleotides deleted at positions 49,50,63 and 83 are indicated in boxes. (B) Helix mutants. Only the 
relevant region of 5S RNA is shown; substituted nucleotides are indicated in boxes. 
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3.2 RESULTS 
To detennine the sequence and structural requirements of 5S RNA for 
fulfilling its various protein associations in vivo, mutant 3zP-Iabelled 5S RNAs were 
synthesised using 17 RNA polymerase-mediated in vitro transcription. The mutant 
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5S RNAs were microinjected into the cytoplasm of stage V-VI oocytes and incubated 
48 hours before analysis by immunoprecipitation or non-denaturing gel 
electrophoresis. Antisera for TFIIIA and 60S ribosomal subunits were kindly 
provided by Dr M. Ie Maire (CEA et CNRS, Gif-sur-Yvette, France). 
I. Characterisation of Antisera 
The anti-TFIIIA antiserum reacts specifically with TFillA; no cross-reaction 
was noted with any other protein by immunoblotting (Viel et al., 1990; Allison et al., 
1993). The anti-TFillA antiserum also recognises 7S RNPs: immunoprecipitation 
with the anti-TFillA antiserum of stage V oocytes labelled in vivo with eZp]GTP 
revealed coprecipitation of 5S RNA only (Fig. 3-4A, lane 1), whereas nonnal rabbit 
serum did not precipitate any RNA species (lane 5). The coprecipitability of 5S RNA 
was destroyed by prior treatment of oocyte extracts with proteinase K (lane 2), 
showing the antibody is specific for the protein component of 7S RNPs and does not 
recognise the naked 5S RNA molecule. 
The anti-60S ribosomal subunit antiserum detects two major bands in extracts 
of 60S ribosomal subunits: a 37 kD band corresponding to ribosomal protein L2; and 
a 14-15 kD protein which migrates similarly to ribosomal proteins in the range 
L17-L20 (Allison et al., 1993). This antiserum does not immunoprecipitate 7S RNPs 
(Allison et al., 1993), but does precipitate intact 80S ribosomes, as demonstrated by 
the presence of the 40S subunit RNA, 18S rRNA, in immunoprecipitates (data not 
shown), and the presence of proteins that react with and-40S ribosomal subunit 
antiserum (Allison et ai., 1993). 
In vivo labelling of oocytes with [32p]GTP overnight, followed by 
immunoprecipitation with the and-60S subunit antiserum did not precipitate 
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32P-Iabelled 5S RNA, although a higher molecular weight RNA, which is probably 
5.8S rRNA, was precipitated (Fig. 3-4A, lane 3). This RNA was not precipitated after 
proteinase K digestion (lane 4) or with normal rabbit serum (lane 5), indicating it is 
specifically precipitated with the anti-60S antiserum. The lack of 5S RNA in 
immunoprecipitates probably reflects the small amount of 5S RNA synthesised in 
stage V oocytes (as shown in immunosupernatant fractions in Figure 3-4B), and also 
the presence of a pool of unlabelled 5S RNA in the nucleus (see Chapter 4). Similar 
results were noted by Knight and Darnell (1967) in HeLa cells. 
n. Analysis of Mutant RNAS for Incorporation into 7S RNPS and 60S 
Ribosomal Subunits by Immunoprecipitation 
i. 7S RNP formation 
To assess the formation of 7S RNPs after injection of mutant 5S RNAs into 
the cytoplasm of oocytes, oocyte homogenates were immunoprecipitated with the 
anti-1FIIIA antiserum. The RNA was then extracted from the immunoprecipitates 
and analysed by polyacrylamide gel electrophoresis (pAGE) and autoradiography. 
Figure 3-5 shows the results of immunoprecipitation of a representative 
selection of 5S RNA mutants, and the complete results are presented in Table 3-1. 
Each mutant 5S RNA was assayed in a minimum of two different batches of oocytes. 
Since these assays are not quantitative owing to the large amounts of endogenous 
5S RNA and RNPs, RNP formation is expressed as either positive or negative in 
Table 3-1. Immunoprecipitates (Fig. 3-5A) of mutant 5S RNAs were compared with 
that of oocyte-type 5S RNA within each assay, as well as with immunosupernatant 
fractions (Fig. 3-5B). Immunosupernatants confIrmed that approximately equal 
amounts of each RNA were injected per oocyte, and showed that the injected RNA 
was stable. 
The majority of mutant 5S RNA molecules tested showed similar 7S RNP 
formation to oocyte-type (lane 1), for example, mutants 78-81 (lane 3) and L\49,50, 
L\63 and L\83 (lanes 15, 17 and 19, respectively). Out of the 32 mutant 5S RNAs 
Figure 3·4 Immunoprecipitation of endogenous oocyte RNAs with anti-TFIllA and anti-60S subunit 
antisera. Oocyte RNAs were labelled by injection of [32p]GTP into the cytoplasm of stage V oocytes 
followed by an overnight incubation. (A) Immunoprecipitations were performed with anti-TFIllA (7S). 
anti-60S ribosomal subunit (60S) antisera or with normal rabbit serum (NRS). Samples shown in lanes 
2 and 4 were subjected to digestion with proteinase K before immunoprecipitation. RNA was extracted 
from immunoprecipitates and analysed by 8 M urea/8% PAGE and autoradiography. Lane 6. a sample 
of 32p-Iabelled 5S RNA as a marker. (B) Immunosupernatant fractions were recovered from reactions 
in lanes 3 to 5 of panel A. Immunoprecipitates were exposed to X-ray film for four weeks. and 
immunosupematants for three weeks .. 
A B 
7S 60S NRS 5S 60S NRS 
, I , 
5S RNA· _ 
... 5S RNA 
1 2 345 6 11 2 3 
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tested, eight were not immunoprecipitated with the anti-TFIIIA antiserum. Three of 
these mutants, 10-13 (lane 9), C66 (lane 11) and G109 (not shown), with mutations 
centred around the loop A region of 5S RNA, agree with the in vitro binding data 
previously established for these mutants (Ka 0.30, 0.12 and 0.17 relative to oocyte-
type; Romaniuk, 1989; Baudin et ai., 1991). However, many of the mutants found 
defective for TFIIIA binding by immunoprecipitation, for example mutants 14-15 
(lane 7), 64-65 (not shown) and 67-70 (lane 5), do not show significantly impaired 
bindingaffmities for TFIIIA in vitro (see Appendix I; You and Romaniuk, 1990). 
Thus, to confmn the results of the immunoprecipitation assays, 7S RNP formation 
was also assayed by non-denaturing PAGE, as described in section ill. 
ii. 60S ribosomal subunit incorporation 
To test the ability of the mutant 5S RNAs to be incorporated into 60S 
ribosomal subunits after microinjection into the cytoplasm of oocytes, oocyte 
homogenates were immunoprecipitated with the anti-60S subunit antiserum. Figure 
3-5 shows the results of a representative set of mutant 5S RNA molecules after 
immunoprecipitation with anti-60S subunit antiserum. The complete results are 
presented in Table 3-1. As with the anti-TFllIA immunoprecipitations, these 
immunoprecipitations are qualitative only, because of the huge amounts of ribosomes 
which have accumulated by late oogenesis. The results are therefore presented as 
either positive or negative. Most of the mutant 5S RNAs were precipitated with this 
antiserum, indicating stable assembly into 60S subunits, for example mutants 78-81 
(lane 4), 67-70 (lane 6), 14-15 (lane 8), C66 (lane 12) and 883 (lane 20). Of the 32 
mutants tested, only four were reproducibly defective for incorporation into the 
60S subunit: mutant 10-13 (lane 10), which contains nucleotide substitutions in loop 
A; 96-101 (lane 14), where base substitutions have abolished the non-canonical base 
pairing in favour of Watson-Crick base pairs; and mutants 849,50 and 863 (lanes 16 
and 18), in which bulged nucleotides have been deleted. These results indicate that 
these regions of the 5S RNA molecule are important for assembly into the 
60S ribosomal subunit. 
Figure 3·5 Assembly of mutant 5S RNAs into 7S RNPs and 60S ribosomal subunits assayed by 
immunoprecipitation. 32p-Iabelled mutant 5S RNAs were microinjected into the oocyte cytoplasm. 
After 48 hr, homogenates of whole oocytes were immunoprecipitated with anti-1FIIIA (7S) or anti-
60s ribosomal subunit (60S) antisera. Labelled RNAs were recovered from immunoprecipitates (A) 
and immunosupernatants (B) and analysed by 8 M urea/8% PAGE and autoradiography. 
Immunoprecipitates were exposed to X-ray film for 3 weeks and immunosupematants overnight 
Numbers refer to those nucleotides which have been substituted or deleted (Fig. 3-3), 
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III. Analysis of Mutant RNAS for 7S RNP and SS RNP Formation 
by Non-denaturing PAGE 
i. 7S RNP formation 
48 
Since some of the 5S RNA mutants not immunoprecipitated with the anti-
TFIIIA antiserum showed near wild-type in vitro affinities for TFillA, formation of 
7S RNPs was also analysed by non-denaturing gel electrophoresis. Analysis of oocyte 
homogenates after injection of 32P-Iabelled 5S RNA reveals a band of free 5S RNA 
and two 5S RNA-containing species of slower mobility (Fig. 3-6), The identity of the 
slower of these two bands as corresponding to 7S RNPs was established by 
simultaneously running a sample of unlabelled purified 7S RNPs and staining with 
ethidium bromide (Allison et al., 1993). 
A selection of mutant 5S RNAs analysed by this method is shown in Figure 
3-6, and the complete results are summarised in Table 3-1. Only one mutant, 10-13, 
was shown to be defective for TFIIIA binding using this assay (lanes 3 and 4). The 
other seven 5S RNA mutants which were not immunoprecipitated with the anti-
TFIIIA antibody (Fig. 3-5) all show bands corresponding to 7S RNPs (lanes 5 to 11), 
although there is variation in the density of the bands. These conflicting results imply 
that 7S RNP complexes containing these mutant 5S RNAs were not recognised by 
the anti-TFIIIA antiserum, suggesting that they have an altered conformation. This is 
supported by closer examination of the mutant molecules in this category. Mutants 
C66 and 0109 contain substitutions of residues at the junction of helices I, II and IV, 
a region known to be important for the maintenance of the tertiary structure of 
5S RNA (Baudin et al., 1991). Also, mutants 73-76 and 96-101 contain modifications 
in the loop E region of the molecule, which is known to form a complex tertiary 
structure consisting of non-Watson-Crick base pairing (Westhof et al., 1989; 
Wimberly et al., 1993). The remaining three mutants, 64-65, 67-70 and 14-15 all 
contain base substitutions in one side of either helix II or V, thus destroying the 
helical structure of the molecule. Thus, all of these mutations have the potential to 
significantly alter the conformation of the 5S RNA and consequently that of the 
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resulting 7S RNP. It is also possible thatt although these mutants bind TFIllAt the 
RNP is less stable under the conditions of immunoprecipitation. AlternativelYt the 
positive results for these mutants revealed by non-denaturing electrophoresis could be 
due to the binding of another protein of similar size to TFIIIAt resulting in a 
complex with identical mobility to 7S RNPs. However, given that many of these 
mutant 5S RNAs showed in vitro binding affinities similar to wild type 5S RNA, and 
that there are no other known 5S RNA-binding proteins of this size in stage V 
oocytes, this explanation seems unlikely. 
The occurrence of 'false negativest' is not a concern with the anti-60S subunit 
antiserum. The ribosomal proteins recognised by this antiserum do not directly bind 
5S RNA and have not been localised to the same region of the 60S subunit as 
5S RNA. These proteins are therefore unlikely to be susceptible to any local 
conformational changes that may be induced in 60S subunits containing the mutant 
5S RNA molecules. 
In summary, only one mutant, 10-13, consisting of base substitutions in loop 
At out of the 32 mutant 5S RNA molecules tested in vivo, was completely defective 
for binding TFIITA after microinjection into the oocyte cytoplasm. 
ii. 5S RNP formation 
The binding of ribosomal protein L5 to 5S RNA to form a 5S RNP is thought 
to be a precursor to ribosome assembly in a wide range of organisms (Yu and 
Wittmann, 1973; Steitz et al., 1988; Allison et al., 1991; Deshmukh et al., 1993), and 
is also thought to play a role in targeting 5S RNA to the nucleus in Xenopus oocytes 
(Allison et al., 1991; 1993; K. J. Murdoch and L. A. Allison, submitted), Analysis of 
the results of non-denaturing PAGE of homogenised oocytes, after cytoplasmic 
microinjection of 32P-Iabelled 5S RNA, reveals an additional band of intermediate 
mobility between free 5S RNA and 7S RNPs (Fig. 3-6, lane 2), This band was 
shown to correspond to 5S RNA bound to L5 (Allison et al., 1995). Thus, this assay 
also provided a means of testing the mutant 5S RNAs for their ability to bind L5 
in vivo. 
Examination of the oocyte-type 5S RNA-containing complexes after non-
denaturing electrophoresis shows only a faint band corresponding to 5S RNPs: the 
Figure 3·6 Non-denaturing gel electrophoresis of mutant 58 RNAs showing formation of 58 RNPs 
and 78 RNPs. 32p·labelled mutant 58 RNAs were microinjected into the cytoplasm of oocytes. After 
incubation for 48 hr. oocyte homogenates were electrophoresed on 6% polyacrylamide gels containing 
0.1 % Triton X·I00. followed by exposure to X·ray film for 1 to 14 days. Numbers above the lanes 
refer to nucleotides which were substituted or deleted (Fig. 3-3). Lane 1. sample of 32p-Iabelled 
58 RNA as a marker. Lanes 3 and 4 show the results for mutant 10-13 in two different batches of 
oocytes. Lanes 2 to 6 and 7 to 12 represent experiments in which samples were electrophoresed for 
different lengths of time. 
78RNP 
78RNP 
58 RNP 58RNP 
58 RNA 58 RNA 
1 2 3 4 5 6 7 8 9 10 11 12 
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majority of 5S RNA is either bound to TFIIIA or exists free (Fig. 3-6, lane 2). This 
pattern of RNP formation was highly reproducible within many different batches of 
oocytes, irrespective of the amount of 5S RNA injected Analysis of the mutant 
5S RNA molecules reveals different patterns. For example, mutants 10-13 and 14-15 
(lanes 3, 4 and 6) show preferential binding to L5, with only low (14-15), or no 
(10-13) amounts of 7S RNP detectable. To take this variation into account, RNAs 
showing a strong preference for either L5 or TFllIA have been recorded in Table 3-1 
as "+++", whereas a single "+" merely denotes the presence of a particular RNP. 
All of the mutant 5S RNAs tested formed detectable complexes with L5 
(Fig. 3-6, lanes 2 to 12). These results concur with the in vitro binding data 
presented in Appendix I, where none of the mutants were significantly impaired for 
L5 binding (Q. You, W. Q. Zang, P. 1. Romaniuk, in prep.). 
52 
Table 3·1 Summary of incorporation of mutant SS RNAs into oocyte RNPs 
Immuno:Qreci:Qitationb Non-denaturing PAGE" 
Region of Molecule 5S RNA Mutant" anti 7S anti 60S 7S RNP 5SRNP 
Oocyte type + + +++ + 
Helix II 14-15 + + + 
64-65 + + + 
14-15/64-65 IR + + + 
16-21 + + ND ND 
57-62 + + + + 
16-21/57-62 + + + + 
Helix III 27-32 + + + + 
45-52 + + + + 
Helix IV 78-81 + + ND ND 
95-98 + + + + 
78-81/95-98 + + ND ND 
82-86 + + ND ND 
91-94 + + + + 
82-86/91-94 + + ND ND 
Helix V 67-70 + + + 
105-108 + + ND ND 
67-70/105-108 + IR + + 
71-72 + IR ND ND 
103-104 + + ND ND 
71-72/103-104 + + ND ND 
Loop A 10-13 + 
LoopB 22-26 + + + + 
LoopC 33-39 + + + + 
41-44 + + + + 
Loop D 87-90 + + + + 
Loop E 73-76 + + + 
96-101 + + 
Bulged nucleotides A49,50 + + + 
A63 + + + 
A83 + + + +++ 
Hinge nucleotides C66 + + + 
G109 + + + 
a The numbers in the designations refer to those 5S RNA nucleotides which have been substituted or 
deleted (Fig. 3-3), 
b Assays were perfonned as described in the legend to Figure 3-5. IR, inconclusive results due to RNA 
with low specific activity. 
cAssays were perfonned as descn'bed in the legend to Figure 3-6. A single U+U denotes the presence of 
a RNP, whereas "+++" indicates the RNA showed a strong preference for a particular RNP. ND, not 
determined. 
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3.3 DISCUSSION 
The results described above further characterise regions of the 5S RNA 
molecule important for protein binding and ribosome assembly within Xenopus 
oocytes. Surprisingly, the majority of introduced modifications were tolerated for the 
various interactions, and all of the mutant RNAs were stable in oocytes, probably 
because all could bind to either TFIllA or L5. 
I. TFllA Binding 
Of all the mutations tested, only one, with base substitutions at residues 10-13 
in loop A, was completely defective in binding TFIIIA, as judged by both 
immunoprecipitation and non-denaturing PAGE assays. This mutant has also been 
shown to have a low in vitro binding affinity to TFIllA (0.3 relative to oocyte-type; 
Romaniuk:, 1989). These results suggest that loop A either provides base-specific 
contacts for interaction with TFIllA, or is important in maintaining the correct 
conformation of 5S RNA for TFIllA binding. The former is not supported by 
numerous footprinting experiments conducted on the 5S RNA-TFIllA complex, 
where protection of loop A was never observed (Andersen et al., 1984b; Romaniuk:, 
1985; Huber and Wool, 1986a; Christiansen et al., 1987). It has been proposed, 
therefore, that the residues of loop A may act to orient helices II and V optimally for 
the interaction with TFIIIA (Romaniuk:, 1989; Baudin et al., 1991), 
Some of the results presented here do not completely correlate with the 
in vitro binding data, highlighting the importance of the cellular context. Several 
mutants with low in vitro binding affinities to TFIllA (similar to that of 10-13), for 
example C66, G109 and 41-44 (see Appendix I), were clearly capable of binding 
TFIllA in vivo. These results reflect the situation in the oocyte, where TFIIIA is not 
the only protein 5S RNA can bind to once injected into the oocyte cytoplasm, and 
where the mutants must compete with the endogenous, wild-type 5S RNA for protein 
binding. If mutants C66, G109 and 41-44 have an even lower affinity for another 
5S RNA-binding protein, for example LS, then they may be more likely to bind 
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TFllIA in the oocyte. It is interesting to note in this context that mutant 10-13 shows 
a high degree ofL5 binding in vivo, whereas C66, 0109 and 41-44 show moderately 
low levels of L5 binding. 
Many of the mutant 58 RNAs tested here have also previously been tested for 
their ability to compete with wheat germ 58 RNA in binding TFIDA (Baudin and 
Romaniuk:, 1989; Romaniuk, 1989; Baudin et al., 1991). These competition results 
are also presented in Appendix I. This assay is thought to provide a more sensitive 
indication of the specificity of the TFllIA-58 RNA interaction (Romaniuk:, 1985). 
Comparison of the in vitro competition strengths reveals that mutant 10-13 is 
approximately twenty-fold less effective in competing for TFIDA binding than wild-
type 58 RNA (Romaniuk:, 1989), whereas mutants C66 and 0109 show only a five-
fold reduction and mutant 41-44 showed only a two-fold reduction in competition 
strength compared with wild-type (Baudin et al., 1991). Thus, the differences 
observed in vivo between mutants 10-13 and C66, 0109 and 41-44 possibly reflect 
this difference in their ability to compete with endogenous, wild type 58 RNA. The 
above results emphasise the complexity of the intracellular setting, but also highlight 
the value of performing in vivo studies as a comparison with in vitro assays. 
II. LS Binding 
Analysis of the 58 RNA mutants tested showed that all were capable of 
binding L5 when injected into oocytes. These data are compatible with the in vitro 
binding data for these mutants presented in Appendix I, where the majority of 
mutants bound to L5 with near wild-type affinity (Q. You, W. Q. Zang, and 
P. J. Romaniuk:, in prep.). Mutants most severely impaired for L5 binding in vitro 
were 27-32 and 45-54 (Ka 0.52 and 0.54 relative to oocyte-type) located in helix ID. 
Both of these mutants were able to bind L5 in vivo. These results taken together 
suggest that the requirements of 58 RNA for L5 binding are less stringent than for 
TFllIA binding. 8imilar findings were also reported by Ouddat et al. (1990), where a 
series of mutant 58 RNAs containing internal deletions were expressed in oocytes. 
All of these deletion mutants were able to bind L5 to some degree, but none were 
able to bind TFIDA (although this was analysed by immunoprecipitation). 
Chapter 3 55 
Interestingly, the bulged cytidine at position 63 is not required for 5S RNA 
binding to L5 in Xenopus. In E. coli, where there are three 5S RNA-binding proteins, 
the equivalent residue at position 66 is highly important for L18 binding (Peattie 
et al., 1981; Christiansen et al., 1985). However, this bulged nucleotide was 
necessary for incorporation into the 60S ribosomal subunit in Xenopus (see below). 
Thus, although it has been proposed that the single eukaryotic 5S RNA-binding 
protein evolved from fusion of the genes encoding two or three of the prokaryotic 
5S RNA-binding proteins (Nazar et al., 1982), the results presented here suggest that 
the single eukaryotic 5S RNA-binding protein does not retain all of the properties of 
the three prokaryotic 5S RNA-binding proteins. 
ill. Assembly into 60S Ribosomal Subunits 
Four of the mutant 5S RNAs tested were not precipitated with the anti-60S 
ribosomal subunit antiserum, indicating that these mutants were not assembled into 
stable 60S subunits. These results indicate that binding to L5 is not sufficient for 
ribosome assembly, since all of the mutants defective in ribosome assembly formed 
5S RNPs in vivo. The mutants defective for ribosome incorporation identify four 
regions of the 5S RNA molecule that are essential for assembly into 60S ribosomal 
subunits, either by providing direct contacts for interaction with other ribosomal 
components, or by maintaining the necessary secondary or tertiary structure. It is of 
interest that each of these defective 5S RNAs contains changes or deletions of 
particular RNA structures which are known to be important in other RNA-protein 
interactions. Each of these is discussed below. 
i. Mutant 10-13 
Mutant 10-13, which contains nucleotide substitutions at positions 10, 11 and 
13 in loop A was not incorporated into 60S ribosomal subunits. Subsequent studies 
using mutant 5S RNAs with individual mutations in loop A showed that nucleotide 
substitutions at positions 11 and 13 impair the molecule for ribosome assembly 
(L. A. Allison and P. J. Romaniuk, in prep.). As discussed above, loop A is thought 
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to perfonn a major role in the coaxial stacking of helices n and V (Christiansen 
et al., 1987; Romaniuk, 1989; Baudin et al., 1991). In the molecular model of 
Westhof et al. (1989), the colinearity of helices n and V is constrained by a triple 
base interaction between A13, 066 and U109. It therefore seems plausible that 
mutant 10-13 is defective for ribosome incorporation because of an altered 
confonnation rather than due to a loss of sequence-specific contacts. 
56 
Base triple interactions have also been found to occur in other RNAs, where 
they are known to fix the relative orientations of helices, or to allow controlled 
relative motion of helices that are necessary for the biological function of the RNA 
(reviewed in Wyatt and Tinoco, 1993). Internal loops have also been shown to be 
important in protein binding to other RNAs. For example, E. coli ribosomal protein 
Ll recognises an internal loop in 23S rRNA and its own mRNA (reviewed in Draper, 
1989), and ribosomal protein S8 also binds a helix-loop-helix motif present in 
16S rRNA and its own mRNA (reviewed in Draper, 1989; Wu et al., 1994). 
ii. Mutants A49,50 and A63 
The secondary structure of 5S RNA from all species contains nucleotides 
bulged out of helical regions; in Xenopus these are at positions 49, 50, 63 and 83. 
Deletion of the bulged adenosines at positions 49 and 50, or of the cytidine at 63 
resulted in RNA molecules defective for ribosome assembly. Deletion of the bulged 
adenosine at position 83 had no effect on ribosome incorporation, indicating not all 
bulged nucleotides are necessary for integration. 
The bulged nucleotide corresponding to C63 also appears to be important for 
ribosome biogenesis or function in yeast: Strains expressing mutant 5S RNAs in 
which this nucleotide was deleted were not viable (Van Ryk et al., 1992). As 
discussed above, the bulged nucleotide in E. coli corresponding to C63 is critical for 
binding ribosomal protein L18 (Peattie et al., 1981; Christiansen et al., 1985). When 
this bulged nucleotide in E. coli was mutated from an adenosine to cytidine, the 
resulting RNA was still able to bind L18, and to be assembled into 50S subunits 
(Meier et al., 1986). This result suggests that the actual identity of the bulged residue 
is not important, but that it confers a confonnational structure that is recognised by 
L18 or other ribosomal proteins. This is supported by the observation that the 
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identity of this bulged nucleotide varies among the major phylogenetic divisions: 
adenosine in aerobic bacteria and yeast; cytidine in animals; and uridine in plants 
(Peattie et al., 1981). Bulged nucleotides are thought to introduce axial kinking in 
RNA duplexes, and nuclear magnetic resonance spectroscopy has shown that single 
base bulges are usually stacked within the helix (Lilley, 1995), further suggesting 
conformational features are responsible for protein recognition. 
Bulged nucleotides have been found to be part of the RNA structure 
recognised by a growing number of proteins. For example, the bacteriophage R17 
coat protein represses translation by binding a hairpin loop structure containing a 
bulged adenosine in the R17 RNA (Romaniuk et al., 1987b; Wu and Uhlenbeck, 
1987). This bulged adenosine could also be substituted with guanosine without 
affecting coat protein binding, and it was suggested that the bulged residue was 
intercalated into the helix (Wu and Uhlenbeck, 1987). Other examples of bulged 
nucleotides having a role in protein interactions are found in the binding of Ro 
protein to hY RNA (Pruijn et al., 1991) and in the iron-responsive-element binding 
protein interaction with its cognate RNA (Jaffrey et al., 1993; Henderson et al., 
1994). 
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One of the most studied RNA-protein interactions is that between the human 
immunodeficiency virus type 1 (HIV-l) regulatory protein, Tat, and a sequence at the 
5' terminus of all mv transcripts, known as the trans-activation-responsive region 
(TAR). The binding site for Tat on TAR RNA is defined by a uracil-rich 
trinucleotide bulge located on a hairpin stem. Essential residues for Tat recognition 
are one uracil within the bulge and two base pairs immediately above the bulge 
(Weeks and Crothers, 1991; reviewed in Gait and Karn, 1993). The mv type 2 Tat 
protein (Tat-2) also recognises stem-loop structures in the HIV-2 TAR RNA. In this 
case, two dinucleotide bulges are responsible for protein recognition (Rhim and Rice, 
1994). 
The size of the HIV -1 TAR RNA bulge was shown to be important for 
recognition by Tat. Mutants with bulges of two or three residues bound with similar 
affmity, whereas bulges of one or four nucleotides bound with lower affinity (Weeks 
and Crothers, 1991). These workers proposed a model in which the presence of 
bulges of two or three uracil residues distorts the conformation of the sugar-
phosphate backbone sufficiently to widen the major groove to allow interactive 
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access of amino acid side chains. This hypothesis is supported by studies with diethyl 
pyrocarbonate (DEPC) and Rh(phen)z(phi)3+, which can be used to assess the 
accessibility of regions of RNA to proteins. Results showed that positions abutting 
bulges of two or three nucleotides were readily accessible, whereas RNA with no 
bulges or one nucleotide bulges showed little or no reactivity to these probes (Weeks 
and Crothers, 1993; Neenhold and Rana, 1995). 
It is thus possible that the adenosine dinucleotide bulge at positions 49 and 50 
of 5S RNA allows binding of ribosomal proteins in helix ill by widening the major 
groove, analogous to Tat binding TAR RNA. Support for this hypothesis comes from 
experiments in which 5S RNA was probed with Rh(phenMphi)3+, which promotes 
strand cleavage at accessible sites in the major groove. Sites of cleavage included 
helix ill, opposite the dinucleotide bulge, but not at sites of single nucleotide bulges 
(Chow et al., 1992). Deletion of the dinucleotide bulge would result in a perfect 
A-form RNA helix, with the major groove inaccessible for protein interactions, 
thereby preventing necessary associations for ribosomal subunit assembly. 
iii. Mutant 96-101 
The structure of the loop E region of 5S RNA has been the subject of much 
investigation, with several conformational models put forward. Although differing in 
details, all of the models propose the existence of non-canonical base pairs, of the 
A-A, U-U and A' G types (Andersen et al., 1984a; Romaniuk et al., 1988; Westhof 
et al., 1989; Wimberly et al., 1993). The model proposed by Wimberly and 
colleagues is shown in Figure 3-1B. The unusual structure of the loop provides a 
number of easily recognisable potential protein binding sites: the bulged guanosine at 
position 75 in the major groove; the convoluted backbone of the 5' strand; and the 
narrow groove widths (Wimberly et al., 1993). Similar RNA loop motifs have 
subsequently been identified in many RNAs, including 28S rRNA (sarcin/ricin loop; 
Szewczak et al., 1993), 16S and 23S rRNAs, the central conserved region of viroid 
RNAs and also in the self cleaving RNA of the hairpin ribozyme (reviewed in 
Wimberly, 1994), This motif has been hypothesised to play an important role in 
specifying the tertiary structure of RNAs or perhaps the quaternary structure of some 
intermolecular RNA interactions (Wimberly, 1994), 
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Mutant 96-101 was constructed to allow the fonnation of canonical Watson-
Crick base pairs, extending helix N through the loop E region to helix V 
(Romaniuk, 1989). As shown here, these changes resulted in a 5S RNA molecule 
defective for ribosome assembly. Mutant 73-76, which contains base substitutions on 
the 5' side of loop E which retain the single-stranded nature of the region, was 
competent for ribosome assembly. In addition, subsequent experiments using a 
mutation with base substitutions on the 3' side of loop E, which also retained the 
single stranded nature of the loop, showed that this mutant was competent for 
ribosome assembly (L. A. Allison and P. J. Romaniuk, in prep.). These results imply 
that the actual structure fonned by the non-canonical base pairs, abolished in mutant 
96-101, provide an important confonnational feature for protein recognition, rather 
than specific sequence requirements. 
The importance of non-canonical base pairing for protein recognition has also 
been demonstrated for the HN regulatory protein Rev, which binds to the Rev-
responsive element (RRE) found in certain viral mRNAs. An important structural 
feature of RRE RNA for Rev binding is a stem-bulge-stem structure, with G' G and 
G'A type non-canonical base pairs within the bulge (Bartel et al., 1991). Analogous 
to the model for loop E in 5S RNA, the fonnation of these non-canonical base pairs 
predicts a single bulged uracil residue. Since an A·A pair was able to functionally 
replace the G' G pair, it was proposed that the non-canonical base pairs distort the 
sugar-phosphate backbone, allowing sufficient opening of the major groove for 
specific recognition (Bartel et al., 1991; reviewed in Gait and Karn, 1993). This was 
also supported by molecular modelling studies (i.e et al., 1994). 
iv. Functional implications 
The results presented here do not address the ability of the 60S subunits 
containing the mutant 5S RNAs to function in protein synthesis. However, some 
correlations can be made with the results of other functional studies. Probing of 
5S RNA within mouse 60S subunits and 80S ribosomes showed that regions of 
5S RNA that were accessible were located in loops C and D, as well as the bulged 
nucleotide at position 83 (Holmberg et al., 1992), suggesting that they do not interact 
directly with other ribosomal components. This correlates with the results presented 
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here, where mutations in these regions did not affect assembly into 60S subunits 
(although these results only show that the sequences of these loops are not essential: 
further studies by L. A. Allison and P. J. Romaniuk [in prep.] have shown that the 
single-stranded nature of loops B and C is essential for ribosome assembly). Loop C 
is also the region of 5S RNA which has been postulated to interact with tRNA 
(Erdmann, 1976), so would need to be exposed for this interaction. Probing of 60S 
subunits from rat with DEPC also identified an additional cleavage site at adenosine 
11 (loop A; Lo and Nazar, 1982). Since this residue is contained within the mutation 
10-13, which was defective in ribosome assembly, this provides further evidence that 
loop A is critical for maintenance of the tertiary structure of 5S RNA, rather than 
providing base-specific contacts for ribosome assembly. 
These results also do not distinguish between the formation of 60S subunits 
and 80S ribosomes. Since the bulk: of stored ribosomes in Xenopus oocytes are in the 
form of 80S ribosomes (Miller, 1974; Dixon and Ford, 1982b), binding to the 
40S subunit may be critical for the stability of 60S subunits containing mutant 
5S RNAs. It is of interest then, that mutations 10-13 and 96-101 both lie within 
regions of 5S RNA that have been shown to base pair with 18S rRNA in vitro (Sarge 
and Maxwell, 1991). It is possible that 5S RNA containing these mutations is 
assembled into 60S subunits, but that these subunits are not stable as they can not 
interact with 40S subunits. 
The results presented in this chapter indicate that more than one region of the 
5S RNA molecule is important for ribosome assembly, suggesting the RNA may 
interact with more than one other ribosomal component. The secondary/tertiary 
conformation appears to be more important than the nucleotide sequence, with 
structures such as bulges, loops and non-canonical base pairs providing opportunities 
for protein recognition. 
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DISTRIBUTION OF 5S RNA WITHIN THE 
XENOPUS OOCYTE NUCLEUS 
4.1 INTRODUCTION 
To be assembled into ribosomes, stored 5S RNA must fIrst be imported into 
the oocyte nucleus and targeted to the nucleoli, the sites of ribosome biogenesis. The 
mechanism by which 5S RNA is targeted to nucleoli and incorporated into 
assembling 60S subunits is largely unknown. In the preceeding chapter, the necessary 
sequences and conformational structures of 5S RNA for protein associations in the 
cytoplasm, and for assembly into ribosomal subunits were investigated. Four mutant 
5S RNA molecules were found to be defective for ribosome incorporation. As 
discussed in Chapter 3, the defective ribosome incorporation observed for these 
mutants may have resulted from conformational changes within the 5S RNA 
structure, rendering it unable to perform interactions necessary for integration into the 
60S subunit. Alternatively, the lack of ribosome incorporation may have resulted 
from an earlier step of the 5S RNA pathway, such as nuclear import or nucleolar 
targeting. All of the mutant 5S RNA molecules were previously shown to be capable 
of nuclear import (data presented in Appendix I; Allison et al., 1993; L. A. Allison 
and P. J. Romaniuk, in prep.). To determine whether the deficiency in ribosome 
assembly was due to defective nucleolar targeting, and to gain insight into the 
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process by which 5S RNA is incorporated into the 60S ribosomal subunit, I have 
investigated the distribution of endogenous and exogenous wild-type and mutant 
5S RNAs, as well as 5S RNA-protein associations within the nucleus of Xenopus 
oocytes. 
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In order to investigate the process by which 5S RNA is incorporated into 
60S subunits, an understanding of the site and process of ribosome synthesis is fIrst 
necessary. The following sections review the structure and function of the nucleolus, 
describe some common nucleolar components, and fInally review how these 
components are targeted to the nucleolus. 
I. Structure and Function of the Nucleolus 
In eukaryotes, ribosome biogenesis takes place within a specialised organelle, 
the nucleolus. Mature ribosomes are synthesised via a series of ordered steps, the 
general outline of which is shown in Figure 4-1. The nucleolus is the most prominent 
feature of the interphase nucleus. Although not bound by a membrane, it is 
exceedingly well defined, and appears refractile when viewed with phase contrast 
microscopy. It consists of three main components when viewed at the electron 
microscopic level: the fibrillar centre, the dense fibrillar component and the granular 
component. The fibrillar centre, named for the presence of five nanometre fibrils, is 
usually spherical, and has a low electron density. It is surrounded by the dense 
fIbrillar component, which is also made up of five to ten nanometre fibrils. These 
fibrils are densely packed, causing a higher electron opacity. The dense fibrillar 
component is in turn surrounded by the granular component, which consists of 
loosely packed granules approximately fifteen nanometres in diameter, which closely 
resemble cytoplasmic ribosomes (reviewed in Goessens, 1984; Hadjiolov, 1985; 
Wachtler and Stahl, 1993). The arrangement of these components within nucleoli is 
variable and dynamic, depending on the species, cell type and physiological state of 
the cell. Current models propose that the ultrastructural components of the nucleolus 
are not fIxed, but are fonned by the transcription and subsequent processing of rRNA 
molecules (Dundr et al., 1995; Hozak, 1995; Shaw et al., 1995). 
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In Xenopus oocytes the rRNA genes are selectively amplified, resulting in the 
formation of approximately 1500 nucleoli per nucleus (Brown and Dawid, 1968; 
Perkowska et al., 1968). These extrachromosomal nucleoli consist of inner fibrillar 
cores, surrounded with a granular cortex, similar to those of somatic cell nucleoli 
(Thomas, 1972; Van Gansen and Schram, 1972), In many cells, including Xenopus 
oocytes, nucleoli have been located close to, or in contact with the nuclear membrane 
(Bourgeois and Hubert, 1988). This has been postulated to facilitate the nuclear 
export of mature ribosomal subunits from the nucleolus to the cytoplasm. 
The function of each of the three main nucleolar components has been the 
subject of intensive research, and has been extensively reviewed (Hadjiolov, 1985; 
Scheer and Benevente, 1990; Warner, 1990; Fischer et al., 1991a; Wachtler and 
Stahl, 1993; Risuefio and Testillano, 1994; Hozak, 1995; M6lese and Xue, 1995). 
Early studies using short term labelling with tritiated uridine showed that the dense 
fibrillar component was labelled before the granular component, suggesting a 
precursor-product relationship between the two (Granboulan and Granboulan, 1965). 
The actual location of the rDNA and the site of rRNA transcription have been 
controversial for many years, with some workers advocating the fibrillar centres and 
others the dense fibrillar component. More recently, non-isotopic ultrastructural 
methods have revealed that rRNA transcription appears to occur mainly within the 
dense fibrillar component, or at the border between the dense fibrillar component and 
the fibrillar centres (Dundr and Raska, 1993; Schofer et al., 1993; Hozak et al., 1994; 
Raska et al., 1995). 
Transcription of rDNA in eukaryotes yields a primary pre-rRNA transcript of 
35-47S, depending on the species. The general arrangement of sequences within this 
transcript, from 5' to 3' are: 5' external transcribed spacer (5' ETS), 18S rRNA, 
internal transcribed spacer 1 (ITSl), 5.8S rRNA, internal transcribed spacer 2 (ITS2), 
28S rRNA, 3' external transcribed spacer (3' ETS; reviewed in Eichler and Craig, 
1994). Mature 18S, 5.8S and 28S rRNAs are produced by a series of endonucleolytic 
and exonucleolytic cleavages, which generally occur from the 5' to 3' end of the 
nascent transcript. The order and intermediates generated during processing varies 
among species, as well as with growth and development in the same species 
(reviewed in Eichler and Craig, 1994). For example, in Xenopus oocytes, two 
alternative rRNA processing pathways were shown to coexist in the same cell 
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(Savino and Gerbi, 1990). Detailed understanding of the mechanisms of the 
processing steps is currently limited. Proteins thought to be involved in processing 
include fibrillarin, NOPl, GAR-I, SSBI and RNase MRP (reviewed in Eichler and 
Craig, 1994). In addition, a series of small nucleolar RNAs (snoRNAs) have been 
identified and proposed to function in rRNA processing (reviewed in Maxwell and 
Fournier, 1995). For example, in Xenopus, U3 snoRNA is necessary for cleavage of 
the 5' ETS segment (Mougey et al., 1993), U3 and U8 both influence processing at 
the ITSI-5.8S boundary (Savino and Gerbi, 1990; Peculis and Steitz, 1993), and U8 
is required for cuts on the 3' side of 5.8S rRNA and both ends of 28S rRNA (Peculis 
and Steitz, 1993). U22 (also called RNA Y) is necessary for 18S rRNA maturation 
(Tycowski et al., 1994). 
In addition to processing, pre-rRNAs are also modified, including base and 
ribose methylations and pseudouridylation. These modifications are non-randomly 
distributed within rRNA sequences, and are clustered at evolutionarily conserved, 
functionally important sites. Possible roles of these modifications include serving as 
recognition signals for processing sites, effectors of rRNA conformation, and binding 
sites for specific proteins that effect the assembly of ribosomal subunits (reviewed in 
Maden, 1990; Eichler and Craig, 1994). 
The fourth ribosomal RNA, 5S RNA, is transcribed from genes that are not 
nucleolar-associated (reviewed in Hadjiolov, 1985). Thus, 5S RNA must first be 
targeted to the nucleolus for ribosome incorporation. In Xenopus oocytes, where 
5S RNA is stored in the cytoplasm, it must first be imported into the nucleus. 
Similarly, the ribosomal proteins which are synthesised in the cytoplasm must also be 
imported into the nucleus and targeted to the nucleolus for ribosome assembly 
(Fig. 4-1). 
The actual steps of rRNA processing and ribosomal subunit maturation that 
take place within each nucleolar component remain to be elucidated. As the rRNA is 
transcribed, it is immediately coated with ribosomal and non-ribosomal proteins 
(Kumar and Warner, 1972; Chooi and Leiby, 1981). Thus, when the primary 
pre-rRNA transcript is released from the DNA template it is already assembled in the 
form of a preribosomal particle. Two types of preribosomal particles were initially 
identified in HeLa cells: an 80S particle containing the 45S pre-rRNA, and a 
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Figure 4·1 Ribosome biosynthesis in a typical eukaryotic cell. The diagram shows the various 
stages of ribosome synthesis and where each stage is thought to occur within the nucleolus. FC, 
fibrillar centre; DFC, dense fibrilIar component; GC, granular component. rRNA transcription is 
shown to occur in the dense fibrillar component, at the border of the fibrillar centre. 5S RNA is 
incorporated in the dense fibrillar component, and is present in the 55S preribosomal particle. See 
text for references. 
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55S particle, containing 32S pre-rRNA, which is thought to be a precursor particle to 
the 60S ribosomal subunit (Warner and Soeiro, 1967). Similar complexes have since 
been identified in other species, including amphibian oocytes (Rogers, 1968; 
reviewed in Hadjiolov, 1985). 
Recently, Shaw et al. (1995), using in situ hybridisation and parallel electron 
microscopy on pea root cells, revealed the presence of the external transcribed spacer 
in the dense fibrillar component only, whereas a probe to the entire 45S pre-rRNA 
showed a higher concentration in the surrounding granular component. Since excision 
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of the external transcribed spacer is one of the first pre-rRNA processing events, 
these results suggest that only the very early rRNA processing steps occur in the 
dense fibrillar component, with the remainder of maturation steps occurring in the 
granular component. 
66 
The finding that 5S RNA was present in 55S preribosomal particles indicated 
that 5S RNA is incorporated into ribosomes at an early stage of assembly (Knight 
and Darnell, 1967; Warner and Soeiro, 1967). This was further substantiated by 
recent ultrastructural mapping of 5S RNA, using in situ hybridisation, to both the 
granular component and the dense fibrillar component in HeLa cell nucleoli (Raska 
et al., 1995). 
IT. Nucleolar Proteins 
Since the dense fibrillar component is surrounded by the granular component, 
the site of 5S RNA integration into preribosomal subunits may not be readily 
accessible from the outside of the nucleolus. It could be proposed therefore that 
5S RNA interacts with other nucleolar components which act as receptors, and 
provide a pathway to the site of integration into preribosomal particles. Many non-
ribosomal, nucleolar proteins have been identified which are essential for ribosome 
biogenesis in eukaryotes, although their exact roles are unknown. None of these 
proteins have been shown to interact directly with 5S RNA, although some are 
associated with preribosomal particles containing 5S RNA (see below). Four 
nucleolar proteins which are known to have roles in ribosome biogenesis, and which 
may interact with 5S RNA/5S RNPs en route to the ribosome are described in detail 
below (summarised in Table 4-1), followed by a brief description of other proteins 
identified in the nucleolus to date. 
Fibrillarin, named because of its location within fibrillar regions of the 
nucleolus, is a 34 kD protein found in all eukaryotes (Ochs et al., 1985), including 
yeast, where it is called NOPI (Schimmang et al., 1989). Fibrillarin antibodies 
coprecipitate small nucleolar RNAs, including U3 (Lischwe et al., 1985), U8 and 
U13 (Tyc and Steitz, 1989), as well as U14, U15, U16, U18, U20, U21, U22 and 
U24 (reviewed in Maxwell and Fournier, 1995). Mutations of NOP1 in yeast 
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revealed roles in pre-rRNA processing, pre-rRNA methylation and ribosome 
assembly (Tollervey et al., 1993). 
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B23 (also called nucleophosmin, numatrin, ribocharin, and N038 in Xenopus) 
is a 38 kD phosphoprotein which has been localised to the dense fibrillar and 
granular components of the nucleolus in a variety of different cell types (Spector 
et al., 1984; Htigle et al., 1985; Schmidt-Zachmann et al., 1987; Biggiogera et al., 
1989). B23 contains two domains rich in aspartic and glutamic acid, and the amino-
terminal 124 amino acids show similarity to Xenopus nucleoplasmin. B23 binds to 
double and single stranded DNA and to rRNA via sequences at its carboxy-terminus 
(Wang et al., 1994), exhibits RNA helix destabilising activity (Dumbar et al., 1989), 
and has been shown to form stable oligomers in vitro and in vivo (Schmidt-
Zachmann et al., 1987; Chan and Chan, 1995). In further studies, B23 was shown to 
be associated with the induction of proliferation in B lymphocytes (Feuerstein and 
Mond, 1987), stimulated the activity of DNA polymerase-a (Takemura et al., 1994), 
and also formed a complex with the transcription factor YY1, thus reversing 
transcriptional repression induced by YY1 (Inouye and Seto, 1994). B23, and an 
isoelectric variant initially termed ribocharin, have been found associated with 
80S and 55S preribosomal components in HeLa cells and with 60S subunit precursor 
particles in Xenopus laevis oocytes, respectively (Htigle et al., 1985; Yung et al., 
1985). Finally, B23 was recently shown to have ribonuclease activity, suggesting it 
may playa role in rRNA processing (Herrera et al., 1995). 
Another abundant nucleolar protein is nucleolin (also called C23; homologues 
in Saccharomyces cerevisiae and Saccharomyces pombe are called NSRI and GAR-2, 
respectively), which is present in all eukaryotes and has a molecular weight ranging 
from 92-105 kD (Hernandez-Verdun, 1991). Nucleolin has three distinct domains: an 
acidic amino-terminal region, four RNA-binding motifs and a glycine-rich carboxy-
terminus (Lapeyre et ai., 1987; Caizergues-Ferrer et ai., 1989). Nucleolin is localised 
to the dense fibrillar and granular components of nucleoli (Biggiogera et ai., 1989), 
and binds to DNA (Olson et ai., 1983), including matrix-associated regions 
(Dickinson and Kohwi-Shigematsu, 1995), and to the external transcribed spacer of 
pre-rRNA via interactions with its RNA recognition motifs (Ghisolfi et ai., 1990; 
1992; Gamberi et ai., 1994). In addition, other described activities of nucleolin 
include chromatin condensation, feedback regulation coupling rDNA transcription 
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Table 4-1 Nucleolar proteins involved in ribosome assembly 
Protein Nucleolar Activities! Reference 
Componen~ Functions 
Fibrillarin FC andDFC Association with snoRNAs; Lischwe et 01., 1985 
rRNA processing and Tollervey et 01., 1993 
methylation 
B23/nucleophosmin/ DFC andGC Associated with preribosomal Hugle et 01., 1985 
N038 subunits; 
Binds DNA and rRNA; Wang et 01., 1994 
Destabilisalion of RNA helices; Dumbar et 01., 1989 
Induction of lymphocyte Feuerstein and Mond, 
proliferation; 1987 
Stimulation of DNA Takemura et 01., 1994 
polymerase-a; 
Ribonuclease activity; Herrera et aI., 1995 
Shuttles between cytoplasm and Borer et 01., 1989 
nucleolus; 
Binds NLSs Goldfarb, 1988 
Nucleolin/C23 DFC andGC Binds DNA; Olson et 01., 1983 
Binds pre-rRNA; Ghisolfi et 01., 1992 
Associated with matrix-associated Dickinson and Kohwi-
regions; Shigematsu, 1995 
Shuttles between cytoplasm and Borer et 01 .• 1989 
nucleolus; 
Binds NLSs Xue et 01., 1993 
Noppl40/xNoppl80 DFC Shuttles between cytoplasm and Meier and Blobel, 1992 
nucleolus; 
Binds NLSs Meier and Blobel, 1990 
.. FC. fibrillar centre; DFC, dense fibrillar component; GC, granular component See text for references. 
with rRNA processing, and binding to preribosomes containing 45S pre-rRNA 
(reviewed in Gerbi et al., 1990). Also, the yeast homologues, NSRI and GAR-2, are 
necessary for formation of 18S rRNA and 40S subunit assembly (Lee et ai., 1992; 
Gulli et al., 1995). 
Another nucleolar protein which was identified in rat is Nopp14O (nucleolar 
phosphoprotein of 140 ill; Meier and Blobel, 1990; 1992), a homologue of which 
has recently been cloned in Xenopus, called xNopp180 (Cairns and McStay, 1995). 
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Nopp140 contains a ten-fold repeated motif of highly conserved acidic serine clusters 
that contain an abundance of phosphorylation consensus sites for casein kinase II. 
and is localised to the dense fibrillar component (Schmidt-Zachmann et al .• 1984; 
Meier and Blobel, 1992). 
In addition to being non-ribosomal, nucleolar proteins, the above three 
. phosphoproteins, B23, nucleolin and Nopp140 share two further characteristics: each 
has been shown to shuttle between the nucleolus and cytoplasm (Borer et al., 1989; 
Meier and Blobel, 1992), and each has been shown to specifically bind to the nuclear 
localisation sequences from either the SV -40 large T antigen or histone H2B 
(Goldfarb. 1988; Meier and Blobel, 1990; Lee et al., 1991; Xue et al., 1993; Szebeni 
et ai., 1995). It has therefore been suggested that these proteins act as chaperones, 
either targeting ribosomal proteins to the nucleolus, mediating ribosomal protein 
interaction with rRNA, or facilitating the export of ribosomal subunits to the 
cytoplasm. However, there is no direct evidence for any of these postulated functions. 
Other proteins found in the nucleolus include those involved in rRNA 
transcription, such as RNA polymerase I and the transcriptional activator, UBF 
(upstream binding factor); proteins and RNPs necessary for rRNA processing, such as 
the product of the Saccharomyces cerevisiae NOP41NOP77 gene (Berges et al., 1994; 
Sun and Woolford, 1994) and 7-2 RNP (Reimer et al., 1988); and a prolyl cis-trans 
isomerase (NP146), proposed to be involved in the assembly or folding of ribosomal 
proteins (Shan et al., 1994). In addition, many proteins whose functions in this 
organelle are as yet unknown have been localised to the nucleolus. These include 
topoisomerase II (Fischer et al., 1993); three Hox homeoproteins (Corsetti et al., 
1995); fibroblast growth factor 3 (Kiefer and Dickson, 1995); the interferon-inducible 
autoantigen, IFI 16 (Dawson and Trapani, 1995); protein p120, which plays a role in 
proliferation-associated nucleolar activity (Valdez et al., 1994); and angiogenin, a 
potent inducer of angiogenesis (Moroianu and Riordan, 1994). In addition, many viral 
proteins have been found to be localised to the nucleolus of infected cells. The 
human T-cell leukaemia virus type I (HTLV-I) regulatory protein Rex (also called 
p27x-m), the mv Rev and Tat proteins, Semliki Forest virus capsid protein, and the 
herpes simplex virus regulatory protein, ICP27 all localise to nucleoli (Hauber et al., 
1987; Siomi et al., 1988; Felber et al., 1989; Jakob, 1993; 1994; Mears et al., 1995). 
Two of these proteins, Rev and Rex, have been shown to specifically associate with 
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protein B23 in vitro (Fankhauser et al., 1991; Adachi et al., 1993; Szebeni et al., 
1995), and Rev has also been shown to shuttle between the nucleolus and cytoplasm 
(Meyer and Malim, 1994). 
Ill. Nucleolar Targeting 
The mechanism by which ribosomal proteins and 5S RNA are localised to 
nucleoli for ribosome assembly are currently unknown. Ribosomal protein L5 bound 
to 5S RNA is a precursor to ribosome assembly in a range of cell types (Steitz et al., 
1988; Allison et al., 1991; Deshmukh et al., 1993). In Xenopus oocytes, L5 is 
thought to bind 5S RNA in the cytoplasm and to mobilise it for nuclear import and 
ribosome assembly (Allison et al., 1991). Targeting of 5S RNA to nucleoli could 
therefore be conferred by sequences or structures within the RNA or protein moieties 
of the RNP, or a combination of the two. The following sections review current 
knowledge on the process of targeting of proteins and RNAs to the nucleolus. 
i. Nuclear import 
The first requirement for the nucleolar targeting of molecules that are 
synthesised (for example, proteins) or stored (for example, 5S RNA) in the 
cytoplasm, is nuclear import. Nuclear import is an active process which occurs 
through the nuclear pore (reviewed in Stochaj and Silver, 1992; Agutter and 
Prochnow, 1994). Nuclear import of proteins is conferred by the presence of a 
nuclear localisation sequence (NLS) within the protein, of which there are two main 
types: short sequences of four to seven basic amino acids, as typified by the Simian 
virus 40 (SV-40) large T antigen NLS (Kalderon et al., 1984a,b); and a bipartite NLS 
consisting of two sequences of basic amino acids separated by ten less conserved 
spacer amino acids, as typified by the nucleoplasmin NLS (Robbins et al., 1991), By 
definition, NLSs are both necessary and sufficient for nuclear import: deletion of the 
NLS abolishes import of the resulting protein, and fusion of the NLS to a 
heterologous, cytoplasmic protein confers nuclear localisation on that protein. 
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The nuclear transport of most RNAs is thought to occur in association with 
proteins (for example, Mehlin et al., 1992). Thus, nuclear import signals of RNA-
protein complexes could reside either in the amino acid sequence of the protein, in 
the nucleotide sequence of the RNA, or in a combination of the two. As an example, 
the nuclear import of VI small nuclear RNA (snRNA) requires the 
. triroethylguanosine cap structure as well as the binding site for the common 
Sm proteins (Fischer and Liihrmann, 1990; Hamm et al., 1990). The nuclear import 
of V2 snRNA also requires the trimethylguanosine cap, but the import of V4 and V5 
appears to have a less stringent requirement for this cap structure (Fischer et al., 
1991b). 
Other factors involved in nuclear import include the nuclear pore targeting 
complex which consists of two subunits, importin-a and B (also called karyopherin a 
and B; Radu et al., 1995). Jmportin-a binds to NLSs, and together with importin-B, 
targets nuclear import substrates to the nuclear pore (reviewed in Simos and Hurt, 
1995). Also involved in nuclear import is the GTP-binding protein Ran{I'C4 (Ras-
related nuclear protein), which forms a complex with a dimer of a protein called 
Ranip (Ran-interacting protein), and mediates the translocation of nuclear pore-
docked karyophilic substrates into the nucleus (reviewed in Simos and Hurt, 1995). 
In Xenopus oocytes, ribosomal protein L5 has been suggested to mobilise 
stored 5S RNA for import into the nucleus (Allison et al., 1991). Preassembled 
5S RNPs have been shown to be imported into the nucleus at a faster rate and to a 
higher extent than free 5S RNA, suggesting that binding to L5 is a prerequisite for 
nuclear import (K. J. Murdoch and L. A. Allison, submitted), Also, competition 
assays showed that nuclear import of 5S RNA was inhibited by the presence of 
excess P(lys)-BSA, a synthetic karyophilic protein which contains the SV-40 
T antigen NLS, but not by excess VI snRNA or V3 snoRNA (K. J. Murdoch and 
L. A. Allison, submitted). These results suggest that 5S RNA follows a similar 
pathway to many karyophilic proteins, rather than other RNA pathways for nuclear 
import. 
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ii. Nucleolar localisation 
a. Proteins 
Once inside the nucleus, at least two mechanisms can be envisioned whereby 
molecules are localised to the nucleolus: 1) nucleolar targeting occurs via a signal-
dependent, possibly active mechanism, involving energy and nucleoplasmic receptors 
which function in transporting molecules to the nucleolus, or 2) since the nucleolus is 
not membrane bound, nucleolar localisation could occur by diffusion through the 
nucleoplasm and retention at nucleoli due to associations with other nucleolar 
components. 
Initially, studies perfonned on the nucleolar targeting of viral proteins in 
mammalian cells supported the fonner mechanism. For example, a highly basic 
amino acid sequence at the amino-tenninus of the Rex protein was shown to confer 
nucleolar localisation on E. coli B-galactosidase (Siomi et al., 1988). Similar basic 
sequences were subsequently identified in the HIV proteins Rev and Tat, and in the 
herpes simplex virus protein ICP27, which could also direct nucleolar localisation 
when fused to cytoplasmic proteins (Kubota et al., 1989; Cochrane et al., 1990; 
Siomi et al., 1990; Mears et al., 1995). 
However, subsequent targeting studies using cellular nucleolar proteins 
revealed that the requirements for nucleolar localisation were not so simple. For 
example, nucleolar localisation of nucleolin in both mammalian cells and Xenopus 
oocytes was found to be dependent not only on its NLS, but also on the RNA-
binding domains and the glycine/arginine-rich domain (Creancier et al., 1993; Heine 
et al., 1993; MeBmer and Dreyer, 1993; Schmidt-Zachmann and Nigg, 1993). Since 
both the RNA-binding and the glycine/arginine-rich domains are necessary for 
specific and efficient binding of nucleolin to rRNA (Ghisolfi et al., 1992), it was 
postulated that the nucleolar localisation of nucleolin was due to binding to rRNA. 
Similar results were also obtained for the yeast homologue of nucleolin, NSRI (Yan 
and M6lese, 1993) and with B23/N038 in Xenopus oocytes, where the carboxy-
tenninal region was found to be necessary, but not sufficient for nucleolar 
localisation (Peculis and Gall, 1992). This carboxy-tenninal region was subsequently 
shown to be necessary for interaction with nucleic acids (Wang et al., 1994). In 
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addition, the transcription factor UBF was found to require both the HMO-box 1 
sequence, which binds to DNA, and the acidic tail region, which is speculated to 
interact with another transcription factor SP-l, for nucleolar localisation (Maeda 
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et al., 1992). Finally, although a specific domain of ribosomal protein S6 was 
recently shown to be essential for nucleolar localisation, this sequence was not 
sufficient to target the protein to the nucleolus (Schmidt et al., 1995). It has therefore 
been suggested that there is no such thing as a nucleolar localisation sequence 
analogous to the NLS, but that nucleolar localisation is conferred by binding of 
functional domains to other nucleolar components. 
Retention of molecules at the nucleolus due to the binding of functional 
domains implies the corollary that active functioning is necessary for localisation. 
This is supported by nucleolar localisation studies on UBF and B23. A reduction in 
the phosphorylation levels of the transcription factor UBF was shown to impair the 
ability of UBF to trans activate RNA polymerase I, and to also cause a redistribution 
of UBF between the nucleolus, nucleoplasm and cytoplasm in Chinese hamster ovary 
cells (O'Mahony et al., 1992). Also, drugs which inhibited transcription or processing 
of rRNA caused translocation of B23 from the nucleolus to the nucleoplasm in HeLa 
cells. High doses of (l-amanitin, inhibiting transcription of 5S RNA, also caused B23 
translocation, however inhibition of protein synthesis had no effect (Yung et ai., 
1985). These results suggest that ongoing rRNA transcription and processing, as well 
as the presence of 5S RNA, is required for nucleolar localisation of B23. Treatment 
with actinomycin D has also been shown to cause the redistribution of Rev from the 
nucleolus to the cytoplasm in mammalian cells, possibly due to the concomitant 
redistribution of B23 (Dundr et ai., 1995). Another requirement for nucleolar 
localisation of B23 appears to be OTP. HeLa cells in which cellular OTP pools were 
reduced by 70% with dehydrogenase inhibitors resulted in a shifting of B23 from the 
nucleolus to the nucleoplasm (Finch et al., 1993), These data support the idea that 
localisation to nucleoli is via association of functional domains to other nucleolar 
components. 
However, exceptions to the above findings were observed for some cellular 
proteins. Amino acids 31-35 from human angiogenin were sufficient to target non-
nuclear proteins to the nucleolus in permeabilised endothelial cells (Moroianu and 
Riordan, 1994), and a seventeen amino acid sequence, plus the NLS, from protein 
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p120 was sufficient to target B-galactosidase to nucleoli (Valdez et al., 1994). Closer 
inspection of the six proteins for which discrete nucleolar localisation sequences have 
been identified (Rex, Rev, Tat, ICP27, angiogenin and p120) reveals that three of 
these (Rex, Rev and p120) have been shown to specifically associate with the 
nucleolar protein B23 in vitro (Fankhauser et al., 1991; Adachi et al., 1993; Valdez 
et al., 1994). In each case, the amino acids found to interact with B23 were within 
the sequence identified as the nucleolar localisation sequence. 
It is thus tempting to speculate the following model for nucleolar localisation, 
whereby integral nucleolar proteins, such as B23, nucleolin and UBF, are anchored at 
the nucleolus due to the binding of functional domains to their respective substrates, 
for example, rDNA or rRNA. Other nucleolar proteins, such as angiogenin and p120, 
as well as viral proteins may then use the nucleolar localisation of the integral 
nucleolar proteins for their own localisation. This could be achieved by either of two 
mechanisms. In the first, thesl.( proteins are imported into the nucleus via their own 
NLS, and then subsequently localised to the nucleolus via interactions with proteins 
such as B23. Alternatively, since B23 has been shown to shuttle between the 
nucleolus and cytoplasm, it may have a more active role by binding these proteins in 
the cytoplasm, and directing them into the nucleus and to the nucleolus. 
The utilisation of the "B23-directed" pathway of nucleolar localisation may 
provide more opportunities for the regulation of nucleolar localisation. For example, 
phosphorylation of B23 by casein kinase II was shown to enhance the binding of 
NLS peptides two-fold (Szebeni et al., 1995). Since casein kinase II is present in the 
nucleolus, and its activity is enhanced in actively growing cells (Belenguer et al., 
1989), increased phosphorylation of B23 could result in increased localisation of 
protein p120 to nucleoli. Although B23 also binds to the SV-40 large T antigen NLS, 
it has a ten times higher affinity for Rev (Szebeni et al., 1995). It seems possible 
then, that the mv Rev protein has evolved to take advantage of a nucleolar 
localisation mechanism already occurring in host cells. 
Since B23 is known to bind NLSs, its role could be extended to include the 
nucleolar targeting of other proteins, such as ribosomal proteins, including L5 and 
5S RNPs. As both nucleolin and Nopp140 have also been shown to shuttle between 
the nucleolus and cytoplasm, and to bind NLSs (Borer et al., 1989; Meier and 
Blobel, 1990; 1992; Xue et al., 1993), these proteins may also perform a similar 
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function to that postulated for B23. Thus, a separate pathway may exist in cells for 
the nuclear import and subsequent nucleolar localisation of ribosoma1/nucleolar 
proteins. 
b.RNA 
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Very few studies have focussed on the mechanism of localisation of RNAs to 
the nucleolus. Nucleolar RNAs that are not transcribed on site include 5S RNA, the 
snoRNAs and 7-2 RNA (a component of RNase MRP). In addition, mRNAs 
encoding c-myc, N-myc and myoD were found to be localised to nucleoli in a number 
of diverse cell types (Bond and Wold, 1993). The functional significance of the 
localisation of these transcripts is not yet known. 
Since RNAs are transcribed and processed in the nucleus (with the exception 
of 5S RNA, which is stored in the cytoplasm of amphibian oocytes), nucleolar 
localisation may occur by diffusion through the nucleoplasm and subsequent binding 
to other nucleolar components. Many snoRNAs have been found to contain 
remarkable sequence complementarities to rRNA (up to 21 nucleotides). This has led 
to the suggestion that these RNAs function in rRNA folding, maturation, or 
ribosomal RNP assembly via direct base pairing to rRNA (Bachellerie et al., 1995). 
Furthermore, this sequence complementarity could also provide a mechanism for 
these molecules to be retained at the nucleolus. Alternatively, RNAs may bind either 
to proteins with which they are normally found associated; for example, U3 with 
fibrillarin or 5S RNA with L5, or with specialised receptor molecules in the 
nucleoplasm which target the RNAs to the nucleolus, perhaps using an active 
mechanism. 
Experiments in cells depleted of the nuclear protein RCCI, which functions as 
a guanine nucleotide exchange factor for the GTPase, Ran{fC4, showed that newly 
synthesised U3 snoRNA is not localised to the nucleolus under these conditions 
(Cheng et al., 1995). In addition, processing and maturation of pre-rRNA was 
impaired, suggesting necessary factors for these steps were also absent in these cells. 
These authors suggested the following model for intranuclear RNA transport. 
GTP-Ran{fC4, generated by RCC1, complexes with newly formed RNPs, promoting 
their diffusion through the nucleoplasm. Interactions with an RNP-specific GTPase-
activating protein would then result in hydrolysis of GTP by Ran{fC4 and deposition 
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of the RNP. The location of the GTPase-activating protein would therefore determine 
the localisation of RNPs within the nucleoplasm. These findings also correlate with 
the above-mentioned results that the nucleolar localisation of B23 requires GTP 
(Finch et al., 1993). 
IV. The Present Investigation 
To detennine the mechanisms by which 5S RNN5S RNPs are localised to 
nucleoli in Xenopus oocytes, the intranuclear distribution of endogenous 5S RNA was 
first established, before that of exogenously added 5S RNA. As described in the . 
General Introduction, there are two types of 5S RNA synthesised in oocytes, oocyte-
type and somatic-type, which differ by six nucleotides (Fig. 4-2). The predominant 
type of 5S RNA in oocytes is. oocyte-type (Ford and Southern, 1973). Somatic-type 
5S RNA has been shown to be imported into oocyte nuclei at a faster rate and to a 
greater extent than oocyte-type after injection into the cytoplasm, and more was 
incorporated into 60S ribosomal subunits (Allison et al., 1995). It was therefore of 
interest to compare the abilities of these two molecules to be localised to nucleoli. 
To detennine if the nucleolar localisation of ribosomal protein L5 paralled that of 
5S RNA, the distribution of radiolabelled, in vitro synthesised L5 within the oocyte 
nucleus was also analysed. To detennine the requirements of 5S RNA for nucleolar 
localisation, the ability of a series of mutant 5S RNA molecules to be localised to 
nucleoli was tested. These results are compared with the results presented in Chapter 
3 and with previous nuclear transport data. As a preliminary investigation to ascertain 
proteins with which 5S RNA is associated in the nucleus, immunoprecipitation assays 
were performed on nuclear and nucleoplasmic fractions of oocytes. 
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Figure 4-2 Secondary structure of Xenopuslaevis 5S RNA showing somatic-specific substitutions. 
Nucleotides indicated by arrows, at positions 30, 47. 53, 55, 56 and 79 are those present in 
somatic-type 5S RNA. 
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4.2 RESULTS 
I. Nucleolar Localisation of Endogenous 5S RNA 
To investigate the nucleolar localisation of 5S RNA, a biochemical 
fractionation assay was utilised to isolate oocyte nucleoli, as described in Peculis and 
Gall (1992). Nuclei were manually dissected and broken open by sonication. The 
sonicated preparation was then centrifuged at 13 000 rpm to pellet the nucleoli. This 
procedure does not yield a pure preparation of nucleoli, since fragments of nuclear 
membrane, chromosomes and other insoluble aggregates are also pelleted under these 
conditions (Peculis and Gall, 1992). 
The presence of intact nucleoli in the pellet fraction was confmned by two 
means: detection of the nucleolar protein B23/N038 and of 18S and 28S rRNA. 
Proteins were extracted from cytoplasmic, nucleolar and nucleoplasmic fractions from 
stage V oocytes and separated by SDS-PAGE. B23/N038 was detected by 
immunoblotting with the anti-N038 antibody, No-185 (Schmidt-Zachmann et al., 
1987). Results shown in Figure 4-3A reveal that all of the B23/N038 was present in 
the nucleolar fraction (lane 2), consistent with previous localisation studies of this 
protein (Schmidt-Zachmann et al., 1987; Peculis and Gall, 1992). In parallel 
experiments, total RNA was extracted from nucleolar and nucleoplasmic fractions, 
separated by agarose gel electrophoresis and analysed by northern blotting using a 
Xenopus rDNA probe. The results of this assay show that all of the rRNA was 
present in nucleolar fractions (Fig. 4-3B, lanes 1 and 3). These results indicate that 
all of the extrachromosomal nucleoli were pelleted by the centrifugation. 
Since the genes encoding 5S RNA are not associated with nucleoli, it was 
possible that, unlike the other rRNAs, the distribution of 5S RNA in the nucleus 
would not be entirely nucleolar. Thus, I next determined the distribution of 
endogenous 5S RNA within the nucleus of oocytes. Total RNA was extracted from 
nucleolar and nucleoplasmic fractions, separated by agarose gel electrophoresis and 
analysed by northern blotting using an antisense 5S RNA probe, which binds 
specifically to 5S RNA (see Chapter 5). Analysis of stage V oocytes from three 
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different batches of oocytes revealed that on average, only 33% of endogenous, 
nuclear 5S RNA was associated with nucleoli (data not shown), Since the rate of 
ribosome assembly has begun to slow down by this stage of oogenesis, the 
distribution of 5S RNA within the nucleus was determined at various stages 
throughout oocyte development. Figure 4-4 shows the nucleolar localisation of 
endogenous 5S RNA from stage IT to V oocytes. The large amount of 5S RNA 
present in stage IT nuclei (lane 2) reflects the high rate of synthesis of 5S RNA in 
previtellogenic oocytes (Ford, 1971). Bands from this experiment were quantified by 
scanning densitometry, and the percentages of nucleolar localisation are presented in 
Table 4-2. Similar patterns of nucleolar localisation were observed in other 
experiments with different batches of oocytes (data not shown). The percentage of 
5S RNA in the nucleus that is associated with nucleoli peaked at 40% in stage IV 
oocytes, coinciding with the peak of ribosome synthesis. These results indicate that 
throughout oogenesis there isa pool of 5S RNA within the nucleus that is not 
localised to the nucleoli. 
II. Nucleolar Localisation of Exogenous 5S RNA 
The large amount of 5S RNA not associated with nucleoli in the nucleus 
could represent newly synthesised 5S RNA which is en route to the nucleoli or 
cytoplasm. To test this, and to determine if exogenously added 5S RNA shows a 
similar nuclear distribution to endogenous 5S RNA, 32P-Iabelled 5S RNA was 
microinjected into the cytoplasm of oocytes, thereby mimicking stored 5S RNA. The 
oocytes were incubated for 20 hours to allow nuclear import and nucleolar 
accumulation. The RNA was then extracted from cytoplasmic, nucleolar and 
nucleoplasmic fractions and analysed by PAGE and autoradiography. Figure 4-5 
shows that oocyte-type 5S RNA is distributed similarly to endogenous 5S RNA 
within the nucleus. On average, 33% of the microinjected 5S RNA that had been 
imported into the nucleus was associated with nucleoli (lanes 1 and 2). Somatic-type 
5S RNA, however, showed a different distribution pattern, with 70% of the RNA in 
the nucleus associated with nucleoli (lanes 3 and 4). This pattern was highly 
reproducible in many batches of oocytes, and did not appear to depend on the 
Figure 4·3 Distribution of the nucleolar protein B23/N038 and of rRNA within the Xenopus oocyte 
nucleus. (A) Distribution of B23/N038. Nucleolar (No) and nucleoplasmic (Np) fractions were 
prepared from 50 isolated nuclei from stage V oocytes, by sonication and centrifugation to yield 
nucleolar pellets and supernatant (nucleoplasmic) fractions. Cytoplasmic fractions (Cy) were prepared 
from five enucleated oocytes only. Proteins were extracted from each fraction, separated by 
8D8·PAGE, and the subcellular distribution of B23/N038 visualised by immunoblotting with an 
anti·N038 antibody. (B) Distribution of rRNA. Nucleolar (No) and nucleoplasmic (Np) fractions from 
40 oocytes were prepared as described in part (A). Total RNA was extracted from these fractions, 
separated by agarose gel electrophoresis and the distribution of rRNA determined by northern blotting 
using a labelled Xenopus rDNA probe (pXlrl01A). The blot shows replicate samples of each fraction. 
Figure 4-4 Nucleolar localisation of endogenous 58 RNA throughout oogenesis in Xenopus oocytes. 
Nucleolar (No) and nucleoplasmic (Np) fractions were prepared from 40 isolated nuclei by sonication 
and centrifugation. Total RNA was extracted and separated by agarose gel electrophoresis. The 
distribution of 58 RNA was determined by northern analysis using an antisense 58 RNA probe. 
Oocyte stages n to V (Dumont, 1972) are indicated. 
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Cy No Np 
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Table 4-2 Nucleolar localisation of 5S RNA throughout oogenesis 
Stage of Oogenesisa 
II 
III 
IV 
V 
• Oocyte stages according to Dumont (1972). 
% Nucleolar Localisationb 
6.3 
21.6 
40.8 
34.4 
b % Nucleolar localisation indicates the percentage of endogenous 5S RNA within the nucleus 
associated with nucleoli. 
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amount of RNA injected (data not shown). As a control, microinjected U1 snRNA 
was shown to be confined to nucleoplasmic fractions in most assays (lanes 5 and 6), 
although in a few experiments some U1 (approximately 10%) was detected in 
nucleolar pellets (data not shown). This was attributed to U1 being assembled into 
liB snurposomes", large granules present in amphibian oocyte nuclei that are thought 
to function in mRNA splicing (Wu et ai., 1991). In contrast to U1, U3 snoRNA 
showed a predominantly nucleolar distribution (data not shown). 
To further confrrm that the 5S RNA present in nucleolar fractions was not 
due to non-specific entrapment or sticking, 32P-Iabelled 5S RNA was added to 
isolated nuclei after sonication treatment and the nucleoli pelleted by centrifugation. 
All of the added 5S RNA was found in the supernatant fraction (Fig. 4-5, lanes 7 and 
8), indicating that the 5S RNA in nucleolar fractions is due to specific associations 
with nucleoli. 
The results from these biochemical fractionation assays were confirmed using 
in situ localisation studies with semi-thin sections of oocytes. For these assays, 
33P-Iabelled RNAs were injected into the cytoplasm of oocytes, which were incubated 
Figure 4-5 Nucleolar localisation of exogenous RNAs. 32p-Iabelled oocyte-type 5S RNA, somatic-type 
5S RNA or Ul snRNA were injected into the cytoplasm of stage V oocytes as indicated and incubated 
overnight. Nucleolar (No) and nucleoplasmic (Np) fractions were prepared from ten isolated nuclei by 
sonication and centrifugation. Total RNA was extracted from each fraction and analysed by 
8 M urea/8% PAGE and autoradiography. Nuclei + 5S, nuclei were dissected from uninjected oocytes 
and 32p-Iabelled5S . RNA was added, followed by preparation of nucleolar and nucleoplasmic fractions 
and analysis as described above. 
Oocyte Somatic U1 Nuclei 
type type snRNA + 5S 
/ \/ 1/ \/ 
No Np No Np No Np No Np 
• 
1 2 3 456 7 8 
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for 20 hours. The oocytes were then fixed, sectioned and subject to autoradiography. 
These results are shown in Figure 4-6. Panel (a) shows a non-injected oocyte 
nucleus, with very few silver grains, indicating low background levels. Oocyte-type 
SS RNA showed a relatively homogeneous distribution within the nucleus, not 
dissimilar to that of U1 snRNA (compare panels b and c). Somatic-type SS RNA, 
however, showed dramatic nucleolar localisation, consistent with the biochemical 
fractionation results above (panel d). 
ill. Nucleolar Localisation 5S RNA Mutants 
To determine if specific sequences or secondary structures of the SS RNA 
molecule are required for targeting to the nucleolus, the series of mutant SS RNA 
molecules described in Chapter 3 were further assayed for their ability to be localised 
to nucleoli. Since the results described above indicated that the biochemical 
fractionation of nucleoli gave a more sensitive and quantitative assay of nucleolar 
localisation than analysis by semi-thin sections, this assay was used to assess the 
nucleolar localisation of the SS RNA mutants. To avoid overloading the nucleus and 
saturation of putative nucleolar binding sites, 32P-Iabelled mutant SS RNAs were 
injected into the cytoplasm of stage V oocytes, rather than directly into the nucleus. 
The oocytes were incubated for 20 hours to allow nuclear import and nucleolar 
localisation, and the RNA extracted from nucleolar and nucleoplasmic fractions. The 
distribution of RNA within the nucleus was analysed directly by liquid scintillation 
counting, or by PAGE and autoradiography followed by quantification using scanning 
densitometry. Nucleolar localisation for each mutant was calculated as a percentage 
of the RNA in the nucleus. Therefore, the results do not reflect the differences in 
nuclear import which have previously been observed (Allison et al., 1993), or 
possible differences in nuclear export, of the different mutants. Since there is slight 
variation between batches of oocytes, the nucleolar localisation of each mutant was 
compared with that of oocyte-type SS RNA within the same batch of oocytes, and all 
mutants were tested in at least two different batches from different frogs. 
The results from a selection of mutants are shown in Figure 4-7, and a 
summary of all the mutants tested, made relative to oocyte-type, is presented in 
a 
b 
Figure 4-6 In situ nucleolar localisation of exogenous RNAs in Xenopus oocytes. 33P-labelled RNAs 
were injected into the cytoplasm of stage V oocytes, which were incubated overnight. Oocytes were 
then fixed, sectioned at four to seven microns, subject to autoradiography and stained with Giemsa. 
(a) non-injected control oocyte; (b) oocyte injected with UI snRNA; 
c 
d 
(c) oocyte injected with oocyte-type 5S RNA; (d) oocyte injected with somatic-type 5S RNA. 
Cy, cytoplasm; N, nucleus; arrows indicate some of the extrachromosomal nucleoli. 
Bars 30 pm. 
84 
Chapter 4 85 
Figure 4-8. The actual percentages of nucleolar localisation for each mutant are 
presented in Appendix n. None of the mutants tested were completely defective for 
nucleolar localisation using this assay, although there was variation in the amounts 
localised. The majority of 5S RNA mutants showed similar nucleolar localisation to 
oocyte-type 5S RNA, for example, mutant 27-32 (Fig. 4-7, lanes 3 and 4). However. 
a few mutants. for example, mutants with substitutions at positions 14-15 and 16-21 
in helix n. showed lower levels of nucleolar accumulation (lanes 5, 6. 13 and 14); 
and other mutants. for example 57-62 and 95-98. showed higher amounts of 
nucleolar localisation than oocyte-type (Fig. 4-8). 
Of particular interest were the four mutants which were shown to be defective 
for incorporation into the 60S ribosomal subunit. Mutant 10-13 showed a similar 
nucleolar localisation to oocyte-type (30.5%; Fig. 4-7. lanes 15 and 16). whereas 
mutant 96-101 showed slightly less localisation than oocyte-type (lanes 7 and 8). The 
two deletion mutants. ~49.50 (lanes 11 and 12) and ~63 (lanes 9 and 10), however, 
repeatedly showed much higher levels of nucleolar localisation (78.6% and 61.2%. 
respectively). 
To confIrm that these results did indeed represent nucleolar localisation. 
in situ localisation assays were also performed with a selection of the mutant 
5S RNAs. Most of the mutants tested in this assay showed nucleolar localisation 
characteristics consistent with the biochemical fractionation results, for example. 
mutants 10-13 and 96-101 (Fig. 4-9. panels a and b). However. the two mutants. 
~49,50 and ~63, which showed high nucleolar localisation according to the 
biochemical fractionation, did not show a corresponding nucleolar localisation in the 
in situ assays (Fig. 4-9, panels c and d). Rather, the distribution of these two mutants 
within the nucleus was very similar to oocyte-type 5S RNA. Silver grains appeared 
homogeneously distributed throughout the nucleus, including over nucleoli, and were 
not aggregated or associated with specific structures such as the nuclear envelope. 
These results imply that these two mutant RNAs are binding to other structures 
within the nucleus, resulting in their presence in nucleolar pellets. When 32P-Iabelled 
~49 ,50 was added to isolated nuclei, followed by isolation of nucleoli and extraction 
of RNA, all of the added ~49,50 was in the nucleoplasmic fraction (data not shown), 
similar to oocyte-type 5S RNA (Fig. 4-5, lanes 7 and 8). This shows that the 
Figure 4-7 Nucleolar localisation of mutant 5S RNA molecules. 32p-Iabelled oocyte-type (oocyte) or 
mutant 5S RNA molecules were injected into the cytoplasm of stage V oocytes, followed by an 
overnight incubation. Nucleolar (No) and nucleoplasmic (Np) fractions were prepared from ten isolated 
nuclei by sonication and centrifugation. Total RNA was extracted and analysed by 8 M urea! 
8% PAGE and autoradiography. Mutant designations refer to those areas of the molecule which were 
substituted or deleted (Fig. 3-3). 
Oocyte 27-32 14-15 96-101 .:\63 L\49,50 16-21 10-13 
I \; \1 \/ " \; \1 \; \ 
No Np No Np No Np No Np No Np No Np No Np No Np 
1 2 3 4 5 6 7 8 9 10 11 121314 1!5 16 
Figure 4-8 
Figure 4·8 Summary of nucleolar localisation of 5S RNA mutants. Nucleolar localisation was 
calculated as a percentage of the RNA in the nucleus (data presented in Appendix II), and expressed 
re1ative to the nucleolar localisation of oocyte-type 5S RNA within the same batch of oocytes. Mutant 
designations refer to those areas of the 5S RNA molecule which were substituted or deleted (Fig. 3-3). 
SS RNA 
Mutants 
Oocyte-type 
Somatic-type 
Helix II 
14-15 
64-65 
16-21 
57-62 
16-21/57-62 
Helix III 
27-32 
45-52 
Helix IV 
95-98 
Helix V 
105-108 
71-72 
103-104 
Loop A 
10-13 
B 
22-26 
Loop C 
41-44 
Loop E 
96-101 
Bulged Nue!. 
D49,50 
D63 
D83 
Hinge Nue!. 
C66 
G109 
-
I 
I 
-
-
I I I I I I I I I I I I I I I I I I I I I I 
o 1 2 3 
Amount of RNA in Nucleolus Relative to 
Oocyte-type 
87 
a 
b 
Figure 4·9 In situ nucleolar localisation of 5S RNA mutants. 33P-labelled mutant 5S RNAs were 
injected into the cytoplasm of stage V oocytes, which were incubated overnight. Oocytes were fixed, 
sectioned at four to seven microns. subject to autoradiography and stained with Giemsa. (a) oocyte 
injected with mutant 10-13; (b) oocyte injected with mutant 96-101; 
c 
d 
(c) oocyte injected with mutant .149,50; (d) oocyte injected with mutant L\63. 
Cy, cytoplasm; N, nucleus; arrows indicate some of the extrachromosomal nucleoli. 
Bars 30 pm. 
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presence of 849,50 in nucleolar pellets was not due to some spontaneous interaction 
with nuclear components. 
IV. Nucleolar Localisation of Ribosomal Protein L5 
Since ribosomal protein L5 has been implicated in the transport of 5S RNA 
into the oocyte nucleus (Allison et al., 1991; 1995; K. J. Murdoch and L. A. Allison, 
submitted) and has also been postulated to target 5S RNA to the nucleolus in HeLa 
cells (Steitz et al., 1988), it was of interest to determine the nuclear distribution of 
this protein. 35S-labelled L5 was synthesised using a rabbit reticulocyte lysate-coupled 
transcription-translation reaction, and this lysate mixture was injected directly into the 
cytoplasm of oocytes. After 20 hours incubation in the presence of cycloheximide to 
prevent incorporation of excess [35S]methionine into oocyte proteins, nucleolar 
fractions were prepared as above, and the proteins extracted and analysed by SDS-
PAGE and fluorography. Quantitation of bands indicated that 40% of L5 within the 
nucleus was nucleolar-associated (Fig. 4-10), As a control for the presence of 
cycloheximide, the distribution of 5S RNA was also assessed under the same 
conditions. The average oocyte-type 5S RNA nucleolar localisation in these assays 
was 23.5% (data not shown). This value is below the average nucleolar localisation 
observed for oocyte-type 5S RNA, but is not out of the range of values observed 
owing to oocyte variability (see Appendix ll). Cycloheximide has also been shown 
not to affect the nucleolar localisation of B23 (Yung et al., 1985). 
The L5 localisation results were also confirmed using in situ localisation 
assays. Since the 35S-labelled L5 was not purified from the unincorporated 
[35S]methionine in the reaCtion mixture, controls were performed in which oocytes 
were injected with the product of a transcription-translation reaction which was 
primed with H20 instead of template DNA. A typical section of such an oocyte is 
shown in Figure 4-11. Most of the [35S]methionine was localised within the 
cytoplasm, with only a small number of silver grains in the nucleus, which appeared 
to be randomly distributed (panel a). Thus, the intranuclear distribution of injected 
35S_L5 (panel b) reflects mostly localisation of L5 protein and not background 
[35S]methionine. These sections showed distinct accumulations of silver grains over 
No Np No Np 
1 2 3 4 
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Figure 4-11 
Figure 4·11 In situ nucleolar localisation of ribosomal protein L5. Stage V oocytes were 
cytoplasmically injected with the 3sS-labelled product of an in vitro transcription-translation reaction 
either primed with H20 as a control (a) or with L5 template (b), and incubated overnight. Oocytes 
were then fixed and sectioned at five microns, subject to autoradiography and stained with Giemsa. 
Cy, cytoplasm; N, nucleus; arrows indicate some of the extrachromosomal nucleoli. Bars 30 pm. 
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and around nucleoli, although not to the extent shown by somatic-type 5S RNA. 
Thus, these results support the biochemical nucleolar localisation results for L5, 
where the amount associated with nucleoli was higher than that observed for oocyte-
type 5S RNA, but less than somatic-type. 
Since the rabbit reticulocyte lysate contains excess 5S RNA (Zehavi-Willner 
and Danon, 1972), the majority of L5 synthesised binds to this 5S RNA, forming 
5S RNPs (see Section V, Fig. 4-12, lane 1). Also, L5 synthesised using the same 
method was shown to be bound within 5S RNPs after microinjection into Xenopus 
oocytes (K. J. Murdoch and L. A. Allison, submitted). It is not known, however, 
whether after microinjection, an exchange reaction takes place, similar to that which 
can occur in vitro (Nazar and Wildeman, 1983; Huber and Wool, 1986b; Allison 
et al., 1995), whereby the rabbit 5S RNA is replaced by oocyte-type 5S RNA. Thus, 
the distribution of L5 in the nucleus reflects the distribution of L5 bound to either 
rabbit reticulocyte 5S RNA or Xenopus oocyte-type 5S RNA, or a mixture of the 
two. 
V. 5S RNA-protein Associations in the Nucleus 
The above results suggest that there are pools of both 5S RNA and ribosomal 
protein L5 in the nucleus of oocytes which are not associated with nucleoli. To 
determine whether these pools of 5S RNA and L5 were associated in the form of 
5S RNPs, and to determine if 5S RNA is bound to any other proteins in the nucleus, 
non-denaturing gel electrophoresis was performed on nuclear homogenates. In 
contrast to cytoplasmic fractions, where three bands, corresponding to free 5S RNA, 
5S RNPs and 7S RNPs have been identified (Fig. 4-12, lanes 5 and 6), nuclear 
5S RNA was present in a high molecular weight complex, which could be resolved 
into two bands (Fig. 4-12, lane 7). This complex was formed by both oocyte-type 
and somatic-type 5S RNA (compare lanes 4 and 7), as well as many of the mutants 
tested (data not shown), and was stable in up to 500 mM KCI (data not shown), 
Treatment of nuclei with proteinase K abolished this complex (lane 10), indicating 
the involvement of proteins. To determine whether this complex was a preribosomal 
particle, nuclear homogenates were treated with EDT A, which is known to release 
Figure 4-12 Non-denaturing gel electrophoresis of oocyte fractions. Lane 1. in vitro-generated 
35S-labelled ribosomal protein L5. showing formation of 5S RNPs in the rabbit reticulocyte lysate. 
Lanes 2 to 13, stage V oocytes were injected with 32p-Iabelled somatic-type (lanes 2 to 4) or oocyte-
type 5S RNA (lanes 5 to 13) and incubated overnight. Three whole oocytes (W), cytoplasms (C), or 
ten nuclei (N) were homogenised, and immediately analysed (lanes 2 to 7) or subsequently treated 
with proteinase K (pro. K) or EDTA Samples were analysed by 6% PAGE containing 0.1 % Triton 
X-I00 followed by autoradiography. HMW,high molecular weight complex containing 5S RNA in 
nuclei fractions. Lanes 1 to 4 and 5 to 13 represent experiments which were electrophoresed for 
different lengths of time. 
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5S RNPs from 60S subunits (Blobel, 1971). EDTA treatment did not release 5S 
RNA from the complex (Fig. 4-12, lane 13), indicating it is not a precursor 
ribosomal particle. Although both U1 and U3 snRNAs were shown to form high 
molecular weight complexes in nuclei under the same conditions, these were not of 
the same size as that containing 5S RNA (data not shown). The biological 
significance of this complex was not investigated further, and it is not known 
whether it represents a real 5S RNA-containing complex found in oocyte nuclei, or is 
fonned by non-specific interactions during preparation of nuclear homogenates. 
A second approach was therefore utilised to determine which proteins 
5S RNA is associated with in the nucleus. Immunoprecipitation assays were 
performed using antibodies against the known 5S RNA-binding proteins, TFIIIA and 
L5, and also 60S ribosomal subunits. Association with another 5S RNA-binding 
protein, La, was not analysed, since this is thought to bind only transiently to newly 
transcribed 5S RNA (Gottlieb and Steitz, 1989; Guddat et al., 1990). The anti-TFIDA 
and anti-60S ribosomal subunit antisera were described in Chapter 3. 
The anti-L5 antibody was prepared against 5S RNPs purified from Anemia 
salina, and specifically recognises L5 in preparations of both Artemia and rat 
60S subunit proteins (Kenmochi and Ogata, 1989). This anti-L5 antibody also 
recognised a purified preparation of Xenopus laevis L5, and L5 in a sample of total 
soluble oocyte proteins, as shown by western analysis (Fig. 4-13A, lanes 1 and 3). 
The antibody did not react above background levels with a preparation of TFIIIA 
(lane 2), but did show some cross reactivity to other oocyte proteins (lane 1). 
Secondary reactivities have also been observed with another anti-L5 antibody in 
BeLa cells (Steitz et al., 1988) and Xenopus embryos (Wormington, 1989), To 
confInn that the the anti-L5 antibody was able to recognise Xenopus L5 when bound 
to 5S RNA, oocyte RNAs were labelled with [32p]GTP and oocyte homogenates 
immunoprecipitated with the anti-L5 antiserum. The RNA was extracted from 
immunoprecipitates and analysed by PAGE and autoradiography. Figure 4-13B shows 
that 5S RNA was the only RNA precipitated with this antibody (lane 2), indicating 
that 5S RNPs were recognised. The absence of the other rRNAs in 
immunoprecipitates suggests that intact 60S subunits or 80S ribosomes were not 
recognised by this antibody. Prior treatment of oocyte extracts with proteinase K 
Figure 4-13 Characterisation of Anemia anti-L5 antiserum. (A) Total stage V oocyte proteins (Total), 
purified 78 RNPs (78) or purified 5S RNPs (5S) were separated by SDS-PAGE and transferred to 
nitrocellulose membrane. Proteins were visualised by immunoblotting with the anti-L5 antisera. 
(B) Oocyte RNAs were labelled by injection of 32p[GTP] into the cytoplasm of stage V oocytes 
followed by an overnight incubation. Oocyte homogenates Oanes 1 and 2), or oocyte homogenates 
previously treated with proteinase K (lane 3) were immunoprecipitated with normal rabbit serum 
(NRS) or anti-L5 antisera (L5). RNA was extracted from immunoprecipitates and analysed by 
8 M urea/8% PAGE and autoradiography. 
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abolished the precipitability of 5S RNA (lane 3), showing that the antibody 
recognised the protein component of the RNP and not the naked RNA. 
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To determine if there were any differences between oocyte-type and somatic-
type 5S RNA-protein associations within the nucleus, it was necessary to be able to 
directly compare immunoprecipitates of the two types of RNA. Previously it was 
shown that when comparable amounts of RNA were injected into the cytoplasm, 
twice as much somatic-type 5S RNA was imported into the nucleus compared with 
oocyte-type (Allison et ai., 1995). Thus, to ensure equal amounts were present in the 
nucleus, twice as much oocyte-type as somatic-type 5S RNA was injected into the 
cytoplasm of oocytes. After incubation, the nuclei were dissected and subject to 
immunoprecipitation (Fig. 4-14A). Immunosupernatant fractions show that this 
treatment resulted in almost identical amounts of each type of 5S RNA present in 
nuclei fractions (Fig. 4-14B, compare lanes 1-4 and 5-8), 
In order to compare amounts precipitated by the different antibodies, it was 
also important to ensure that saturating quantities of antibody were used. To test this. 
nuclear homogenates were subject to sequential immunoprecipitations with the same 
antibody. The sequential immunoprecipitations show that the amounts of the anti-
TFillA. anti-L5, and anti-60S antibodies used were not saturating, as these complexes 
were not immuno-depleted during the fIrst precipitation (Fig. 4-14A, cf. lanes 1 and 
2. 3 and 4, 5 and 6, 11 and 12). However, subsequent trials with increasing 
concentrations of anti-L5 antibody failed to increase the amount of 5S RNPs 
precipitated. 
Although these results are not quantitative. both oocyte-type and somatic-type 
5S RNAs were clearly predominantly associated with L5 in the nucleus (lanes 3, 4, 
11 and 12) with only negligible amounts of 7S RNPs detected (lanes 1,2, 9 and 10). 
Since the amounts of antisera used were not saturating, it could be argued that the 
low amount of 5S RNA immunoprecipitated with the anti-TFmA antiserum is 
because this is a weaker antiserum than the anti-L5 antiserum. However. 
immunoprecipitations of whole oocytes presented in Chapter 3. which used only half 
as much anti-TFmA antiserum, clearly precipitated greater amounts of labelled 
7S RNPs, even though the cytoplasm contains a large store of unlabelled. competing 
7S RNPs (see Fig. 3-5A). This suggests that the small amount of 7S RNPs 
Figure 4·14 Immunoprecipitation of oocyte nuclear fractions. Stage V oocytes were cytoplasmically 
injected with 32p·labelled somatic-type or oocyte-type 5S RNA and incubated overnight. Nuclear 
homogenates from 20 oocytes were immunoprecipitated twice with anti·TF1IIA (7S), anti-L5 (5S), or 
anti-60S ribosomal subunit (60S) antisera, or with normal rabbit serum (NRS). RNA was extracted 
from immunoprecipitates after the first and second immunoprecipitations, as shown in consecutive 
lanes for each antisera (A) or immunosupematants after the second immunoprecipitation (B), and 
analysed by 8 M urea/8% PAGE and autoradiography. Immunoprecipitates were exposed for three 
weeks, immunosupematants were exposed overnight. 
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precipitated from nuclear fractions is, in fact, because there are not many of these 
RNPs present in this compartment. 
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The above results are in contrast to the behaviour of oocyte-type 5S RNA in 
the cytoplasm, where it predominantly associates with TFllIA (Fig. 4-12, lanes 5 and 
6), but supports the proposal that it is L5 that targets 5S RNA to the nucleus for 
eventual incorporation into the 60S ribosomal subunit. Consistent with the nucleolar 
localisation results and with previous data (Allison et al., 1995), somatic-type 
5S RNA showed greater amounts of ribosome incorporation than oocyte-type 
(Fig. 4-14, cf. lanes 5 and 6 with lanes 13 and 14). Comparison of oocyte-type and 
somatic-type 5S RNA reveals that more somatic-type 5S RNA overall was 
immunoprecipitated with the three antibodies, although there were equal amounts of 
each RNA in the nucleus (Fig. 4-14A and B). This suggests that a substantial amount 
of oocyte-type 5S RNA is not associated with TFIIIA or L5, or that, if it is, these 
proteins are not recognised by their respective antibodies, perhaps due to the binding 
of some other nuclear component(s). 
The above results clearly indicate the presence of 5S RNPs in the nucleus, but 
do not show whether these RNPs are nucleolar or nucleoplasmic. To determine the 
intranuclear location of these complexes, immunoprecipitations were performed on 
nuclear extracts which were depleted of nucleoli using the nucleolar fractionation 
procedure described above. Since oocyte-type 5S RNA showed lower precipitability 
in the previous experiment, this assay was performed only with somatic-type 
5S RNA. The results clearly show the presence of 5S RNPs in non-nucleolar, 
nucleoplasmic fractions (Fig. 4-15, lane 1), even though only 30% of somatic-type 
5S RNA is found in this fraction (Fig. 4-5). This confIrms that at least some of the 
pool of 5S RNA and L5 in the nucleoplasm is associated in the form of 5S RNPs. 
No 5S RNA was precipitated with the anti-60S subunit antibody in non-nucleolar 
fractions, indicating that the majority of the ribosomal subunits are associated with 
the nucleoli (Fig. 4-15, lane 2). 
A B 
5S 60S NRS 5S 60S NRS 
1 2 3 1 2 3 
Figure 4-15 immunoprecipitation of oocyte nucleoplasmic fractions. 12 P-Iahdktl somatic-type 'is 
I{NA was injectetl into the cytoplasm ul stage V oocytes, which were then incuhatetlovernight. 
Nucleoplasmic fractions were prepared from 20 isolated nuclei hy sonication antl centrifugation, 
and immunoprecipitated with anti-i.'i (.'is) or anti-60S ribosomal suhunit (fiOS) antisera, or with 
normal rabbit serum (NRS). RNA was extracted from immunoprecipitates (A) and 
immunosupernatants (B), and analysed hy X M urea /Xo/r PA(JI': and autoradiography. 
lmmunoprecipitates were exposed for four weeks and immunosupcrnatants lor three tlays. 
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4.3 DISCUSSION 
The results presented in this chapter further characterise the distribution of 
. 5S RNA in the nucleus of Xenopus laevis oocytes. One of the interesting findings is 
the low percentage of 5S RNA in the nucleus that is actually associated with nucleoli 
and therefore being assembled into ribosomal subunits. This was not simply due to 
an overloading of the system with exogenous RNA, since endogenous 5S RNA 
showed a similar distribution pattern. Conversely, the low amount of endogenous 
5S RNA associated with nucleoli was not simply newly synthesised RNA en route to 
the nucleolus, since exogenous 5S RNA showed the same nuclear distribution. All of 
the B23/N038, which is found in the same nucleolar components as 5S RNA and is 
also associated with 60S preribosomal particles (Spector et al., 1984; Hiigle et al., 
1985; Yung et al., 1985; Schmidt-Zachmann et al., 1987; Biggiogera et al., 1989), 
and all of the 18S and 28S rRNAs were detected in nucleolar fractions. It is therefore 
unlikely that the low level of 5S RNA associated with nucleoli is due to almost 
completed ribosomal subunits detaching during the preparation process. The 
consistency between the endogenous and exogenous 5S RNA results, as well as 
between the two different techniques utilised, suggests that this pattern reflects the 
situation in vivo. Even in stage IV oocytes, where ribosome assembly is occurring at 
a maximum rate, only 40% of the endogenous, nuclear 5S RNA was localised to 
nucleoli. Since oocyte-type 5S RNA is the predominant form of 5S RNA in oocytes, 
this distribution is likely to reflect that of oocyte-type 5S RNA. These results are 
consistent with previous in situ hybridisation studies which showed that the 
localisation of 5S RNA over nucleoli peaked in stage N oocytes (Allison et al., 
1991). 
I. Requirements for the Nucleolar Localisation of SS RNA 
In contrast to oocyte-type 5S RNA, 70% of somatic-type 5S RNA in the 
nucleus was associated with nucleoli. This nucleolar localisation of somatic-type 
5S RNA resembles that shown by HeLa cell 5S RNA after microinjection into 
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Xenopus oocytes (De Robertis et al., 1982). Interestingly, somatic-type 5S RNA is 
more closely related to HeLa ce115S RNA in sequence than oocyte-type 5S RNA 
(Ford and Southern, 1973). 
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The striking difference in nucleolar localisation between oocyte-type and 
somatic-type 5S RNAs correlates with previous findings on the behaviour of somatic-
type 5S RNA in oocytes. Somatic-type 5S RNA was imported into the nucleus at a 
faster rate and to a greater extent than oocyte-type 5S RNA, and a greater amount 
was assembled into 60S ribosomal subunits (Allison et aI., 1995). These results were 
explained by the different protein binding activities of the two types of RNA in the 
cytoplasm: somatic-type was predominantly associated with ribosomal protein L5, 
whereas oocyte-type preferentially associated with TFIIIA, forming storage 7S RNPs 
(Allison et al., 1995). Since L5 is thought to be involved in the nuclear import of 
both oocyte-type and somatic-type 5S RNA, all of the 5S RNA in the nucleus would 
be expected to be associated with L5, rather than TFIIIA, unless L5 was replaced by 
TFIIIA in the nucleus. It seems unlikely, therefore, that differences in L5 binding 
explain the different nucleolar localisation characteristics of the two types of 
5S RNA. This is supported by the immunoprecipitation results, which showed that 
both oocyte and somatic-type were predominantly bound with L5 rather than TFIIIA 
in the nucleus. 
Nucleolar localisation studies of L5 showed it to be associated with nucleoli 
in an amount intermediate to that of oocyte-type and somatic-type 5S RNAs. This L5 
is likely to be bound to a mixture of rabbit 5S RNA and oocyte-type 5S RNA. If a 
higher degree of L5 binding was responsible for the high degree of nucleolar 
localisation observed for somatic-type 5S RNA, a similarly high proportion of L5 
would be expected to localise to nucleoli, irrespective of the type of 5S RNA it was 
associated with. Since this was not the case, this further supports the notion that the 
different nucleolar localisation characteristics of oocyte-type and somatic-type 
5S RNAs are not conferred by differences in L5 binding. This implies that the 
sequence differences between oocyte-type and somatic-type 5S RNA, or 
conformational differences caused by these sequences, are directly recognised by 
other nuclear factors. These may be other ribosomal and/or nucleolar components, to 
which somatic-type has a higher affinity, or nucleoplasmic components to which 
oocyte-type 5S RNA has a higher affinity. 
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Thus, L5 binding, although hypothesised to mobilise 5S RNA for import into 
the nucleus in Xenopus oocytes, does not appear to determine the distribution of 
5S RNA once inside the nucleus. Instead, its own distribution appears to be 
dependent on the type of 5S RNA to which it is bound. This dependence of L5 on 
the sequence of 5S RNA to which it is bound for nucleolar localisation could be 
more directly demonstrated by analysing the distribution of 3sS-L5 preassembled with 
either oocyte-type or somatic-type 5S RNA. This can be achieved by adding excess 
unlabelled 5S RNA to the L5 in vitro transcription-translation reaction, as was 
previously performed with Xenopus L5 (K. 1. Murdoch and L. A. Allison, submitted) 
and yeast L1 (Yeh and Lee, 1995a), to form 5S RNPs. 
All of the mutant 5S RNA molecules tested showed some degree of nucleolar 
localisation. Since mutations in most regions of the molecule were tested, these 
results imply that a specific sequence of the 5S RNA molecule does not confer 
nucleolar localisation. This correlates with other studies on nucleolar targeting, where 
nucleolar localisation is not conferred by a linear sequence, but appears to be 
dependent on regions of molecules which are involved in binding to other nucleolar 
components (see Introduction to this chapter). 
The series of 5S RNA mutants tested here have also previously been tested 
for their ability to be imported into the oocyte nucleus after injection into the 
cytoplasm, where similar results were obtained. All of the mutants were capable of 
nuclear import, although to varying degrees (Allison et al., 1993; L. A. Allison and 
P. 1. Romaniuk., in prep.). It is interesting that all of the mutants capable of nuclear 
import and nucleolar localisation are all capable of binding L5 (Chapter 3), It is 
therefore possible that L5 binding is a necessary, although not sufficient, requirement 
for the nucleolar localisation of 5S RNA. This would need to be be tested using 
mutant 5S RNA molecules that do not bind to L5. Conversely, the nucleolar 
localisation of L5 may also require the binding of 5S RNA. This could be tested 
using mutant L5 molecules which were defective for binding 5S RNA. 
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II. Nucleoplasmic 5S RNA 
The nature of the protein interactions of the 5S RNA in the nucleus not 
associated with nucleoli was further investigated by immunoprecipitation of nuclear 
and nucleoplasmic fractions. These assays conflnned that a proportion of this 
5S RNA was associated with L5. However, a significant amount of 5S RNA 
remained in immunosupernatants after immunoprecipitations with either anti-TFIIIA, 
anti-L5 or anti-60S subunit antisera. This effect was more noticeable for oocyte-type 
5S RNA, where less was immunoprecipitated than somatic-type. although more 
oocyte-type 5S RNA should have been available since less is associated with 
nucleoli. These results suggest that either 5S RNPs and 7S RNPs are bound to other 
nuclear components so that they are masked from recognition by their respective 
antibodies, or that 5S RNA is bound to proteins other than L5 or TFIIIA in the 
nucleus. The association of more oocyte-type 5S RNA with nucleoplasmic 
components would also explain the lower levels of nucleolar localisation observed 
with this RNA. The idea that 5S RNA within the nucleoplasm is bound to other 
factors is also supported by the results of non-denaturing gel electrophoresis, where 
all of the nuclear 5S RNA was contained within a high molecular weight complex. 
The factors 5S RNA might be associated with in the nucleoplasm were not 
investigated, but there are several possibilities. These could be factors involved in the 
nuclear import process. The nuclear pore targeting complex is known to be 
translocated through the nuclear pore as a single entity. The B-subunit of the complex 
is released on the nucleoplasmic side of the nuclear envelope. however, importin-a is 
found distributed throughout the nucleus (Gorlich et al., 1995). It is not known at 
what stage importin-a dissociates from the transport substrate, thus it is possible that 
the nucleoplasmic 5S RNA is still bound to this protein. Dissociation of this complex 
may depend on other nuclear factors, which would then allow 5S RNA to be targeted 
to nucleoli. 
Since the GTP-binding protein Ran/TC4 is thought to be important for 
targeting of newly synthesised U3 snoRNA to nucleoli (Cheng et al., 1995), and is 
necessary for protein import (reviewed in Moore and Blobel, 1994), this protein may 
also be associated with nuclear 5S RNA. According to the model of Cheng et al. 
(1995), Ran/TC4 would be released after GTP hydrolysis, catalysed by the presence 
Chapter 4 
of a GTPase-activating protein. In the case of 5S RNPs, the GTPase-activating 
protein would be located at the nucleolus, resulting in deposition of 5S RNPs at 
nucleoli. Interestingly, the guanine nucleotide exchange factor, RCC1 was recently 
shown to fonn a large complex in Xenopus egg extracts, containing Ran/TC4 and 
three other proteins (Saitoh and Dasso, 1995). 
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Finally, nucleoplasmic 5S RNA may represent excess RNA in the nucleus, 
which is being temporarily stored. Thus, the role of the putative 5S RNA-binding 
factors in the nucleus could be to prevent the efflux of 5S RNA back to the 
cytoplasm or to regulate the amount of 5S RNA at the nucleolus at one time. Recent 
studies have suggested that the retention of both proteins and RNAs in the nucleus is 
due to binding interactions with other nuclear factors (Schmidt-Zachmann et al., 
1993; Vancurova et al., 1993; Boelens et al., 1995; Paine et al., 1995; Terns et al., 
1995). Retention of excess 5S RNA in the nucleus would ensure continued 
availability for ribosome synthesis. 
m. Nucleolar Localisation of Mutants Defective for Ribosome Assembly 
Each of the four mutants which were defective for assembly into 
60S ribosomal subunits showed different nucleolar localisation phenotypes. Mutant 
10-13 showed a similar nucleolar localisation to oocyte-type 5S RNA. This result 
indicates that defective nucleolar targeting is not the reason for this mutant not being 
assembled into ribosomal subunits. Mutant 96-101 showed a lower level of nucleolar 
accumulation (0.68) relative to oocyte-type. This could reflect either a lower affinity 
for nucleolar components, or a higher affinity for putative nucleoplasmic 5S RNA-
binding components. The lower level of nucleolar localisation of this mutant is 
probably not the sole reason for it not being detected in 60S subunits, although it 
may be a contributing factor. 
Deletion of the bulged nucleotides at positions 49 and 50 or 63 resulted in 
5S RNA molecules defective for ribosome assembly. Both of these mutant RNAs 
were present in high quantities in nucleolar fractions in the biochemical assay, but 
did not show a corresponding degree of nucleolar localisation in the in situ assays, 
exhibiting a homogeneous distribution throughout the nucleus. These results indicate 
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that 849,50 and 863 are binding to other nuclear structures which are large enough 
to be pelleted under the biochemical fractionation conditions. These larger complexes 
may result from completely non-specific interactions or may represent some normal, 
but unknown cellular process. Two other mutant RNAs, one derived from tRNAmet 
and the other from U1 snRNA, have also shown abnormal behaviour in the nucleus 
of Xenopus oocytes. Both of these mutants were defective in nuclear export due to 
interactions with unidentified, saturable binding sites within the nucleus (Boelens 
et al., 1995). 
The complexes formed by 849,50 and 863 may be part of a degradation 
pathway for defective 5S RNA molecules. Recently, the Ro antigen was found to be 
associated with 5S RNA molecules containing point mutations as well as additional 
nucleotides at the. 3' end, suggesting this protein may be part of a 5S RNA discard 
pathway (O'Brien and Wolin, 1994). However, this seems unlikely here, since of all 
of the mutants tested, 849,50 and 863 were the only mutants which formed this 
complex, and these mutants were also of the correct length. In addition, all of the 
mutants were stable in oocytes during the incubation period, suggesting they were not 
degraded. 
The presence of 849,50 and 863 in nucleolar pellets indicates they are 
associated with relatively large or insoluble complexes in the nucleus. One such 
component of the nucleus is the nuclear matrix. This term refers to the elaborate 
three-dimensional proteinaceous structure which remains after high salt extraction and 
removal of DNA from nuclei. The nuclear matrix is thought to be the site of DNA 
replication, heterogeneous RNA (hnRNA) processing and steroid hormone action, and 
to also determine the higher order chromatin architecture (reviewed in Berezney, 
1991). Preparations of nuclear matrix fractions from oocyte nuclei showed that both 
oocyte-type 5S RNA and 849,50 were contained in the soluble, supernatant fraction 
(pers. observ.), ruling out the possibility that association with the nuclear matrix is 
the reason for these mutants' aberrant behaviour. 
Other large structures within Xenopus oocyte nuclei include different types of 
granules (referred to as spheres, sphere organelles or snurposomes), which range 
from one to ten microns in diameter. These have been shown to contain various 
components of mRNA splicing machinery, as well as a homologue of p80-coilin, 
suggesting they are related to the coiled bodies found in plant and animal cells (Wu 
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et al., 1991; Tuma et ai., 1993; Wu and Gall, 1993). Since p80-coilin may perform a 
structural role in the nucleolus (Bohmann et ai., 1995) and coiled bodies are known 
to contain nucleolar components such as fibrillarin (Raska et ai., 1991), U3 snoRNA 
(Azum-Gelade et al., 1994; Jimenez-Garcia et al., 1994), Nopp140 and its binding 
protein NAP57 (Meier and Blobel, 1994) and ribosomal protein S6 (Jimenez-Garcia 
et al., 1994), and have been identified within the nucleoli of certain breast cancer 
cells (Ochs et al., 1994) and in hepatocyte nuclei from hibernating dormice 
(Malatesta et al., 1994), it is possible that the granules present in amphibian oocyte 
nuclei may also contain nucleolar components. 5S RNPs were not identified in coiled 
bodies in mammalian cells (Raska et al., 1991), however, examination of their 
presence in amphibian oocyte granules has not been reported. Thus, it is possible that 
5S RNA or the mutants A49,50 and A63 are associated with these granules in the 
nuclei of oocytes. 
Recent evidence suggests that bulged nucleotides are capable of modulating 
the strength of protein-RNA interactions. For example, the E. coli ribosomal protein 
S8 binds to both 16S rRNA and to its own mRNA transcript, acting as a repressor of 
translation (reviewed in Nomura et al., 1984). The S8 binding site on 16S rRNA 
consists of two short duplexes that enclose a conserved, asymmetric internal loop. 
The S8 binding site on the mRNA is very similar, in both primary and secondary 
structure, except for the presence of two single bulged nucleotides (Wu et al., 1994). 
The two bulged nucleotides were shown to confer a five-fold decrease in the binding 
affinity of S8 for the mRNA, where deletion of the bulged nucleotides increased S8 
binding five-fold (Wu et al., 1994). 
It is tempting to speculate therefore, that deletion of the bulged nucleotides in 
5S RNA has a similar effect. The resulting 5S RNA would have a higher affInity for 
nucleoplasmic components, which may even be part of the normal pathway taken by 
5S RNA within the nucleus. The mutant RNAs would thus remain associated with 
these components, possibly forming aggregates, resulting in complexes large enough 
to be pelleted during the centrifugation step. This hypothesis is supported by the fact 
that A49,50 and A63, both of which contain deletions of bulged nucleotides, were the 
only mutants showing this aberrant phenotype, with the majority of the other mutants 
showing similar distribution characteristics to oocyte-type. 
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Whatever the composition of these large complexes, it is possible that their 
formation prevents these mutant 5S RNAs being integrated into ribosomal subunits. 
This provides an alternative explanation to that proposed in Chapter 3, where deletion 
of the bulged nucleotides was postulated to prevent incorporation into 60S subunits 
due to a loss of binding interactions with other ribosomal components. Further 
studies are necessary to distinguish between these two possibilities. 
IV. Pathway of 58 RNA to the Ribosome 
As discussed in the Introduction to this chapter, 5S RNA is thought to be 
assembled into eukaryotic ribosomal subunits at a relatively early stage of ribosome 
assembly, in the dense fibrillar component of the nucleolus (Knight and Darnell, 
1967; Warner and Soeiro, 1967; RaSka et al., 1995; Shaw et al., 1995), As these sites 
might not be readily accessible from the outside of the nucleolus, it could be 
proposed that 5S RNA binds to other nucleolar components, which act as receptors 
and provide a pathway to the site of integration into preribosomal particles. Since 
approximately equal amounts of oocyte-type and somatic-type 5S RNAs were 
injected into oocytes in the nucleolar localisation studies, yet more than twice as 
much somatic-type was associated with nucleoli compared with oocyte-type and 
endogenous 5S RNA, this implies that more molecules of somatic-type 5S RNA are 
associated with nucleoli. This suggests that under in vivo conditions, not all possible 
5S RNA binding sites within the nucleolus are occupied. If 5S RNA binds directly to 
preribosomal particles within the nucleolus, this would imply that 5S RNA is a 
limiting factor during ribosome assembly. This seems unlikely in view of the large 
amount of 5S RNA stored in the cytoplasm and, as shown here, present in the 
nucleoplasm. The alternative scenario is that there are additional 5S RNA binding 
sites at the nucleolus before the molecule becomes assembled into preribosomal 
particles. If somatic-type 5S RNA has a higher affinity for these sites, this would 
explain the higher levels of nucleolar accumulation observed for this RNA. Thus, the 
data presented here support the above hypothesis, whereby 5S RNA interacts with 
other nucleolar components before being integrated into preribosomal particles. 
Chapter 4 108 
Figure 4-16 depicts a model which proposes the pathway taken by 5S RNA 
within the nucleus, incorporating the differences observed between oocyte-type and 
somatic-type 5S RNAs. As shown in this model, oocyte-type and somatic-type 
5S RNAs have slightly different conformational structures resulting from the six 
nucleotide substitutions. This confers different binding affinities on the two types of 
RNA for different oocyte proteins. Once imported into the nucleus bound to 
ribosomal protein L5, oocyte-type 5S RNA-containing 5S RNPs bind to 
nucleoplasmic components, to which they have a high affinity. Thus, only a small 
percentage of oocyte-type 5S RNA is associated with nucleoli. Somatic-type 
5S RNA-containing 5S RNPs, however, have a lower affinity for these nucleoplasmic 
factors, but a high affinity for nucleolar receptors. Thus, more somatic-type 5S RNA 
in the nucleus is associated with nucleoli and more is assembled into 60S ribosomal 
subunits. 
In this model, therefore, the intranuclear distribution of 5S RNPs is dependent 
on the sequence of the 5S RNA, rather than L5. Incorporation into preribosomal 
particles, however, requires sequences and/or structures from both the RNA and 
protein moieties of the 5S RNP. 
The identification of both nucleolar and nucleoplasmic factors which interact 
with 5S RNA, and the involvement of known nucleolar proteins such as B23 and 
nucleolin remains to be determined. The model proposed here provides a framework 
for further experimentation which may provide insights into the enigmatic way in 
which ribosomes are assembled in the nucleoli of eukaryotic cells. 
Figure 4·16 Model for the pathway taken by oocyte-type and somatic-type 5S RNAs in Xenopus 
oocyte nuclei. Oocyte-type and somatic-type 5S RNAs are shown to have a slightly different 
conformational structure, which alters their relative binding affinities for oocyte proteins. In the 
cytoplasm, 5S RNA binds to ribosomal protein L5, to which somatic-type SS RNA has a higher 
affinity (Q. You, Q. Zang, P. J. Romaniuk, in prep.), and the resulting complex is transported into the 
oocyte nucleus. In the nucleus, oocyte-type 5S RNA-containing 5S RNPs are proposed to have a 
higher affinity for nucleoplasmic components (nucleoplasmic receptor), so are more likely to bind 
these factors (indicated by thick arrows) than to be targeted to nucleoli. Somatic-type 5S RNA is 
shown to have a higher affinity for receptor molecules on the outside of the granular component of the 
nucleolus (indicated by thick arrows). After binding to these receptors 5S RNPs make their way to the 
dense fibrillar component of the nucleolus, where structures of both the RNA and protein are 
necessary for integration into preribosomal particles. 
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CHAPTER 5 
7S RNP LOCALISATION IN THE CYTOPLASM 
5.1 INTRODUCTION 
Mter SS RNA is synthesised in the nucleus of previtellogenic oocytes, it is 
exported to the cytoplasm where it is stored in one of two RNA-protein complexes, 
which sediment at 42S and 7S. The 42S RNP consists of SS RNA, tRNA and two 
non-ribosomal proteins (Ford, 1971; Picard et ai., 1980). The remaining fifty percent 
of SS RNA is complexed in a one to one ratio with the protein TFIIIA, as a 7S RNP 
(Picard and Wegnez, 1979; Honda and Roeder, 1980; Pelham and Brown, 1980). 
Immunocytochemical studies performed on immature and mature oocytes showed that 
42S RNPs and 7S RNPs are located exclusively in the cytoplasm (Mattaj et al., 
1983; Viel et al., 1990). In addition, immunoprecipitations of cytoplasmic versus 
nuclear fractions from oocytes injected with labelled SS RNA showed that the 
majority of 7S RNPs formed were present in the cytoplasm, whereas SS RNPs were 
found in both compartments (Allison et al., 1991; 1993; Chapter 4). Since TFllIA is 
also a transcription factor which therefore functions in the nucleus (Engelke et al., 
1980), it appears that binding to SS RNA alters the subcellular location of this 
protein. 
The combined size of TFllIA (38.5 kD; Ginsberg et al., 1984) and SS RNA 
(40 kD) is 78.5 kD, which is above the estimated limit for passive diffusion of 
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globular proteins through nuclear pores (Bonner, 1975; Peters, 1984). Thus, one 
explanation for the obsexved cytoplasmic localisation of 7S RNPs is that they are too 
large to diffuse into the nucleus. However, this seems an unlikely explanation, since 
7S RNPs are thought to form in the nucleus and subsequently move through the 
nuclear pores into the cytoplasm (Guddat et al., 1990). Another possibility for the 
cytoplasmic location of 7S RNPs is that 5S RNA binding masks the putative TFIIIA 
nuclear localisation sequence (NLS), which has been speculated to lie between the 
DNA binding domain and transcriptional activation domain (Mao and Darby, 1993). 
Studies performed by L. A. Allison (unpubl. obsexv.) using somatic cell nuclei 
cultured in a Xenopus egg extract showed that both fluorescently labelled TFIIIA and 
7S RNPs were imported into these nuclei, under conditions where non-nuclear 
proteins were excluded. These data suggest that the cytoplasmic location of these 
molecules in oocytes is not due to masking of the TFIIIA NLS or due to the large 
size of the molecule. This implies that another cellular factor(s) is responsible for 
retaining 7S RNPs in the cytoplasm of oocytes. Such a factor(s) could be some 
component of the cytoplasm that binds to 7S RNPs, and thus sequesters them, or 
some component of the nuclear transport machinery that is necessary for 7 S RNP 
import and was present in the in vitro extract above, but is absent in oocytes. The 
latter possibility has some experimental support from studies performed by 
Featherstone et al. (1988). These authors showed that of a group of antibodies which 
recognise nuclear pore complex proteins in rat liver and kidney cells and Xenopus 
A6 kidney cells, only one of these (RLl) reacted with Xenopus oocytes, suggesting 
that there is cell-specific expression of nuclear pore epitopes. However, the absence 
of nuclear import factors also seems an unlikely explanation for the cytoplasmic 
retention of 7S RNPs for the following two reasons. Firstly, TFIIIA is capable of 
nuclear import in oocytes, so necessary import factors must be present for the nuclear 
import of this molecule. Secondly, although a small amount of 5S RNA has been 
detected bound to a TFIIIA-like protein in HeLa cells (Lagaye et al., 1988), 7S RNPs 
are not a predominant form of 5S RNA-containing complex, as in oocytes, so it 
would be unlikely that somatic cells would contain specific nuclear import factors for 
7S RNPs. 
It was therefore of interest to determine if any oocyte cytoplasmic 
components playa role in retaining 7S RNPs in the cytoplasm. Such components 
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could include insoluble filamentous structures, such as the cytoskeleton and internal 
membrane systems. Experimental evidence for the role of each of these components 
in the regulation of nuclear import and/or subcellular localisation is reviewed in the 
following sections. 
I. Evidence for the Role of the Cytoskeleton in Localising Proteins and RNA 
The cytoskeleton of eukaryotic cells contains three major classes of fibres: the 
seven nanometre diameter microfilaments, 24 nanometre diameter microtubules and 
the ten nanometre diameter intermediate filaments. Microfilaments are formed by the 
polymerisation of the protein subunit G-actin. They also contain a diverse array of 
other actin binding proteins, which enable the filaments to form unique structures, or 
to carry out. specific cellular functions (reviewed in Schliwa, 1986). Microtubules are 
formed by the polymerisation of tubulin subunits, and are involved in mitotic spindle 
formation, chromosome movement and cell separation during mitosis, movement of 
cilia and flagella, and provide tracks for the transport of small vesicles within the 
cytoplasm. Intermediate filaments are also made up of subunit proteins, of which 
there are five major classes; vimentin, desmin, glial fibrillary acidic protein, the 
neurofilaments and the cytokeratins; each of which is characteristically expressed in a 
single cell type (reviewed in Schliwa, 1986). The three cytoskeletal components form 
a complex filamentous system which extends throughout the cytoplasm of cells and 
is responsible for maintaining cell shape and rigidity, cell motility, and organelle 
movement and localisation. Other potential functions of the cytoskeleton appear to be 
in retention and localisation of proteins and RNAs in the cytoplasm. 
i. Protein retention 
An example of a protein which is retained in the cytoplasm due to 
associations with the cytoskeleton is the glucocorticoid receptor. The glucocorticoid 
receptor interacts with specific DNA sequences involved in the regulation of gene 
transcription. In the absence of glucocorticoid hormone, the receptor is localised to 
the cytoplasm, but upon addition of hormone it is rapidly translocated to the nucleus. 
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Immunofluorescence microscopy showed that the receptor is localised in the 
cytoplasm in a similar pattern to tubulin, in both interphase and mitotic cells 
(Wikstrom et ai., 1987; Akner et ai., 1990). In addition, treatment of cells with 
colchicine or vinblastine, which depolymerise microtubules, caused a similar 
redistribution of both glucocorticoid receptor and tubulin to the cell periphery (Akner 
et ai., 1990). In the cytoplasm, the receptor is bound in a multiprotein complex 
which includes a dimer of heat shock protein 90 (hsp90; reviewed in Pratt, 1992). 
hsp90 has also been colocalised with microtubules in a variety of cell lines 
(Redmond et ai., 1989). It has thus been proposed that the glucocorticoid receptor is 
docked in the cytoplasm, in association with the cytoskeleton (Pratt, 1992). Addition 
of hormone would result in the dissociation of the receptor from hsp90, thus 
releasing it from its cytoplasmic anchoring site and allowing it to be targeted to the 
nucleus (Pratt, 1992). 
ii. RNA association with the cytoskeleton 
a. Somatic cells 
Lenk et ai. (1977), using Triton X-lOO extraction, flrst showed that mRNA 
was associated with the cytoskeleton of HeLa cells. Extraction of cells with this non-
ionic detergent solubilises cellular lipids and membranes, and removes mitochondria, 
endoplasmic reticulum and 75% of cytoplasmic proteins. The structure of the 
remaining cytoskeleton, as judged by electron microscopy, was shown to resemble 
that of intact cells (Lenk et ai., 1977). These workers observed that most of the 
polyribosomes remained associated with the cytoskeleton after detergent extraction. 
Degradation of mRNA with low levels of ribonuclease released the ribosomes from 
the cytoskeleton, and disaggregation of polyribosomes with fluoride ions resulted in 
the release of ribosomes but not the mRNA, suggesting polyribosomes were attached 
to the cytoskeleton via mRNA (Lenk et ai., 1977; Bag and Pramanik, 1987; 
Taneja et al., 1992). 
Since these initial findings, most studies on RNA-cytoskeletal interactions 
have focussed on mRNAs which are localised within specific regions of the 
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cytoplasm. Many studies using in situ hybridisation have shown specific mRNAs are 
localised to different regions within somatic cells (Lawrence and Singer, 1986; 
Garner et al., 1988; Cripe et al., 1993; Kislauskis et al., 1993; Hesketh et al., 1994; 
reviewed in Bassel, 1993). For example, in chicken embryonic myoblasts and 
fibroblasts, mRNA encoding actin was found to be predominantly localised to the 
periphery of cells in lamellipodia, vimentin mRNA was distributed near the nucleus 
and tubulin mRNA appeared most concentrated in the peripheral cytoplasm 
(Lawrence and Singer, 1986). 
Visualisation of individual mRNA molecules simultaneously with cytoskeletal 
filaments in human fibroblasts showed that 72% of poly(A) mRNA was localised 
within five nanometres of orthogonal networks of actin filaments (Singer et al., 1989; 
Bassel et al., 1994). Poly(A) mRNA also colocalised with vimentin filaments (29%) 
and microtubules (less than ten percent; Bassel et al., 1994). In addition, treatment of 
cells with cytochalasins, causing a depolymerisation of actin and collapse of the 
microfilament network has been shown to release mRNA (Lenk et al., 1977; Bird 
and Sells, 1986; Ornelles et al., 1986; Taneja et al., 1992) and polysomes (Vedeler 
et al., 1991) from the cytoskeletal fraction. Thus, the majority of evidence indicates 
that the cytoskeletal component to which mRNA is bound in somatic cells is the 
microfllaments. 
However, there is also evidence for mRNA association with other cytoskeletal 
components. Localisation studies of the mRNA 5' -cap binding protein in baby 
hamster kidney cells showed it to be present in a fibrous network extending 
throughout the cytoplasm in a radial arrangement, in a pattern directly 
superimposable on the labelling patterns shown by intermediate filaments (Zumbe 
et aI., 1982). The mRNA cap binding protein was also associated with the 
cytoskeletal fraction after Triton X-IOO extraction and behaved like intermediate 
filaments in colchicine treated cells, suggesting a direct or indirect linkage with 
intermediate filaments (Zumbe et al., 1982). In addition, synthesis of viral proteins in 
cells infected with frog virus 3 is thought to occur on intermediate filaments 
(Murti et al., 1989), 
There is also evidence for mRNA association with microtubules in somatic 
cells. Visualisation of the subcellular distribution of mRNA encoding myelin basic 
protein after injection into oligodendrocytes showed that the mRNA formed granules, 
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which were aligned in tracks along micro tubules traversing the cytoplasm and 
processes (Ainger et al., 1993). Extraction of cells with Triton X-lOO did not release 
these mRNA granules, indicating an association with the cytoskeleton. Also, studies 
in primary neuronal cells have shown that tau mRNA, which is localised in the cell 
body and to the proximal portion of the axon, is associated with the microtubule 
system and not with the actin filaments (Litman et al., 1994). It has been suggested 
that microtubules function in the transport of mRNA within cells (reviewed in 
Suprenant, 1993). 
b. Drosophila oocytes 
Specific subcellular localisation of mRNAs is not restricted to somatic cells, 
and is now known to be an important requirement in eggs for the establishment of 
protein gradients that give rise to the embryonic body plan (reviewed in St Johnston, 
1995). In Drosophila oocytes,. localisation of a set of mRNAs including bicoid 
(Berleth et al., 1988), oskar (Kim-Ha et al., 1991), naoos (Wang and Lehmann, 
1991),js(l)K10 (Cheung et al., 1992) and orb (Lantz and Schedl, 1994) is 
responsible for the formation of both anterio-posterior and dorso-ventral axes during 
em bryogenesis. 
Most evidence points towards the role of microtubules in transport and 
localisation of these mRNAs. For example, bicoid mRNA is transcribed in the nurse 
cells and transported into the oocyte via the ring canals, where it is localised to the 
anterior cortex (Berleth et al., 1988). Drugs that depolymerise microtubules perturb 
all aspects of this localisation, whereas cytochalasin has no effect (Pokrywka and 
Stephenson, 1991; Theurkauf et al., 1993). In addition, cellular fractionation using 
Triton X-lOO extraction showed that bicoid, Bicaudal D, fs(1)KlO, orb and oskar 
mRN As were all recovered in the cytoskeletal fraction and were released into the 
soluble fraction after treatment with colchicine, also indicating a role for 
microtubules (Pokrywka and Stephenson, 1994). However, it appears factors other 
than microtubules may be required to maintain localisation (pokrywka and 
Stephenson, 1995). 
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c. Xenopus oocytes 
There are also examples of mRNAs associated with the cytoskeleton in 
Xenopus oocytes. As above, these studies have focussed on RNAs which show 
localisation to specific regions of the cytoplasm. However, there is no reason to 
believe RNA molecules that are distributed homogeneously throughout the cytoplasm, 
such as 7S RNPs, could not also be associated with the cytoskeleton. In Xenopus 
oocytes many mRNAs have been identified and cloned which have a non-
homogeneous distribution relative to the animal-vegetal axis (King and Barklis, 1985; 
Rebagliati et al., 1985; Mosquera et al., 1993). mRNAs localised to the vegetal 
hemisphere include Vg1 (Rebagliati et al .• 1985), which encodes a protein which is a 
member of the TGFj3 family of proteins and is thought to function in the generation 
of dorsal mesoderm (Weeks and Melton, 1987a; Thomsen and Melton, 1993); Xcat2, 
which has homology to the Drosophila nanos protein and is possibly an RNA-
binding protein; Xcat3 (Mosquera et al., 1993); and Xwnt-ll , whose protein is also 
thought to be important for dorso-ventral axis formation (Ku and Melton, 1993). 
mRNAs localised to the animal hemisphere include An1 (Rebagliati et al., 1985), 
which encodes a protein with homology to ubiquitin and contains a putative zinc-
finger motif (Linnen et al., 1993); An2 (Rebagliati et al., 1985), which codes for a 
subunit of mitochondrial ATPase (Weeks and Melton, 1987b); An3 (Rebagliati et al., 
1985), whose protein has an ATP-dependent RNA helicase activity (Gururajan et al., 
1994); and xlan4 which may have a neural-specific function (Reddy et al., 1992). 
Extraction of stage VI Xenopus oocytes with Triton X-lOO showed that only 
small amounts of total RNA (0.5%-2%) or poly (A) RNA (0.5%-5%; depending on 
the extraction procedure used) were present in the detergent insoluble, cytoskeletal 
fraction (Pondel and King, 1988; Yisraeli et al., 1990). Many of the localised 
mRNAs in Xenopus oocytes are enriched in these cytoskeletal fractions, for example 
Vg1 (Pondel and King, 1988; Yisraeli et al., 1990; Forristall et al., 1995), Xcat2 and 
Xcat3 (Mosquera et al., 1993; Forristall et al., 1995). The best studied localised 
mRNA in Xenopus oocytes is Vgl. In young, stage I and IT oocytes, Vg1 mRNA is 
uniformly distributed throughout the cytoplasm. During stage ill, V g1 begins to 
localise to a tight cortical shell (Melton, 1987). Following hormonal maturation of 
the oocyte into an egg, V g1 is released from the tight cortical shell and forms a 
broader band in the vegetal hemisphere which remains in vegetal cells throughout 
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early embryogenesis (Weeks and Melton, 1987a). Localisation of Vg1 mRNA 
appears to be a two step process. The use of cytoskeletal inhibitors suggested that 
microtubules were involved in the translocation of the message to the vegetal 
hemisphere, and microfilaments were important for the anchoring of the message at 
the cortex (Yisraeli et al., 1990). In addition, a proportion of Vg1 mRNA was shown 
to be associated with microtubules in vivo (Elisha et al., 1995). There is also some 
evidence that intermediate filaments may be involved in anchoring Vg1 mRNA at the 
vegetal cortex (Pondel and King, 1988; but see also Klymkowsky et al., 1991). Thus, 
as the above data indicates, there is evidence for a role of all three major cytoskeletal 
components in the localisation of mRNA within cells. 
mRNAs are not the only subset of RNA thought to be associated with the 
cytoskeleton in Xenopus. Xlsirts are a family of interspersed repeat RNAs from 
Xenopus that contain from three to thirteen repeat units (each 79-81 nuc1eotides long) 
flanked by unique sequences, that do not appear to be translated (Kloc et al., 1993). 
Xlsirt RNA is first associated with the mitochondrial mass in stage II oocytes, and is 
translocated to the vegetal cortex at early stage ill (Kloc et al., 1993). Xlsirt repeat 
sequences are required for this translocation, and can cause the translocation of 
heterologous RNA (Kloc et al., 1993). Treatment of stage VI oocytes with 
cytochalasin partially released Xlsirt RNA from the vegetal cortex, indicating that 
anchoring at the vegetal cortex is partly dependent on microfilaments (Kloc and 
Etkin, 1995). Interestingly, when endogenous Xlsirt RNA was destroyed using 
antisense oligodeoxynuc1eotides, V g1 mRNA, but not Xcat2 mRNA was released 
from the vegetal pole, indicating that Xlsirt RNAs are important for V g1 localisation 
(Kloc and Etkin, 1994), 
d. Requirements for localisation 
Experiments using protein synthesis inhibitors such as puromycin and 
cycloheximide showed that neither the translocation or anchoring of actin mRNA was 
affected by these inhibitors in chicken embryo fibroblasts (Sundell and Singet, 1990). 
In Xenopus, in vitro synthesised Vg1 mRNA microinjected into oocytes localised in a 
similar fashion to endogenous V g1 transcripts. Molecules with deletions in the 
5' region, which abolished ribosome binding and translation, were also correctly 
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localised, showing that the necessary infonnation for localisation is present in the 
naked RNA molecule itself (Yisraeli and Melton, 1988). 
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Studies using deletion mutagenesis and chimeric mRNA molecules have 
found that for all mRNAs examined, the 3' Ulltranslated region (3' UTR) of the RNA 
molecule is both necessary and sufficient for mRNA localisation, in somatic cells, 
oocytes and embryos (Macdonald and Struhl, 1988; Davis and Ish-Horowicz, 1991; 
Cheung et al., 1992; Dalby and Glover, 1992; Gavis and Lehmann, 1992; Kim-Ha 
et al., 1993; Macdonald et al., 1993; Kislauskis et al., 1994; Lantz and Schedl, 
1994). For example, in Xenopus, a 340 nucleotide region of the 3' UTR is necessary 
to localise microinjected Vgl mRNA, and is also capable of localising a chimeric, 
non-localised mRNA (Mowry and Melton, 1992). Most analyses have found very 
little homology among the 3' UTRs of localised mRNAs, and it has been suggested 
that it is the secondary structure which may be recognised by cellular factors 
(Macdonald and Struhl, 1988;' Macdonald, 1990). 
The elucidation of the trans-acting cellular factors involved in binding to 
localised mRNA molecules is less well characterised. Proteins have been identified 
from the cytoskeletal compartment of NIH 3T3 cells and from mouse spennatids that 
bind to the 3' UTR of localised mRNAs, and have been suggested to provide a link: 
between mRNAs and the cytoskeleton (Sharpless et al., 1993; Schumacher et al., 
1995). In Drosophila oocytes, localisation of bicoid involves at least three steps, each 
with different protein requirements (for example, Ferrandon et al., 1994; reviewed in 
St Johnston, 1995). In Xenopus, a 69 kD protein has been identified which binds to 
the Vgl 3' UTR. This binding was inhibited by another vegetaIly localised mRNA, 
TGFj35, but not by the animal pole localised An2 mRNA (Schwartz et al., 1992). 
This protein was also shown to associate with microtubules, and is required for the 
specific association of V gl mRNA with microtubules in vitro, thus is likely to play a 
role in the localisation of Vgl mRNA in oocytes (Elisha et al., 1995). 
iii. RNP associations with the cytoskeleton 
In addition to RNA, there is evidence that different types of RNPs are 
associated with the cytoskeleton. One example is prosomes, a class of ubiquitous 
RNPs which consist of variable sets of proteins and RNA, depending on the cell 
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type, which were first discovered as subcomplexes of translationally repressed mRNP 
(reviewed in Scherrer, 1990). Fractionation with Triton X-loo showed a significant 
proportion of pro some protein was associated with the cytoskeletal fraction, and 
immunofluorescence and immunoelectron microscopy showed that pro some antigens 
are extensively associated with the cytokeratin-type intermediate filaments in HeLa 
cells and rat kangaroo kidney epithelial cells (Grossi de Sa et al., 1988). In human 
fibroblasts, which have an intermediate filament network exclusively constituted of 
vimentin, prosomes coincide fully with vimentin fibres; and in proliferating mouse 
myoblasts, where desmins are the dominant constituent of intermediate filaments, the 
prosomal antigens were found partially located on the des min network (Olink-Coux 
et al., 1994). Prosomes have also been detected in Xenopus oocytes and eggs 
(Ryabova et al., 1994). In previtellogenic oocytes, prosomal antigens were clustered 
throughout the cytoplasm and nucleus. During vitellogenesis, prosomal proteins 
acquired a preferential subcortical localisation; and in the fully grown oocyte, 
staining was more intense in the animal hemisphere, as well as in cortical and 
subcortical regions. Double staining of stage VI oocytes demonstrated a correlation in 
the localisation of actin and myosin and prosome particles (Ryabova et al., 1994). 
Thus, it appears that in different cell types prosomes are associated with different 
components of the cytoskeleton. 
Large RNPs called vaults, which have been described in mammals, 
amphibians, birds, and the lower eukaryote Dictyostelium, consist of multiple copies 
of a small RNA and more than 50 copies of a single polypeptide (reviewed in 
Kedersha and Rome, 1990). In stationery fibroblasts, a subpopulation of vaults cluster 
at the ends of actin stress fibres, while in spreading fibroblasts vaults appear 
clustered within the actin-rich ruffling edges of lamellipodia (Kedersha and Rome, 
1990). 
Subcellular fractionation of HeLa S3 cells showed that a group of small 
cytoplasmic RNAs (scRNAs) were present in the cytoskeletal, non-polyribosome 
associated fraction, and that a significant proportion of these scRNAs were released 
by treatment with cytochalasin (Bird and Sells, 1986). These workers also 
demonstrated the presence of 5S RNA in all fractions analysed, including the 
cytoskeletal, non-polyribosome associated fraction. This indicates that in HeLa cells a 
proportion of 5S RNA which is not contained within polyribosomes is associated 
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with the Triton X-IOO cytoskeletal fraction. It is not known what proteins were 
bound to the 58 RNA present in this fraction. 
II. Evidence for the Role of Intracellular Membranes in Localising Proteins 
and RNA 
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As well as the plasma membrane, eukaryotic cells contain an extensive system 
of internal membranes, which enclose and separate specific regions from the rest of 
the cytoplasm. The largest component is the endoplasmic reticulum, a network of 
interconnected closed membrane vesicles in which protein and lipids are synthesised. 
Membranes also form stacks of flattened sacs which constitute the Golgi apparatus, 
which is involved in transporting membrane constituents to appropriate places within 
the cell. Membranes also surround the nucleus, mitochondria, and smaller organelles 
such as lysosomes and peroxisomes (reviewed in Evans and Graham, 1989). Another 
membranous component of cells is the annulate lamellae, which consist of parallel 
membranes, often stacked, that enclose a cavity, or cisterna, and contain numerous 
pore complexes which are structurally similar to those of the nuclear envelope 
(reviewed in Kessel, 1992). Although the function of annulate lamellae is unknown, 
there have been many proposed functions, including a reservoir of nuclear envelope 
components, biogenesis of mitochondria, steroid production, and roles in the release, 
packaging or assembly of stored developmental information, such as mRNA 
(reviewed in Kessel, 1992). 
i. Protein retention 
Type II cyclic AMP (cAMP)-dependent protein kinase, which is involved in 
transcriptional control (reviewed in Nigg, 1990), is an example of a protein which is 
anchored to cytoplasmic membranes. cAMP-dependent protein kinases are composed 
of two regulatory subunits and two catalytic subunits, which together constitute an 
inactive holoenzyme. Binding of cAMP to the regulatory subunit dimer results in the 
release and activation of the catalytic subunits. The subcellular distribution of the 
inactive holoenzyme has been shown by subcellular fractionation and 
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immunofluorescent microscopy to be associated with the Golgi complex in epithelial 
cells and fibroblasts (Nigg et al., 1985a). Treatment of cells with forskolin to 
increase the cAMP levels resulted in the dissociation of the catalytic subunit, which 
then predominantly accumulated in the nucleus. The regulatory subunit remained 
associated with the Golgi complex. The effect of forskolin was reversible in that after 
removal, the catalytic subunits reassociated with the Golgi complex in the cytoplasm 
(Nigg et al., 1985b). 
ii. RNA association with intracellular membranes 
It is well known that a proportion of ribosomes in cells are associated with 
the endoplasmic reticulum (known as the rough endoplasmic reticulum). These 
ribosomes are involved in synthesising proteins destined for extracellular secretion, or 
for incorporation into the plasma membrane or intracellular organelles that comprise 
the endomembrane system. Ribosomes in the process of translating these proteins are 
targeted to the rough endoplasmic reticulum via recognition of a signal sequence 
contained within the nascent polypeptide. This sequence is recognised by a signal 
recognition particle, a complex that consists of one 78 RNA molecule and six 
different polypeptides (Walter et al., 1981; reviewed in Walter and Johnson, 1994). 
The signal recognition particle then binds to a receptor on the endoplasmic reticulum, 
and the nascent polypeptide is translocated across the endoplasmic reticulum 
membrane (Walter and Blobel, 1981a,b). Thus, unlike polyribosome attachment to 
the cytoskeleton, association of ribosomes to the endoplasmic reticulum is not 
thought to be mediated by mRNA. 
However, a role for mRNA binding to intracellular membranes has not been 
entirely ruled out. For example, early studies showed that in both human diploid 
fibroblasts and rat hepatocytes, significant amounts of mRNA remained attached to 
membranes after complete removal of ribosomes and their nascent polypeptides 
chains by treatment with high ionic strength buffer and puromycin (Lande et al., 
1975; Cardelli et ai., 1976). Treatment of these membranes with RNase and EDTA 
indicated that the poly(A), and possibly non-poly(A) portions of the mRNA were 
involved in binding to membranes (Milcarek and Penman, 1974; Lande et al., 1975; 
Cardelli et ai., 1976). Also, dormant cysts of the brine shrimp Artemia, contain 
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latent, poly(A)-rich mRNA, which is to a large extent associated with cytoplasmic 
membranes (Grosfeld et al., 1977; Simons et al., 1978; Nilsson and Hultin, 1982). In 
addition, studies on protein targeting to the endoplasmic reticulum in Saccharomyces 
cerevisiae have shown that cells lacking the signal recognition particle and its 
receptor are viable, indicating that alternative pathways must exist (reviewed in 
Walter and Johnson, 1994). Although it is not known whether this alternative 
mechanism occurs co-translationally or post-translationally, it is possible that 
alternative pathways may be mediated by mRNA interactions. 
Messenger RNA has also been hypothesised to be associated with the 
annulate lamellae. In situ hybridisation to poly(A) RNA in oocytes of the amphibian 
Necturus indicated that poly(A) was localised over cytoplasmic regions of annulate 
lamellae, suggesting maternal mRNA is associated with annulate lamellae (reviewed 
in Kessel, 1992). In addition, there have been numerous reports of a close 
relationship. between the pores of annulate lamellae with polyribosomes and with 
fibrogranular bodies, which are possibly made up of mRNA, rRNA, tRNA and 
protein (Kessel, 1992). Since annulate lamellae are highly prevalent in amphibian 
oocytes, it has been postulated that the low efficiency of translation of maternal 
mRNAs is due to sequestering of the mRNA, and that annulate lamellae have a role 
in this sequestration (Shiokawa, 1983; Kessel, 1992), 
ill. Description of the Cytoskeleton and Membrane Systems in Xenopus Oocytes 
Since immunocytochemistry has shown 7S RNPs to be distributed apparently 
homogeneously throughout the cytoplasm of oocytes (Mattaj et al., 1983; Viel et al., 
1990), any factors involved in the retention of 7S RNPs would need to be distributed 
throughout the cytoplasm in a similar fashion. Thus, before investigating whether 
7S RNPs are sequestered in the cytoplasm of previtellogenic oocytes due to an 
association with the cytoskeletal or internal membrane systems, it was first necessary 
to assess what components of these systems are present in oocytes. The following is 
a description of each of these systems throughout oogenesis, with an emphasis on 
previtellogenic stages. 
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i. The cytoskeleton 
The presence of microtubules throughout oogenesis has been well documented 
using anti-tubulin immunofluorescence microscopy and laser scanning microscopy 
(Palacek et al., 1985; Gard, 1991). Stage I oocytes contain a poorly ordered array of 
cytoplasmic microtubules, which is more dense in the cortical cytoplasm, surrounding 
the nucleus, and surrounding the mitochondrial mass (Palacek et al., 1985; 
Gard, 1991). A radial tubulin array, emanating from the nucleus and extending 
throughout the cytoplasm to the periphery of the oocyte is fIrst visible in stage II 
oocytes (palacek et al., 1985; Yisraeli et al., 1990; Gard, 1991). As the oocyte 
develops and the nucleus is displaced towards the animal pole, the microtubule array 
becomes polarised: the radial array is still present, but only detectable in the animal 
hemisphere of stage VI oocytes. Microtubules are also present in the vegetal 
hemisphere, but appear less ordered, with a network of microtubules and microtubule 
bundles interspersed with the large yolk platelets (Palacek et al., 1985; Yisraeli et al., 
1990; Gard, 1991). It has been estimated that there is about 0.12 Jlg (three percent of 
total soluble protein) tubulin per stage VI oocyte, and 25% of this is in polymeric 
form (Jessus et al., 1987). 
The presence of intermediate ftlaments is also well documented in oocytes. 
Examination of previtellogenic oocytes using electron microscopy has shown the 
presence of intermediate ftlaments crossing the cytoplasm in various directions 
(Godsave et al., 1984a). These intermediate ftlaments were shown to be constituted 
of vimentin and cytokeratins. Early stage I oocytes fIrst show a fIne perinuclear ring 
of vimentin, and as the oocytes grow, more vimentin strands are found throughout 
the oocyte cytoplasm, forming a fIne ftlamentous network. The mitochondrial mass 
and the perinuclear sphere of cytoplasmic masses also contain vimentin (Godsave 
et al., 1984a). By late vitellogenesis, vimentin staining was shown to be asymmetric 
between the animal and vegetal poles. In the animal pole, vimentin is confined to the 
yolk-free areas of the cytoplasm that divide the yolk platelets into columns. In the 
vegetal hemisphere, vimentin is distributed in apparently random loci in the vegetal 
yolk mass and irregularly around the cortical cytoplasm (Godsave et al., 1984a). 
In stage I oocytes, cytokeratins are fIrst found as sparse cortical threads and 
surrounding the mitochondrial mass (Godsave et al., 1984b). During early 
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vitellogenesis, cytokeratins appear around the nuclear membrane and radially 
arranged filaments project towards the cortex, which become much more dense 
throughout vitellogenesis (Godsave et al., 1984b). In mature oocytes, there is a 
distinct anima1/vegetal polarity in cytokeratin organisation. In the vegetal region, 
filaments form a fine network characterised by distinct vertices and fine 
interconnecting fibrils (Klymkowsky et al., 1987), and in the animal hemisphere fine 
filaments project radially from the nucleus through yolk-free tracks towards the 
cortex (Godsave et al., 1984b). 
The presence of actin filaments in Xenopus oocytes is less well characterised. 
In stage I oocytes actin cables were shown to course throughout the cytoplasm 
(reviewed in Gard, 1995). Stage VI oocytes have an extensive network of actin 
cables, which surrounds the germinal vesicle, and is present in yolk-free radii 
extending between the germinal vesicle and cortex, and also forms a dense three-
dimensional network in the vegetal cytoplasm (Gall et al., 1983; reviewed in 
Gard, 1995). Stage VI oocytes have been shown to contain 1.4-1.7 pg of actin 
per oocyte, although 75% of this does not sediment under forces that would pellet 
filamentous actin (Merriam and Clark, 1978). In addition, an actin shell was 
demonstrated around yolk platelets in unfertilised eggs (Colombo et al., 1981). Thus, 
the three major cytoskeletal components are present in Xenopus oocytes, and are 
distributed throughout the cytoplasm of pre vitello genic oocytes such that they could 
be involved in retention of 7S RNPs in the cytoplasm. 
ii. The internal membrane system 
Previtellogenic oocytes contain large amounts of endoplasmic reticulum, but 
only small, inconspicuous Golgi complexes. Scattered throughout the cytoplasm are 
lipids, small groups of mitochondria, and spherical structures consisting of annulate 
lamellae (Dumont, 1972). As well as mitochondria, the mitochondrial mass also 
contains endoplasmic reticulum and a few Golgi complexes. In later stage oocytes, 
membrane structures are restricted to the corridors of yolk-free cytoplasm which 
radiate outwards from the germinal vesicle, and to cortical regions of the oocyte 
(Bement and Capco, 1990). Thus it is also possible that 7S RNPs are sequestered by 
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interactions with these membrane components, as they appear to be present 
throughout the cytoplasm of previtellogenic oocytes. 
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5.2 RESULTS 
Immunocytochemical studies have shown that 7S RNPs are found exclusively 
within the cytoplasm of oocytes (Mattaj et al., 1983; Viel et al., 1990). Although the 
distribution of 7S RNPs appeared homogeneous throughout the cytoplasm, these 
studies were not of high enough resolution to detennine whether the 7S RNPs were 
associated with specific cytoplasmic structures. Thus, a series of biochemical 
fractionation techniques were used to investigate the association of 7S RNPs with 
cytoplasmic structures. 
I. 7S RNPs are not Associated with the Oocyte Cytoskeleton 
To detennine whether endogenous 7S RNPs in the cytoplasm of 
previtellogenic oocytes are associated with cytoskeletal components, Triton X-100 
extraction was perfonned on oocytes of different stages, first using the methods of 
Yisraeli et al. (1990). Whole oocytes were homogenised in Triton X-lOO extraction 
buffer, and centrifuged to yield a pellet of insoluble, cytoskeletal factors and a 
soluble cytosolic supernatant fraction. The RNA was then isolated from each fraction, 
and the distribution of 5S RNA established by northern analysis using an antisense 
5S RNA probe. Alternatively, the detergent insoluble and soluble fractions were 
subject to immunoprecipitation using an anti-TFIIIA antibody. The RNA was then 
extracted from the immunoprecipitate fractions and also analysed by northern 
analysis. 
The results of a typical experiment are shown in Figure 5-1. In both 
previtellogenic and vitellogenic oocytes, the majority of total RNA is located in the 
detergent soluble fraction after Triton X-100 extraction (Fig. 5-1A). In previtellogenic 
oocytes (stages I and IT), all of the endogenous 5S RNA was found in the detergent 
soluble fraction (Fig. 5-1B, cf. lanes 4 and 5). In late vitellogenic oocytes (stage V), 
when most of the stored 5S RNA has been released from binding TFIIIA and 
incorporated into ribosomal subunits, 5S RNA was again detected in the detergent 
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soluble fraction (Fig. 5-1B, cf. lanes 1 and 2). However, in some experiments over-
exposures of fIlms revealed a small amount of 58 RNA in the cytoskeletal fraction of 
stage V oocytes (data not shown). The antisense 58 RNA probe binds only to 
58 RNA; no binding to any higher molecular weight RNA or to tRNA was ever 
observed (cf. Fig. 5-1A and B). As an additional control, an identical experiment to 
that shown in Figure 5-1B was performed using a sense-strand 58 RNA probe. There 
was no hybridisation to 58 RNA, showing that the antisense 58 RNA probe binds in 
a sequence-specific manner to 58 RNA (Fig. 5-1 C). 
As a control for the fractionation technique, identical aliquots of RNA isolated 
from cytoskeletal and soluble fractions were probed with the vegetally localised Vg1 
antisense mRNA. As expected, all Vgl mRNA in mature oocytes was present in the 
cytoskeletal fraction (Fig. 5-1D, cf. lanes 1 and 2). In previtellogenic oocytes, V gl 
mRNA was distributed in approximately equal amounts between the cytoskeletal and 
soluble fractions (lanes 3 and 4), in the same pattern observed by Yisraeli et al. 
(1990). The reason for the altered mobilities of the Vg1 transcript between lanes 
2, 3 and 4 is unknown. The presence of Vgl mRNA in the cytoskeletal fraction of 
previtellogenic oocytes also serves as an internal control, showing that the lack of 
58 RNA in this fraction was not due to loss of the· sample. 
To provide further evidence that 78 RNPs were not present in the cytoskeletal 
fraction, and to determine if the faint amount of 58 RNA observed in the cytoskeletal 
fraction of stage V oocytes was in the form of 78 RNPs, immunoprecipitation assays 
were performed on detergent soluble and insoluble fractions after Triton X-lOO 
extraction, using an anti-TFIIIA antibody. Figure 5-2 shows that for both 
previtellogenic and vitellogenic oocytes, 78 RNPs were only immunoprecipitated 
from the detergent soluble fraction (lanes 2 and 5). The slightly higher running band 
in lane 3 is probably due to impurities in the sample. The above experiments were 
repeated using oocytes from many different female frogs, and at no time were 
78 RNPs ever detected in the cytoskeletal fraction. 
The above results indicated that 78 RNPs were not present in the cytoskeletal 
fraction under the conditions of extraction used by Yisraeli et al. (1990). This 
procedure was optimised by these workers for the specific partitioning of V g 1 
mRN A into the detergent insoluble fraction, and fibronectin mRNA, as a control, into 
the detergent soluble fraction. The extraction buffer contained 300 mM KC1, to 
Figure 5·1 5S RNA is not contained withln the cytoskeletal fraction of oocytes. Ptevitellogenic (St TI) 
or vitellogenic (St V) oocytes were fractionated using Triton X-lOO into cytoskeletal and soluble 
fractions. Total RNA was extracted from each fraction and separated by agarose gel electrophoresis 
and visualised by ethidium bromide staining and UV illumination (A), or transferred to nylon 
membrane and probed with antisense 5S RNA (B). Lanes 1 and 4, cytoskeletal fractions; lanes 2 and 
5, detergent soluble fractions; lanes 3 and 6, total oocytes. A similar membrane was probed with 
sense-strand 5S RNA (C) or antisense Vgl transcript (D). Lanes 1 and 3, cytoskeletal fractions; lanes 
2 and 4, detergent soluble fractions. 
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solubilise yolk proteins (Yisraeli et al., 1990). However, no attempt was made by 
these workers to determine what (if any) cytoskeletal components were present in the 
detergent insoluble fraction using this extraction procedure. To determine whether 
78 RNPs are associated with cytoskeletal components not recovered using the above 
extraction procedure, I used a series of extraction protocols to specifically enrich 
each of the three main cytoskeletal components. 
To specifically enrich oocyte microtubules, Triton X-l00 extractions were 
carried out in the presence of 300 mM sucrose, which is known to stabilise 
microtubules (8uprenant, 1993). The distribution of 58 RNA after extraction with this 
protocol was similar to that described above, with 58 RNA present in the detergent 
soluble fraction only (data not shown). In addition, no differences were observed 
when extractions were carried out at 4°C versus room temperature (data not shown). 
Microfilaments are known to be solubilised in buffers containing 
130 mM KCI or greater (Vedeler et al., 1991). To ensure the stabilisation of actin 
filaments, a low salt extraction procedure was performed. This extraction buffer was 
designed to resemble the intracellular ionic composition of Xenopus oocytes, and 
contained 92.5 mM KCI (Capco and Bement, 1991).58 RNA distribution after total 
RNA extraction from fractions isolated using this protocol is shown in Figure 5-3. 
Both vitellogenic and previtellogenic oocytes show distinct 58 RNA bands in the 
cytoskeletal fraction (lanes 1 and 3), although the majority of 58 RNA is still in the 
detergent soluble fraction (lanes 2 and 4). Under these extraction conditions, the 
localisation of Vgl mRNA was identical to that described above (data not shown). 
To determine if the 58 RNA present in the cytoskeletal fraction after this low 
salt extraction was in the form of 78 RNPs, immunoprecipitation analyses were 
performed on each fraction, as shown in Figure 5-4. After extraction in low salt 
buffer, all 58 RNA immunoprecipitated with the anti-TFllIA antiserum was in the 
detergent soluble fraction (lanes 1 and 2 and 4 and 5), In the above 
immunoprecipitation experiments, total oocyte fractions were homogenised in 
standard immunoprecipitation buffer (IppI50), to show that homogenisation of 
oocytes in the various Triton X-I00 extraction buffers did not impair the ability of 
78 RNPs to be immunoprecipitated. This control clearly shows that there is no 
impairment in the immunoprecipitation of 78 RNPs after extraction in Triton X-IOO 
buffer, since in all cases there are no significant differences between total oocyte 
Figure 5-2 7S RNPs are not contained within the cytoskeletal fmction of oocytes. Vitellogenic (St V) 
or previtellogenic (St ll) oocytes were fractionated into cytoskeletal and detergent soluble fractions and 
the fractions subject to immunoprecipitation with an anti-1FIIIA antibody. The RNA was extracted 
from immunoprecipitates, separated by agarose gel electrophoresis, transferred to nylon membrane and 
probed with antisense 5S RNA. Lanes I and 4, cytoskeletal fractions; lanes 2 and 5, detergent soluble 
fractions; lanes 3 and 6, total oocytes. 
Figure 5·3 Small amounts of 5S RNA are contained in the cytoskeletal fraction after extraction with 
a low salt extraction buffer. Vitellogenic (St V) or previtellogenic (St II) oocytes were fractionated 
with a low salt Triton X-loo extraction buffer into cytoskeletal and detergent fractions, and the 
distribution of 5S RNA analysed as described in Figure 5-1. Lanes I and 3, cytoskeletal fractions; 
lanes 2 and 4, detergent soluble fractions. 
Figure 5·4 7S RNPs are not contained within the cytoskeletal fraction after extraction with a low salt 
buffer. Vitellogenic (St V) or previtellogenic (St ll) oocytes were fractionated into cytoskeletal and 
detergent soluble fractions, and the fractions subject to immunoprecipitation with anti-TFIIIA antisera. 
RNA was extracted from immunoprecipitates and analysed as described for Figure 5-2. Lanes I and 4, 
cytoskeletal fractions; lanes 2 and 5, detergent soluble fractions; lanes 3 and 6, total oocytes. 
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fractions and detergent soluble fractions (Fig. 5-2 and Fig. 5-4, cf. lanes 2 with 3 
and 5 with 6), 
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One further extraction procedure was utilised, in which intennediate filaments 
were enriched in the detergent insoluble fraction. At high salt concentrations 
(1.5 M KCI) most oocyte proteins are solubilised, leaving an intennediate filament-
enriched fraction (Pondel and King, 1988). Under these extraction conditions, as 
expected, all 58 RNA was found in the detergent soluble fraction (data not shown). 
n. 7S RNPs are not Associated with Oocyte Intracellular Membranes 
The above results indicated that 78 RNPs are not associated with any of the 
three main components of the cytoskeletal system in oocytes. To detennine if 
78 RNPs are associated with the internal membrane system in oocytes, an 
intracellular membrane fraction was prepared from oocytes using sucrose gradient 
centrifugation (Colman, 1984). Total RNA was then extracted from membrane and 
cytosol fractions, or fractions were subject to immunoprecipitation with anti-TFIIIA 
antiserum, followed by extraction of RNA and northern analysis to detennine the 
distribution of 58 RNA. 
Figure 5-5 shows the distribution of 58 RNA after total RNA extraction from 
membrane and cytosol fractions of previtellogenic (stages I and II) and vitellogenic 
(stage V) oocytes. These results show that a small amount of 58 RNA was 
distributed within the membrane fraction of both previtellogenic (lane 4) and late 
stage oocytes (lane 1), although most of the 58 RNA was in the cytosolic fractions 
(lanes 2 and 5). To detennine the nature of the 58 RNA present in the membrane 
fractions, immunoprecipitation assays were perfonned, as shown in Figure 5-6. 
58 RNA immunoprecipitated with the anti-TFIIIA antiserum was mostly present in 
the soluble cytosolic fraction of oocytes (lanes 2 and 5). These data show that the 
majority of 78 RNPs are not associated with the internal membrane system in 
oocytes, indicating that the mechanism of cytoplasmic retention is not primarily due 
to binding to insoluble cytoplasmic structures. 
Figure 5-5 Small amounts of 5S RNA are associated with oocyte intracellular membrane fractions. 
Vitellogenic (St V) or previtellogenic (St ll) oocytes were separated into membrane and cytosol 
fractions using sucrose gradient centrifugation, and the total RNA extracted from each fraction and 
separated by agarose gel electrophoresis. Mter transfer to nylon membrane, the distribution of 5S 
RNA was determined by probing with an antisense 5S RNA sequence. Lanes 1 and 4, membrane 
fractions; lanes 2 and 5, cytosol fractions; lanes 3 and 6, whole oocytes. 
Figure 5-6 7S RNPs are not associated with oocyte intracellular membranes fractions. Vitellogenic 
(St V) or previtellogenic (St ll) oocytes were separated into membrane and cytosol fractions, and each 
fraction was subject to immunoprecipitation with anti-TFIllA antisera. RNA was extracted from 
irnrnunoprecipitates, and the distribution of 5S RNA determined as described in Figure 5-5. Lanes 1 
and 3, membrane fractions; lanes 2 and 5 cytosol fractions; lanes 3 and 6, whole oocytes. 
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5.3 DISCUSSION 
The above results show that retention of 7S RNPs in the cytoplasm of 
previtellogenic oocytes is not due to their binding to insoluble cytoplasmic structures. 
7S RNPs were not present in Triton X-1OO insoluble fractions, under all conditions of 
extraction employed, indicating that sequestration in the cytoplasm is not due to an 
association with the cytoskeleton. The 5S RNA which was present in cytoskeletal 
fractions in some treatments possibly reflects RNA present in cytoskeletal-associated 
ribosomes. Isolation of oocyte intracellular membranes also showed that the majority 
of 7S RNPs were not associated with these structures. The small amount of 5S RNA 
that was present in the membrane fraction is also probably in the form of ribosomes, 
functioning in the synthesis of membrane and secretory proteins. 
These results agree with the results from previous studies which indirectly 
suggested that binding to cytoplasmic structures was not the mechanism of 
cytoplasmic retention of 7S RNPs (Mattaj et al., 1983; Mattaj, 1986). In these 
studies, homogenates of previtellogenic oocytes were injected into the cytoplasm of 
fully grown oocytes, and using immunocytochemistry, 7S RNPs were shown to 
diffuse uniformly throughout the cytoplasm, but not enter the nucleus (Mattaj et al., 
1983). Since 7S RNPs were freely diffusable within the cytoplasm, this was seen as 
evidence by these workers for cytoplasmic structures not having a role in retention. 
However, it would be unlikely that there would be a high enough concentration of a 
putative 7S RNP receptor at the site of microinjection to bind all injected 7S RNPs, 
making some diffusion within the cytoplasm very likely. Also, these assays were 
performed using fully grown oocytes, where the mechanism of cytoplasmic retention 
may not be identical to that occurring in previtellogenic oocytes. Since, as detailed in 
section 5.1, the composition and subcellular location of cytoskeletal and 
membraneous structures changes markedly during oogenesis, these assays did not 
adequately discount the possibility of interactions with these components having a 
role in retention of 7S RNPs. 
Having ruled out a role for insoluble cytoplasmic structures, the question 
remains as to what is the mechanism for the retention of 7S RNPs in the cytoplasm 
of previtellogenic oocytes? The following sections describe four alternatives for the 
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regulation of the subcellular distribution of 7S RNPs, based on current knowledge of 
these processes. These include a lack of nuclear retention sites for 78 RNPs, the 
formation of 78 RNP dimers, the role of an inhibitory binding subunit, and post-
translational modifications. The four possible mechanisms are summarised in 
Figure 5-7. 
I. Lack of Nuclear Retention Sites for 7S RNPs 
Recent studies have suggested that, unlike protein import, protein export from 
the nucleus does not require a nuclear export signal, but is instead the default 
pathway (Schmidt-Zachmann et ai., 1993). Nuclear accumulation of proteins is 
thought to result from intranuclear interaction with other nuclear factors (Schmidt-
Zachmann et al., 1993; VancUrova et al., 1993; Paine et al., 1995). Nuclear 
accumulation of RNA also appears to occur via interactions with other nuclear 
factors. The nuclear retention of U6 small nuclear RNA (Vankan et al., 1990), 
U3 small nucleolar RNA (Terns and Dahlberg, 1994) and U8 small nucleolar RNA 
(Terns et al., 1995) is saturable, indicating that localisation is due to the binding of 
some limiting nuclear factor (Boelens et al., 1995; Terns et al., 1995). The 
localisation of 78 RNPs in the cytoplasm could be explained by the hypothesis that 
once newly transcribed 5S RNA binds to TFllIA in the nucleus, TFllIA can no 
longer bind to the 58 RNA gene and, since it no longer has an intranuclear binding 
site, is exported to the cytoplasm. This idea is partly supported by the observation 
that excess 5S RNA inhibits transcription from 5S RNA genes (Pelham and Brown, 
1980; Pelham et al., 1981). In the above scenario, 78 RNPs would actually be 
capable of nuclear import, agreeing with the results of L. A. Allison (unpubl. 
observ.), where import of 7S RNPs was observed into somatic cell nuclei cultured 
in vitro. However, the 7S RNPs would be rapidly re-exported to the cytoplasm, as 
illustrated in Figure 5-7 A, resulting in the predominant cytoplasmic location that is 
observed. This hypothesis could be tested by microinjecting 7S RNPs versus TFIllA 
into the nucleus of oocytes, and analysing the subsequent cytoplasmic-nuclear 
distribution of the protein. If this hypothesis is correct, one would expect to see rapid 
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export of 7S RNPs to the cytoplasm, but retention of some TFlIIA in the nucleus due 
to binding to SS RNA genes. 
II. 7S RNP Dimerisation 
Recent in vitro studies have investigated the assembly behaviour of 7S RNPs. 
Results indicated that complex fonnation is a reversible process, and at low 
concentrations (6 pg/ml), TFIlIA and SS RNA may exist as free entities, but at 
higher concentrations (100 pg/ml) the one to one complex of TFlIIA and SS RNA 
can self aggregate to fonn a dimer, illustrated by the following equation (Callaci 
et al., 1990): 
TFlIIA + SS RNA ~ (TFIlIA-SS RNA) ~ (TFIlIA-SS RNA)2 
Since there is approximately 60 ng of TFIDA per stage I to III oocyte (Shastry et al., 
1984), and the volume of stage I and II oocytes ranges from O.S to 47 nanolitres 
(calculated from diameters ranging from 100 to 4S0 pm; Dumont, 1972), this gives 
an intracellular concentration of TFIlIA ranging from 1 to 100 mg/ml, which is 
orders of magnitude larger than that required for dimerisation to occur. If 
dimerisation were to occur in vivo, this could explain cytoplasmic retention due to a 
masking of the TFIDA NLS, as shown in Figure S-7B. Dimer complexes would not 
be detected by traditional isolation methods, which would in effect, dilute the 
concentration of 7S RNP components, forcing the equilibrium of the above equation 
to the left, favouring the existence of monomer complexes as well as free protein and 
RNA components. The results of L. A. Allison (unpubl. observ.) could also be 
explained, since these assays used an overall concentration of 1.S pg/ml protein, well 
below the concentration necessary for dimerisation. This hypothesis could perhaps be 
tested using cross linking studies to enable in vivo 7S RNP dimers to be detected. 
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ill. Binding of an Inhibitory Subunit to 7S RNPs 
There are many examples of cytoplasmic anchoring proteins playing a role in 
the regulation of nuclear localisation of transcription factors (reviewed in Hunt, 1989; 
Feldherr and Akin, 1994). One of the most extensively studied of these is NF-KB, a 
transcription factor thought to be involved in the transcriptional activation of more 
than twenty genes (reviewed in Schmitz et al., 1991). NF-KB is a heterodimer 
composed of 50 (p50) and 65 (P65) k:D subunits and, in most cell types, resides in an 
inactive form in the cytoplasm. DNA binding is induced by exposure of cells to a 
variety of agents, such as viruses (reviewed in Schmitz et al., 1991). NF-KB DNA 
binding activity is also detected after treatment of cells with deoxycholate, which has 
been shown to release an inhibitory factor, IKB (Baeuerle and Baltimore, 1988a,b). 
Direct evidence for the role of IKB in blocking nuclear import of NF-KB came from 
studies where p65, p50 and IKB were introduced into Vero cells. When over-
expressed individually, all entered the nucleus; however, when p65 or p50 were over-
expressed in the presence of IKB, nuclear import was blocked (Zabel et al., 1993). 
Furthermore, the presence of IKB was shown to block binding of antibodies specific 
for the NLS region of p50 and p65, indicating that the inhibitor acts by masking the 
NLS (Zabel et al., 1993), 
An analogous situation to that of NF-KB occurs in Drosophila, showing that 
this mechanism of regulation of nuclear import is common to a diverse range of 
eukaryotes. The dorsal protein is a transcription factor which functions in the 
formation of the dorso-ventral axis in the Drosophila embryo (reviewed in Courey 
and Huang, 1995). It can act as either an activator or represser of a number of genes, 
depending on its concentration in the nucleus. A nucleocytoplasmic gradient exists in 
the blastoderm between the ventral pole, where dorsal is primarily nuclear, and the 
dorsal pole, where it is localised in the cytoplasm (reviewed in Hunt, 1989; Schmitz 
et al., 1991). Although the establishment of this gradient is a complex process, 
involving several different genes, the protein cactus, which shows sequence similarity 
to IKB (Geisler et al., 1992), seems to play an important role in regulating nuclear 
localisation. In mutants lacking cactus, dorsal is nuclear in both dorsal.and ventral 
regions (Roth et al., 1991). Further studies have suggested that the binding of cactus 
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to dorsal retains dorsal in the cytoplasm (Isoda et al., 1994; reviewed in Courey and 
Huang, 1995). 
Thus, a possible mechanism for the cytoplasmic retention of 7 S RNPs could 
be the binding of an inhibitory subunit protein which could prevent nuclear import, 
perhaps by masking the putative TFIlIA NLS (Fig. 5-7C). However, as 5S RNA 
bound to TFIIIA in oocytes has been found to consistently sediment at 7S, and not in 
higher molecular weight fractions, this mechanism seems unlikely. In addition, 
immunoprecipitations performed using anti-TFIIIA antibodies did not co-precipitate 
any other proteins (pers. observ.). 
IV. Post-translational Modification 
Yet another mechanism for the regulation of nuclear import of proteins is 
post-translational modification (reviewed in Feldherr and Akin, 1994). Studies of the 
nuclear import of hybrid proteins fused with the SV-40 T-antigen showed that the 
rate of nuclear import is significantly enhanced when residues flanking the NLS are 
included in the construct (Rihs and Peters, 1989). This increase in the rate of 
transport was shown to be due to phosphorylation at either of two positions by casein 
kinase IT (Rihs et al., 1991). Phosphorylation also appears to regulate the cell cycle-
dependent nuclear transport of the yeast transcription factor SW15. When three serine 
residues adjacent to the NLS are phosphorylated, SW15 is cytoplasmic. 
Dephosphorylation prior to G 1 is a prerequisite for nuclear import (reviewed in 
Feldherr and Akin, 1994). Thus, phosphorylatiOIi can both positively and negatively 
affect the regulation of nuclear import. 
Thus, the mechanism for the localisation of TFIDA in oocytes may be post-
translational modification. For example, as shown in Figure 5-7D, TFllIA may 
require this modification for high affinity interaction with nuclear import factors. The 
binding of 5S RNA might reduce or block the modification, resulting in a molecule 
with less or no affinity for import factors, that therefore remains cytoplasmic. 
Figure 5·7 Possible mechanisms for the cytoplasmic localisation of 7S RNPs. (A) 7S RNPs are 
capable of nuclear import, but do not accumulate as there is no nuclear retention site. On the left, the 
pathway taken by 1FIIIA is shown, whereby nuclear import is mediated by a receptor molecule which 
recognises the putative 1FIIIA NLS. 1FIIIA is then retained in the nucleus via interactions with the 
5S RNA gene, or other nuclear receptors. 7S RNPs are imported into the nucleus, also via interactions 
with the NLS receptor, but since they cannot interact with the nuclear receptor(s). are rapidly exported 
to the cytoplasm. (8) Nuclear import of 7S RNPs is prevented by the formation of 7S RNP dimers. 
The formation of dimers is dependent on sequences contained within both protein and RNA moieties 
of 7S RNPs, and is concentration dependent The 1FIIIA NLS is thus masked, preventing interaction 
with the NLS receptor, SO nuclear import does not occur. (C) Nuclear import of 7S RNPs is prevented 
by the binding of an inhibitory subunit The NLS is masked from interaction with the NLS receptor, 
SO nuclear import is prevented. (0) Post-ttanslational modification (*) of 1FIIIA is necessary for 
nuclear import. The post-ttanslational modification is necessary for high afftnity interaction with the 
NLS receptor. Binding of 5S RNA to 1FIIIA reduces the ability of TFJIIA to be modifted, reducing 
the affinity for the NLS receptor, and nuclear import. 
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However, there is no evidence that TFllIA is phosphorylated in oocytes (Kim 
et al., 1990), although experiments have shown that it does not appear to be 
glycosylated (Jackson and Tijan, 1988). Two forms of TFllIA have been detected in 
somatic cells, one of which is two k:D larger than the TFllIA found in oocytes, but 
this larger form is thought to arise from initiation of transcription 200 base pairs 
upstream from the start site of the smaller form, rather than from post-translational 
modifications (Kim et al., 1990). 
Further studies are clearly necessary to understand the mechanisms by which 
7S RNP particles are restricted to the cytoplasm in previtellogenic oocytes. It is 
possible that there is not just one major mechanism responsible, and that different 
factors, such as those outlined above, may contribute to effect the cytoplasmic 
localisation that is observed. 
V. Cytoplasmic Retention of other Molecules in Xenopus 
Regulation of nuclear import is not only restricted to 7S RNPs during early 
Xenopus development. During oogenesis, the Xenopus nucleus acquires many 
proteins, several of which are stored for later use in embryogenesis. During oocyte 
maturation and germinal vesicle breakdown, these proteins are released into the 
cytoplasm. Because of the huge size of the oocyte nucleus, the sum of all the 
volumes of all nuclei during cleavage and the early blastula stages of embryogenesis 
is smaller than the original germinal vesicle volume, and it is not until mid-blastula 
that the total volume of all nuclei of the embryo add up to that of the original 
germinal vesicle. Thus, during early embryogenesis, the oocyte nuclear proteins are 
not all located in the nucleus. It has been observed that during this stage of 
development not all of these proteins behave the same with respect to 
nucleocytoplasmic localisation. Some proteins re-enter the embryonic nuclei 
immediately after fertilisation, while others are excluded from nuclei until blastula or 
neural stages of development (Dreyer et al., 1986). 
The mechanism of this regulation of nuclear import has been further 
investigated for the protein xnf7 (Xenopus nuclear factor 7), which re-enters 
embryonic nuclei at the mid-blastula stage. The release of xnf7 from the germinal 
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vesicle at oocyte maturation coincides with phosphorylation, while re-accumulation 
into blastula nuclei correlates with an increase in abundance in the less 
phosphorylated isoforms of the protein (Miller et al., 1991). In addition, a 22 amino 
acid sequence was recently identified which functions cooperatively with two 
phosphorylation sites within the xnf7 molecule to retain the molecule in the 
cytoplasm. Addition of a second NLS to the protein did not relieve the cytoplasmic 
localisation, suggesting retention is not due to a masking of the NLS, but involves an 
anchoring mechanism where the 22 amino acid sequence interacts with an anchor 
protein (Li et al., 1994). Interestingly, xnf7 possesses several zinc-finger-like regions, 
and two acidic regions similar to transcriptional activating domains. In addition, it is 
thought to bind to double stranded DNA, suggesting it might function as a 
transcription factor (Reddy et al., 1991). 
An analogous situation to TFIDA and 5S RNA in oocytes occurs with mRNA. 
During oogenesis, over 80% of the mRNA synthesised is sequestered into messenger 
ribonucleoprotein particles (mRNPs) and stored in the cytoplasm in a translationally 
repressed state. The two major proteins in these mRNPs are mRNP3 and mRNP4 
(Darnbrough and Ford, 1981). Unexpectedly, sequencing of mRNP4 showed that it is 
identical to FRO Y2, a germ cell-specific factor stimulating transcription from Y-box 
promoters (Murray et al., 1992; Deschamps et al., 1992). Thus, analogous to TFIDA, 
mRNP4/FRO Y2 has the dual function in oocytes of promoting transcription from a 
specific set of genes, and associating with a broad spectrum of mRNAs so they are 
masked from the translation machinery (Ranjan et al., 1993; Tafuri and Wolffe, 
1993; Bouvet and Wolffe, 1994). As with TFIDA, mRNP4/FRO Y2 performs its role 
of transcription in the nucleus, but is stored bound to mRNA in the cytoplasm. The 
precise determinants and mechanisms of control of the compartmentalisation of this 
molecule also have not yet been defined. 
The above data indicate that 7S RNPs are not the only molecules which are 
restricted to the cytoplasm in a regulated manner during early development in 
Xenopus. Thus, further investigation of the mechanism by which 7S RNPs are 
sequestered in the cytoplasm may provide insights into the mechanisms of 
localisation of these other molecules, and to the regulation of nuclear import and 
transcription in general. 
CHAPTER 6 
GENERAL DISCUSSION 
After synthesis in previtellogenic Xenopus oocytes, 5S RNA is exported to the 
cytoplasm where it is stored in one of two ribonucleoprotein particles. At the onset 
of vitellogenesis, 5S RNA moves back into the nucleus where it is eventually 
targeted to the nucleolus for incorporation into 60S ribosomal subunits. The results 
presented in this study provide further information on some of the steps taken in this 
pathway. 
6.1 REQUIREMENTS FOR THE PATHWAY TAKEN BY 
5S RNA DURING OOGENESIS 
Out of 32 mutant 5S RNA molecules tested, only one, mutant 10-13 was 
defective for TFIIlA binding in vivo. This mutation contains base substitutions in 
loop A, a region thought to be important for maintaining the tertiary structure of 
5S RNA (Romaniuk:, 1989; Baudin et al., 1991), and which was also shown to have 
a low in vitro binding affinity for TFIIIA (Romaniuk:, 1989). Interestingly, other 
5S RNA mutants which showed in vitro binding affinities for TFIIIA similar to or 
lower than that of mutant 10-13 were capable of binding TFIIIA in vivo. This result 
reflects the differences between in vitro assays and the situation in vivo, where 
TFIIIA is not the only 5S RNA-binding protein, and where the exogenous mutant 
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5S RNAs must also compete with endogenous 5S RNA. A comparison of the 
measured competition strengths of the various 5S RNA mutants for TFIIIA binding 
reveals that mutant 10-13 shows a significantly lower competition strength than any 
of the other mutants (Baudin and Romaniuk, 1989; Romaniuk, 1989; Baudin 
et al., 1991). Thus, the measurement of competition strength appears to give a more 
accurate indication of RNP formation in vivo, and helps to explain why 10-13 was 
the only mutant not detectable in 7S RNPs in vivo. 
None of the mutants tested, including mutant 10-13, were defective in binding 
to ribosomal protein L5. These results are consistent with the in vitro binding data 
for these mutants, where the majority of mutants bound to L5 with near wild type 
affinity (Q. You, W. Q. Zang, and P. J. Romaniuk, in prep.). Deletion of the bulged 
nucleotide at position 63 also did not affect L5 binding, although the equivalent 
nucleotide is necessary for binding of the E. coli 5S RNA-binding protein, L18 to 
5S RNA (Peattie et al., 1981; Christiansen et al., 1985). 
The above results suggest that different structural features of the 5S RNA 
molecule are important for binding TFIIIA and L5. This is not surprising since the 
two proteins share no sequence homology and are thought to bind to 5S RNA via 
different mechanisms. TFIIIA contains an array of nine tandem repeats of a zinc 
binding domain characterised by invariant cysteines and histidines, termed zinc finger 
motifs (Miller et al., 1985). Although the mechanism has not yet been deduced, these 
zinc finger motifs are responsible for the specific DNA and RNA binding activities 
of this protein (Theunissen et al., 1992; Clemens et al., 1993; reviewed in Pieler and 
Theunissen, 1993). In contrast, ribosomal protein L5 does not contain zinc finger 
motifs, but does contain a region of basic amino acids at the carboxy-terminus that is 
conserved from yeast to mammals (Yaguchi et al., 1984; Chan et al., 1987; 
Kenmochi et aI., 1991). These basic amino acids were shown to have a key role in 
the binding of the yeast 5S RNA-binding protein, L1 to 5S RNA (Yaguchi 
et al., 1984; Yeh and Lee, 1995b). 
Four of the 5S RNA mutants tested were not detected in 60S ribosomal 
subunits. These were mutant 10-13, mutant 96-101, in which non-canonical base 
pairs were replaced with Watson-Crick forming base pairs, and mutants .849,50 and 
.863, in which bulged nucleotides in helices III and II were deleted, respectively. 
These results indicate that binding to L5 is not sufficient for assembly of 5S RNA 
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into 60S subunits, since all of the mutants defective for ribosome assembly were 
shown to form 5S RNPs. As discussed in Chapter 3, defective ribosome assembly 
could be due to a loss of recognition features necessary for interactions with other 
ribosomal components, or due to an inherent instability of 60S subunits containing 
these RNAs because of conformational rearrangements or an inability to associate 
with 40S subunits. Support for the former hypothesis comes from studies in yeast, 
where it appeared that mutant 5S RNAs were stable once incorporated into 
60S ribosomal subunits, and no degradation of assembled subunits was observed 
(Van Ryk et al., 1992). Alternatively, the lack of ribosome incorporation exhibited by 
these mutants may have been due to a defect in an earlier step of the 5S RNA 
pathway, such as nuclear import or nucleolar targeting. However, all of the mutants 
were previously shown to be capable of nuclear import (Allison et al., 1993; 
L. A. Allison and P. J. Romaniuk, in prep.), ruling out this step as a reason for the 
lack of ribosome incorporation. Likewise, the results presented in Chapter 4 
demonstrated that a defect in nucleolar localisation was not the reason for the 
inability of these mutants to be incorporated into ribosomes. Mutants 10-13 and 
96-10 1 were both localised to nucleoli to some degree, indicating defective ribosome 
incorporation is due to some later step in the assembly process. Mutants 849,50 and 
863 showed some localisation over nucleoli in the in situ localisation assays, 
however, this was nowhere near the extent indicated by the biochemical fractionation 
assay. These results implied that 849,50 and 863 are associated with high molecular 
weight structures in the nucleus so that they are pelleted in the biochemical 
fractionation of nucleoli. It is possible therefore, that 849,50 and 863 are prevented 
from ribosome incorporation because of formation of these large complexes. 
Together with previous analyses on the nuclear import ability of these 
mutants, the results presented here also provide insights into cellular factors which 
are necessary for the different steps taken by 5S RNA in oocytes. Regions of the 
5S RNA molecule found to be most important for nuclear import were helices II and 
V, and loops C and E (Allison et al., 1993; L. A. Allison and P. J. Romaniuk, 
in prep.). These regions are different from those found to be required for TFIIIA 
binding and for ribosome assembly. It is therefore likely that different cellular factors 
are required for nuclear transport and for ribosome assembly of 5S RNA. Since 
mutant 10-13 was capable of nuclear import, this suggests that TFIIIA binding is not 
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a requirement for this step. It has previously been suggested that the binding of L5 to 
58 RNA in the cytoplasm of oocytes mobilises 58 RNA for nuclear transport and 
nucleolar localisation (Allison et al., 1991). Furthennore, preas sembled 58 RNPs 
were shown to be imported into nuclei at a faster rate and to a greater extent than 
free 58 RNA, suggesting 5S RNP fonnation is a precursor step for nuclear import 
(K. I. Murdoch and L. A. Allison, submitted). Since all of the mutants were able to 
bind L5, the absolute requirement for this protein in nuclear import and for nucleolar 
targeting has yet to be demonstrated. The results presented here do suggest, however, 
that L5 binding is not sufficient for nucleolar localisation. In summary, a picture 
emerges whereby different structural features of 58 RNA, and different oocyte factors 
are required for the individual steps taken by 5S RNA during oogenesis. 
6.2 SUBCELLULAR LOCALISATION OF 5S RNA 
The results presented in Chapter 4 showed that only one third of endogenous 
58 RNA and microinjected oocyte-type 5S RNA were associated with nucleoli in the 
Xenopus oocyte nucleus. Similarly, microinjected ribosomal protein L5 showed only 
slightly higher nucleolar localisation than oocyte-type 5S RNA. These results indicate 
that there is a pool of 5S RNA and L5 in the nucleus, and immunoprecipitation 
assays confirmed that a proportion of these were associated in the fonn of 5S RNPs. 
Since only a small amount of 5S RNA in the nucleus was immunoprecipitated with 
anti-TFIIIA, anti-L5 and anti-60S ribosomal subunit antisera, these results implied 
that 5S RNA is associated with other factors in the oocyte nucleoplasm. These may 
be part of nuclear import complexes, may function in retaining an excess of 5S RNA 
in the nucleus so it is readily available for ribosome assembly, or may be important 
in regulating the amount of 5S RNA at the nucleolus at one time. 
The mechanism by which 7S RNPs are retained in the cytoplasm of 
previtellogenic oocytes remains to be elucidated. The results presented in Chapter 5 
rule out the possibility that retention is due to association with cytoskeletal or 
internal membrane structures. Alternative mechanisms suggested include the role of 
putative inhibitory binding subunits, 7S RNP dimerisation, post-translational 
modifications, or simply a lack of nuclear retention sites for 7S RNPs. 
Chapter 6 145 
Since mutant 10-13 was shown to be defective for binding TFIlIA in vivo, it 
would be interesting to detennine the subcellular distribution of this mutant in 
previtellogenic oocytes. Furthennore, mutant 1FIIIA molecules, which are defective 
in either RNA or DNA binding could provide infonnation on the mechanism of 
cytoplasmic retention. 
6.3 BEHAVIOUR OF SOMATIC·TYPE 5S RNA IN OOCYTES 
Although somatic-type 5S RNA is synthesised in oocytes (Ford and Southern, 
1973), it was previously not detected in long tenn storage particles or ribosomes 
(Denis and Wegnez, 1977). More recently, somatic-type 5S RNA was shown to be 
imported into the nucleus at a faster rate and to a greater extent than oocyte-type, 
and more was assembled into 60S ribosomal subunits after injection into the oocyte 
cytoplasm (Allison et al., 1995). This was explained by the different protein binding 
activities of the two RNAs in the cytoplasm. Oocyte-type was predominantly 
associated with TFIIIA, whereas somatic-type 5S RNA preferentially associated with 
ribosomal protein L5. These results suggested that oocyte-type 5S RNA is more 
adapted for storage, whereas somatic-type is rapidly mobilised and assembled into 
ribosomes. 
The nucleolar localisation results described in this study support this model. 
While only one third of oocyte-type was associated with nucleoli, over two thirds of 
somatic-type 5S RNA was nucleolar. Thus, even after import into the nucleus, which 
is the first step for incorporation into 60S ribosomal subunits, oocyte-type 5S RNA 
appears to be "stored," whereas somatic-type is localised over nucleoli, and therefore 
being assembled into ribosomal subunits. Interestingly, this result was not explained 
by differences in L5 binding between the two RNAs in the nucleus, since both were 
predominantly immunoprecipitated with anti-L5 antiserum. This indicates that other 
nuclear factors directly recognise the different sequences of oocyte-type and somatic-
type 5S RNAs. These factors could be other nucleolar/ribosomal components which 
have a higher affinity for somatic-type 5S RNA, or nucleoplasmic factors which have 
a higher affinity for oocyte-type 5S RNA. These results are incorporated into a model 
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presented in Chapter 4 for the pathway taken by 5S RNA in the nucleus of Xenopus 
oocytes. 
Xenopus somatic-type 5S RNA is more similar in sequence to mammalian 
5S RNA than oocyte-type, and it has been suggested that the mutations which have 
occurred in oocyte-type are unlikely to be neutral (Ford and Southern, 1973). It 
appears that oocyte-type 5S RNA is specialised for the unusual route taken by this 
molecule during oogenesis, which includes bidirectional nuclear transport and long 
term storage in the cytoplasm, and perhaps storage in the nucleus. 
6.4 THE PATHWAY TAKEN BY 58 RNA 
The complicated pathway taken by 5S RNA in amphibian oocytes is largely 
thought to be peculiar to this cell type. In somatic cells, 5S RNA is generally thought 
to be targeted directly to nucleoli after synthesis, and assembled into 60S ribosomal 
subunits. However, a re-evaluation of the literature suggests 5S RNA may also 
follow a more complex route in somatic cells. 
Studies in HeLa cells showed that up to 25% of 5S RNA is not associated 
with ribosomes, representing a pool of 5S RNA in the nucleus (Knight and Darnell, 
1967). In addition, it has been shown that four times as much 5S RNA than 
28S rRNA is synthesised in exponentially growing HeLa cells, far more than is 
required for ribosome assembly (Leibowitz et al., 1973). Steitz et al. (1988) showed 
that 50% of the non-ribosome associated 5S RNA in HeLa cells was bound to L5, as 
a 5S RNP. Further studies showed that a fraction of 5S RNA in HeLa cells was 
precipitable with antibodies specific for a 37 kD HeLa protein, which is antigenic ally 
related to Xenopus TFIIIA (Lagaye et al., 1988). 5S RNA bound to this protein was 
found in both nuclear and cytoplasmic fractions. These workers suggested that excess 
5S RNA binds to the 37 kD protein, and is then targeted to the cytoplasm for 
degradation. 
In both HeLa cells and rat liver cells, kinetic labelling studies detected 
5S RNA in soluble, cytoplasmic fractions immediately after synthesis (Leibowitz 
et al., 1973; Ogata et al., 1993). In one of these studies, the cytoplasmic 5S RNA 
was proposed to re-enter the nucleus and be incorporated into 60S subunits 
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(Leibowitz et al., 1973), but in the other study, the cytoplasmic 5S RNA was thought 
not to be a precursor to ribosomal 5S RNA, and to remain in the cytoplasm (Ogata 
et al., 1993). 
Taken together, the above data suggest that the pathway taken by 5S RNA in 
somatic cells may not be as straight forward as initially thought. Additional steps, 
such as a detour to the cytoplasm, similar to that occurring in Xenopus oocytes, may 
also be relevant to other cell types. The 5S RNA in the cytoplasm of somatic cells 
may simply be excess RNA targeted for degradation, or may have some other 
function, an idea which is partially suggested by its association with a range of 
cellular factors, described in the following section. 
6.5 5S RNAIL5-CONTAINING COMPLEXES 
5S RNA has been found in a number of RNP complexes in both oocytes and 
somatic cells, as summarised in Table 6-1. As well as 7S RNPs, 5S RNA is stored in 
42S RNPs in previtellogenic oocytes. The 5S RNA-binding protein in 42S RNPs is 
p43, a protein which contains nine zinc finger domains that show homology to 
TFllIA (Joho et al., 1990). The other 42S RNP protein is p48, which binds to 
aminoacyl tRNA. p48 is structurally homologous to EF-I a, an elongation factor 
which functions in transferring aminoacyl-tRNAs to the ribosome (Viel et al., 1990; 
Coppard et al., 1991), Evidence that aminoacyI-tRNA is transferred from 42S RNPs 
to ribosomes (Ie Maire and Denis, 1987) led to the suggestion that p48 is a stage-
specific elongation factor. In addition, a small fraction of tRNA molecules purified 
from 42S RNPs were shown to carry a peptide or protein chain, suggesting that 
42S RNPs carry out a ribosome-independent, incorporation of amino acids into 
protein (Denis and Ie Maire, 1987). 
5S RNA, tRNA and mRNA have also been detected in RNPs sedimenting at 
100-200S in previtellogenic Xenopus oocytes (Denis and Ie Maire, 1987). This 
fraction contained few, if any poly somes and was not simply aggregates of 
42S RNPs. The function of these large particles remains to be established. 
As mentioned in Chapter 4, certain 5S RNA variants have been found 
associated with the Ro autoantigen in Xenopus oocytes. These 5S RNA variants 
Chapter 6 148 
Table 6·1 5S RNA and/or LS-containing complexes 
Complex components Species/cell type Possible functions References 
5S RNP: 5S RNA, L5 HeLa cells Precursor to ribosome Steitz et aI., 1988 
Xenopus oocytes assembly Allison et aI., 1991; 1995 
Xenopus embryos Wonnington, 1989 
Yeast Deshmukh et aI., 1993 
Nuclear import Allison et aI., 1991; 1995 
Nucleolar targeting Steitz et aI., 1988 
7S RNP: 5S RNA, Xenopus oocytes Storage Picard and Wegnez, 1979 
TFIIIA HeLa cells Degradation Lagaye et ai., 1988 
Nuclear export Guddat et ai., 1990 
42S RNP: 5S RNA, p43, amphibian oocytes Storage Picard et ai., 1980 
tRNA, p48 Delivery of aminoacyl- Ie Maire and Denis, 1987 
tRNAs to ribosome 
Peptide bond formation Denis and Ie Maire, 1987 
lOO-200SRl\lP: 5S RNA, Xenopus oocytes Unknown Denis and Ie Maire, 1987 
tRNA,mRNA 
mutant 5S RNAs, Ro Xenopus ovary 5S RNA quality control O'Brien and Wolin, 1994 
autoantigen pathway 
5S RNA, L5, 5.8S rRNA rat liver Unknown MetspaIu et ai., 1980 
5S RNA, L5, tRNA rat liver Aminoacylation of tRNA Ogata et ai., 1991a,b 
synthetases Ogata et ai., 1994 
Ogata et aI., 1995 
55 RNA, L5, mdm- mouse fibroblast Unknown MarechaI et ai., 1994 
2/mdm-2-p53 
L5, protein phosphatase chicken gizzard Activate phosphatase Hirano et ai., 1995 
type 1 activity 
contain one or more point mutations as well as additional 3' nucleotides (O'Brien 
and Wolin, 1994). Since these mutant 5S RNAs were inefficiently processed and 
eventually degraded, it was suggested that Ro may function as part of a quality 
control or discard pathway for 5S RNA production. 
In preparations of rat liver cytosol, 5S RNPs were found associated with a 
macromolecular complex containing nine tRNA synthetases (Ogata et al., 1991a), and 
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with a smaller complex containing threonyl- and histidyl-tRNA synthetases (Ogata 
et al., 1994). 5S RNA was shown to interact with methionyl-tRNA and methionyl-
tRNA synthetase in the macromolecular aminoacyl synthetase complex (Ogata 
et al., 1995). Furthermore, 5S RNPs enhanced the activities of some of the tRNA 
synthetases within the macromolecular complex (Ogata et al., 1991b), and the 
threonyl-tRNA synthetase activity of the threonyl-histidyl-tRNA synthetase complex 
(Ogata et al., 1994). 5S RNA in rat liver cytosol was also shown to form a ternary 
complex with L5 and 5.8S rRNA in vitro (Metspalu et al., 1980). 
The protein product of the oncogene mdm-2 is known to associate with p53, a 
protein involved in the response to DNA damage, giving rise to G 1 arrest or cellular 
apoptosis. In mouse 3T3 cells which over-express mdm-2, 5S RNPs were found 
associated with mdm-2 and with the mdm-2-p53 complex (Marechal et al., 1994). 
Finally, ribosomal protein L5 was shown to be associated with the catalytic subunit 
of the type 1 protein phosphatase, and also activated the phosphatase activity of a 
myosin-bound phosphatase, and the type 1 phosphatase catalytic subunit (Hirano 
et al., 1995). It was suggested by these authors that L5 may target the phosphatase to 
the ribosome for dephosphorylation of ribosomal proteins, or to the mdm-2-p53 
complex for dephosphorylation of p53. 
The functional significance of most of these 5S RNAlL5-containing 
complexes is largely unknown and remains enigmatic. Possible functions could 
include as regulators or mediators of specific steps in ribosome biosynthesis or 
protein synthesis, or could be totally unrelated. Further research should clarify the 
roles of these complexes, and provide insights into the processes of ribosome 
biogenesis and protein synthesis in both oocytes and somatic cells. 
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a The numbers in the designations refer to those 58 RNA nucleotides which have been 
substituted or deleted (Fig. 3-3). 
b Ratio of the apparent association constant <Ka) measured for the mutant 58 RNA divided by 
the K,. measured for wild-type 58 RNA. Data summarised from Baudin and Romaniuk, 1989; 
Romaniuk, 1989; You and Romaniuk, 1990; Baudin et al., 1991. 
C Ratio of concentrations of mutant 58 RNA to wild-type 58 RNA required to give a 
50% competition value. ND, not determined. Data summarised from Baudin and Romaniuk, 
1989; Romaniuk, 1989; Baudin et al., 1991. 
d Binding affinity of mutant 58 RNA made relative to wild-type. Data from Q. You, 
W. Q. Zang, P. 1. Romaniuk, in prep. 
e Nuclear transport of mutant 58 RNA relative to wild-type after microinjection into the 
oocyte cytoplasm. Data from Allison et al., 1993; L. A. Allison and P. J. Romaniuk, in prep. 
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APPENDIX I 
SUMMARY OF MUTANT SS RNA PHENOTYPES 
Region of 5SRNA TFIIIA TFIIIA L5 binding<i Nuclear Molecule Mutant" bindingb competitionc transport" 
Oocyte type 1.00 1.00 1.00 1.00 
Helix II 14-15 0.85 ± 0.22 ND 1.11 ± 0.05 0.49 ± 0.03 
64-65 0.74 ± 0.24 ND 1.02 ± 0.13 0.97 
14-15/64-65 1.11 ± 0.32 ND 1.00 ± 0.28 1.04 ± 0.16 
16-21 0.32 ± 0.15 ND 0.82 ± 0.05 0.25 ± 0.05 
57-62 0.40 ± 0.15 ND 0.99 ± 0.03 0.73 
16-21/57-62 1.09 ± 0.48 ND 0.94 ± 0.13 1.88 
Helix III 27-32 0.75 ± 0.10 ND 0.52 ± 0.15 0.70 ± 0.23 
45-52 0.76 ± 0.12 ND 0.54 ± 0.12 1.45 ± 0.34 
Helix IV 78-81 0.88 ± 0.01 ND 1.11 ± 0.13 0.99 
95-98 0.78 ± 0.02 ND 0.99 ± 0.10 0.86 
78-81/95-98 0.86 ± 0.01 ND 1.00 ± 0.26 1.19 ± 0.46 
82-86 0.81 ± 0.30 ND 1.28 ± 0.19 1.75 ± 0.02 
91-94 0.96 ± 0.18 ND 1.06 ± 0.09 0.85 ± 0.31 
82-86/91-94 1.21 ± 0.35 ND 1.42 ± 0.26 1.38 ± 0.19 
Helix V 67-70 0.75 ± 0.12 ND 1.18 ± 0.11 1.18 ± 0.44 
105-108 0.39 ± 0.06 ND 1.11 ± 0.01 0.46 ± 0.15 
67-70/105-108 0.71 ± 0.01 ND 1.03 ± 0.07 1.07 ± 0.34 
71-72 0.35 ± 0.21 ND 0.88 ± 0.17 0.44 ± 0.12 
103-104 0.50 ± 0.23 ND 1.08 ± 0.08 0.48 ± 0.18 
71-72/103-104 1.18 ± 0.32 ND 1.08 ± 0.10 1.37 ± 0.43 
Loop A 10-13 0.30 ± 0.01 0.06 ± 0.01 1.19 ± 0.23 0.63 ± 0.00 
LoopB 22-26 1.00 ± 0.02 1.24 ± 0.04 0.86 ± 0.05 1.18 
LoopC 33-39 1.00 ± 0.02 1.75 ± 0.13 0.92 ± 0.41 0.97 ± 0.25 
41-44 0.40 ± 0.10 0.52 ± 0.05 1.03 ± 0.22 0.33 ± 0.06 
LoopD 87-90 0.71 ± 0.10 1.45 ± 0.05 1.20 ± 0.02 1.26 
LoopE 73-76 0.57 ± 0.02 0.38 ± 0.05 0.77 ± 0.25 1.60 ± 0.20 
96-101 0.59 ± 0.01 0.52 ± 0.05 0.63 ± 0.04 0.36 ± 0.04 
Bulged nucleotides .M9,50 1.00 ± 0.02 1.00 ± 0.13 0.91 ± 0.02 0.76 ± 0.38 
L\63 1.00 ± 0.02 1.00 ± 0.02 1.05 ± 0.18 1.04 ± 0.40 
L\83 1.00 ± 0.05 1.00 ± 0.02 1.22 ± 0.25 0.88 ± 0.09 
Hinge nucleotides C66 0.12 ± 0.01 0.19 ± 0.02 ND 0.43 ± 0.05 
GI09 0.17 ± 0.05 0.14 ± 0.10 ND 0.77 ± 0.02 
APPENDIX II 
NUCLEOLAR LOCALISATION OF 5S RNA MUTANTS 
5S RNA Mutant 
Oocyte-type 
Somatic-type 
Helix II 
14-15 
64-65 
16-21 
57-62 
16-21/57-62 
Helix III 
27-32 
45-52 
Helix IV 
95-98 
Helix V 
105-108 
71-72 
103-104 
Loop A 
10-13 
LoopB 
22-26 
Loop C 
41-44 
LoopE 
96-101 
Bulged Nucleotides 
049,50 
D63 
D83 
Hinge Nucleotides 
C66 
0109 
% Nucleolar" 
33.2 ± 1.4 (70) 
70.1 ± 2.3 (14) 
25.1 ± 1.9 (14) 
27.9 ± 1.4 (11) 
21.7 ± 1.7 (11) 
50.9 ± 2.6 (6) 
31.0 ± 2.7 (6) 
21.5 ± 1.9 (7) 
38.6 ± 2.0 (8) 
42.3 ± 2.6 (6) 
68.0 ± 2.7 (9) 
34.0 ± 3.2 (11) 
29.6 ± 2.5 (11) 
30.5 ± 3.9 (12) 
31.9 ± 2.5 (10) 
28.6 ± 3.3 (10) 
28.0 ± 2.7 (16) 
78.6 ± 2.2 (14) 
61.2 ± 3.0 (11) 
36.7 ± 3.8 (11) 
32.7 ± 2.4 (9) 
31.2 ± 3.2 (9) 
Oocyte-type % NOb 
32.3 ± 1.8 
33.3 ± 2.4 
32.9 ± 2.8 
36.0 ± 2.3 
30.7 ± 2.5 
30.7 ± 2.5 
16.5 ± 0.7 
16.5 ± 0.7 
21.5 ± 2.7 
52.3 ± 5.0 
32.9 ± 2.8 
25.8 ± 3.9 
34.4 ± 2.4 
18.9 ± 1.7 
35.0 ± 1.9 
44.5 ± 3.5 
31.7 ± 1.8 
46.6 ± 5.7 
31.4 ± 2.6 
30.5 ± 1.7 
32.3 ± 1.5 
189 
a Nucleolar localisation was calculated as a percentage of the RNA in the nucleus after injection into the 
oocyte cytoplasm. The number of replicates is shown in parentheses. 
b The percentage of nucleolar localisation (% No) for oocyte-type 5S RNA in the same batches of oocytes. 
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APPENDIX ill 
JOURNAL PUBLICATIONS 
1. The attached reprint from Molecular and Cellular Biology contains part of the 
results presented in this thesis. My contribution to this publication consisted of 
immunoprecipitation and non-denaturing gel electrophoresis assays, to determine the 
ability of a series of mutant 5S RNA molecules to be incorporated into oocyte 
ribonucleoprotein particles, These data were presented in Chapter 3 of this thesis. 
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Structural requirements of 5S rRNA for nuclear transport and RNA-protein interactions have been studied 
by analyzing the behavior of oocyte-type 5S rRNA and of 31 different in vitro-generated mutant transcripts 
after microinjection into the cytoplasm of Xenopus oocytes. Experiments reveal that the sequence and 
secondary and/or tertiary structure requirements of 58 rRNA for nuclear transport, storage in the cytoplasm 
as 7S ribonucleoprotein particles, and assembly into 60S ribosomal subunits are complex and nonidentical. 
Elements of loops A, C, and E, helices II and V, and bulged and hinge nucleotides in the central domain of 58 
rRNA carry the essential information for these functional activities. Assembly of microinjected 58 rRNA into 
60S ribosomal subunits was shown to occur in the nucleus; thus, the first requirement for subunit assembly is 
nuclear targeting. The inhibitory effects of ATP depletion, wheat germ agglutinin, and chilling on the nuclear 
import of 58 rRNA indicate that it crosses the nuclear envelope through the nuclear pore complex by a pathway 
similar to that used by karyophilic proteins. 
The orchestration of ribosome biogenesis in eUkaryotic 
cells is a process that requires transfer of macromolecules 
into and out of the nucleus. InXenopus oocytes, SS rRNA is 
shuttled between the nuclear and cytoplasmic compartments 
of the oocyte during different stages of oogenesis in a 
complex pathway involving different protein associations. In 
previtellogenic oocytes, SS rRNA is synthesized before 
other components of ribosomes are available, is exported 
from the nucleus, and stored in the cytoplasm as 7S ribonu-
cleoprotein particles (RNPs) (SS rRNA complexed with 
transcription factor IlIA [TFIIIA]) or as 42S RNPs (SS 
rRNA complexed with other nonribosomal proteins and 
tRNA). During vitellogenesis, the SS rRNA is released from 
storage and a SS rRNA-ribosomal protein LS complex, 
which is a precursor to assembly into the 60S large ribosomal 
subunit, forms (reference 3 and references therein). We are 
interested in the mechanisms that govern the subcellular 
trafficking of SS rRNA within the oocyte, particularly the 
requirements for the mobilization of stored SS rRNA during 
ribosome assembly. 
There is ample evidence that transit of RNA and RNPs 
into and out of the nucleus occurs exclusively via the nuclear 
pores (20, 4S; for a review, see reference 30). Although 
nuclear localization of proteins has been well characterized 
(1, 10, 21, 49; for a review, see reference 61), the factors 
governing nuclear export and import of RNA and RNPs 
remain enigmatic. Nuclear export of tRNA (7S), pre-small 
* Corresponding author. Electronic mail address: l.allison@csc. 
canterbury.ac.nz. 
t Present address: Section de Biophysique des Proteines et des 
Membranes, Departement de Biologie Cellulaire et Moleculaire, 
Commissariat a I'Energie Atomique et Centre National de la Re-
cherche Scientifique URA 1290, CE Saclay, F-91191 Gif-sur-Yvette 
Cedex, France. 
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nuclear RNAs (SO), mRNA (16), 40S and 60S ribosomal 
subunits (6, 38), and SS rRNA (24) occurs in a manner 
consistent with a mediated process. Analysis of the nuclear 
transport of U small nuclear RNAs has multiple defined, 
kinetically distinct targeting pathways (27, 47, 48). Nuclear 
transport of different classes of RNA may thus involve 
targeting to the pore complex by different cytoplasmic 
receptors and then translocation into the nucleus by the 
same pore complex-mediated mechanism. Specific RNA • 
structures have been implicated as requirements for both 
nuclear import and export (S, 22, 32, 33, 67, 7S). Transloca-
tion of RNA molecules across the nuclear envelope may also 
require interaction with specific proteins (28, 31, 33, 43, 62). 
RNA-protein interactions are important for many regula-
tory processes. There is growing evidence that RNA struc-
tures, such as helices, loops, bulges, mismatches, and 
pseudoknots, are key elements in protein recognition (for a 
review, see reference 19). The sequence and structural 
requirements for binding of TFIIIA to SS rRNA have been 
the subjects of extensive research (7, 8, S6, 66, 74). In 
comparison, the structural elements of the SS rRNA mole-
cule required for assembly into ribosomes and for its func-
tional activity within the ribosome remain to be elucidated 
(34, 37, 69). 
We report here the results of a structural analysis of 31 
different SS rRNA mutants by nuclear transport and RNP 
assembly assays in Xenopus oocytes. The results are dis-
cussed in relation to the abilities of these same SS rRNA 
mutants to bind TFIIIA in vitro (7, 8, S6, 74). We show that 
determinants of nuclear transport, TFIIIA binding, and 
ribosome incorporation within the SS rRNA molecule are 
complex and nonidentical. The results suggest that TFIIIA 
binding is not a prerequisite for nuclear targeting of SS 
rRNA, consistt(nt with earlier studies indicating that 7S 
RNPs are not imported (3, 44). We show that microinjected 
6820 ALLISON ET AL. 
5S rRNA is incorporated into 60S ribosomal subunits in the 
nucleus; thus, the first requirement for assembly is nuclear 
import. Finally, we demonstrate that nuclear import of 5S 
rRNA is sensitive to general inhibitors of nuclear pore" 
mediated translocation. 
MATERIALS AND METHODS 
Syntbesis of mutant 5S rRNAs. The 5S rRNA genes used in 
these experiments were constructed from a series of syn" 
thetic oligonucleotides that were subsequently introduced 
into pUC18 as previously described (56, 58). Internally 
labelled 5S rRNAs were produced by in vitro transcrip" 
tion from these gene templates with T7 RNA polymerase 
(Boehringer Mannheim N.Z. Ltd., Auckland, New Zealand) 
and 50 to 100 IJ-Ci of [a_32P]GTP (3,000 Ci/mmol; Amersham 
Australia Pty Ltd., Auckland, New Zealand). The mixture 
was incubated for 1.5 h at 37°C and then treated with 
RNase-free DNase (Boehringer Mannheim). The sample was 
extracted with phenol and chloroform, and the RNA tran-
scripts were precipitated twice with 2.5 M ammonium ace-
tate and ethanol. The RNA pellet was resuspended in TE (10 
mM Tris-HCl, 1 mM EDTA), pH 7.6, and stored at -80°C. 
RNA concentration was quantified by DNA Dipstick (Invit-
rogen Corp., San Diego, Calif.), according to the manufac-
turer's instructions.· 
Microinjection and analysis of nuclear transport. An ovary 
lobe was surgically removed from an adult Xenopus laevis 
(reared at the University of Canterbury on a diet of cock-
roaches), and the oocytes were separated by brief collage-
nase treatment as previously described (3). Stage 5-6 oocytes 
were microinjected with 40 to 80 nl of RNA (0.2 to 0.5 ng of 
RNA per oocyte) into the oocyte cytoplasm with a PV 830 
PicoPump (World Precision Instruments, Inc., New Haven, 
Conn.) by previously published proeedures (3). After over-
night incubation (18 h) in O-R2 medium (3), nuclei were 
manually dissected from oocytes in 1 % trichloroacetic acid 
and collected for analysis (3). RNA was extracted from 
nuclear and cytoplasmic fractions as deseribed by Allison et 
a1. (3). RNA was analyzed by 8% polyacrylamide-8 M urea 
gel electrophoresis as described previously (3). Dried gels 
were autoradiographed on Amersham Hyperfilm-MP at 
-80°C. A Kontron Uvikon 860 spectrophotometer equipped 
with a gel scan accessory was used to measure the intensity 
of bands on suitable exposures of autoradiograms (within the 
linear range of signal intensity of the film); data were 
quantified with software package 8543. The system has high 
resolution, and the software accommodates background 
levels and irregularly shaped bands. Only mutants that 
showed less than 50% nuclear transport relative to oocyte-
type 5S rRNA were considered to be significantly impaired. 
For ATP depletion assays, oocytes were preinjected with 
50 nl of 1-U/IJ-I apyrase (grade VIII; Sigma Chemical Co., St. 
Louis, Mo.) in phosphate-buffered saline (PBS) (3) to give a 
final intracellular concentration of 100 U/m1. Alternatively, 
50 nl of PBS was preinjected as a control. After 30-min 
incubation at 18"C, oocytes were injected with labelled 
RNA. After an additional 6-h incubation, oocytes were 
analyzed for nuclear import as described above. ATP deple-
tion was verified with a CLS ATP bioluminescence kit 
(Boehringer Mannheim). Single oocytes were homogenized 
in boiling 20 mM HEPES (N-2-hydroxyethylpiperazine-N'-
2-ethanesulfonic acid), pH 7.5, and incubated for 5 min at 
100°C, and samples were then diluted 1:500 in double-
distilled water. A 500-lJ-l sample was added to an equal 
volume of luciferase extract immediately prior to measure-
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ment of luminescence with an SAl ATP photometer (model 
2000). 
Wheat germ agglutinin (WGA) (Sigma Chemical Co.) was 
dissolved in PBS at concentrations ranging from 0.25 to 2 
mg/m!. WGA (50 nl) or PBS (as a control) was injected into 
the oocyte cytoplasm. After incubation for 3 h, oocytes were 
injected with labelled RNA and analyzed for nuclear import 
as described above. As a control for the specificity of 
preinjection of 50 nl of 1-mg/ml WGA, 50 nl of 1-mg/ml WGA 
and 500 mM N-acetylglucosamine (Sigma Chemical Co.) 
were coinjected into oocytes prior to injection of labelled 5S 
rRNA. As a control for nonselective diffusion, oocytes were 
injected with 50 nl of 100-mg/ml fluorescein isothiocyanate-
dextran (molecular weight, 10,000 or 150,000; Sigma Chem-
ical Co.). After overnight incubation, nuclei were dissected 
out in nucleus isolation buffer (3) and viewed by fluorescence 
microscopy for diffusion of the dextran into the nucleus. 
Since there can be variability in synthetic activity between 
different batches of oocytes, experiments were repeated a 
minimum of two times with oocytes from different animals. 
Antisera. The antibodies raised against TFIIIA have been 
shown to react with the relevant protein; no cross-reaction 
with any other protein was noted by immunoblotting (70). 
Preparation of the antibodies raised against Xenopus 60S 
ribosomal subunits is described by Viel et a1. (70); however, 
there is a slight difference in the reaction of the anti-60S 
ribosomal subunit antiserum used in this study (anti-serum 
number 2679; sampling date, 7 November 1985) and of the 
antiserum described by Viel et a1. (70). Immunoblot analysis 
was performed on total protein from ribosomal subunits 
purified from mature Xenopus ovaries by ultracentrifugation 
techniques (70) or from 7S fractions obtained after sucrose 
density centrifugation of cell homogenates of Xenopus ova-
ries (41). The proteins were fractionated by polyacrylamide 
gel electrophoresis and either stained with Coomassie blue 
or transferred to lmmobilon-P polyvinylidene difluoride 
membranes (Millipore S.A., Saint-Quentin Yvelines, 
France). Membranes were incubated with diluted antiserum 
(1:287) in a solution of 10 mM sodium phosphate (pH 7.4), 
150 mM NaCl, and 1 % bovine serum albumin, washed in the 
same buffer, treated with 35S-labelled-protein A in order to 
label the antigen-antibody complexes, washed again, and 
exposed to X-ray films at -80°C by previously published 
procedures (70). 
To further ensure that the anti-60S antiserum did not 
cross-react with 7S RNPs, immunoprecipitation analyses 
were performed on 7S RNPs purified from immature Xeno-
pus ovaries as previously described (3). Immunoprecipita-
tion assays were performed as described by Allison et a1. (3), 
using approximately 10 IJ-g of 7S RNPs and 10 IJ-l of anti-
serum bound to protein A-Sepharose (Pharmacia LKB Bio-
technology, Auckland, New Zealand). Immunoprecipitates 
were vortexed briefly in sample buffer (2% sodium dodecyl 
sulfate, 100 mM dithiothreitol, 60 mM Tris [pH 6.8], 0.01% 
bromophenol blue), heated at 100°C for 5 min, and then 
centrifuged for 30 s. Proteins from the supernatant were 
resolved by polyacrylamide gel electrophoresis and silver 
stained with a Bio-Rad silver stain kit (Bio-Rad Laboratories 
Pty Ltd., Auckland, New Zealand), according to the manu-
facturer's instructions. 
Immunoprecipitation assays. Microinjected oocytes were 
incubated for 48 h at 18°C. Immunoprecipitation assays were 
performed as described by Allison et al. (3), using homoge-
nates of 20 microinjected oocytes and 10 IJ-I of antiserum 
bound to protein A-Sepharose. For nuclear immunoprecipi-
tations, 20 nuclei were isolated in nucleus isolation buffer 
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(3). RNA was recovered from the immunoprecipitates and 
immunosupernatants and resolved on 8% polyacrylamide-8 
M urea gels, and then autoradiography was performed. 
Results were interpreted qualitatively by comparing the 
amounts of the different mutants immunoprecipitated with 
the amount of oocyte-type 5S rRNA immunoprecipitated 
and by comparing the relative specific activities of the RNA 
mutants and the amounts of RNA injected, using the super-
natant fractions. 
Electrophoretic mobility shift assays. After a 48-h incuba-
tion at 18°C, five microinjected oocytes were homogenized 
in 20111 ofRNP homogenization buffer (20 mM Tris [pH 7.6], 
100 mM KCI, 1.5 mM MgCl2, 2 mM dithiothreitol, 0.1 mM 
phenylmethylsulfonyl fluoride, 10 U of RNasin per ml; 
Promega:Pacific Diagnostics Pty. Ltd., Auckland, New 
Zealand). A crude cellular lysate was prepared by disrupting 
oocytes with a Gilson tip, spinning down the cellular debris 
(yolk and pigment) by centrifugation at 9,000 X g for 10 min 
at 4°C, and removing the supernatant, taking care not to 
disturb the lipid pellicle floating on the surface. Glycerol-dye 
loading buffer was added to the supernatant, and samples 
were loaded directly onto a 6% polyacrylamide-0.1 % Triton 
X-IOO gel in Tris-borate-EDTA buffer plus 0.1% Triton 
X-IOO. Samples were electrophoresed at 300 V; gels were 
dried at 80aC for 30 min, and then autoradiography was 
performed. A sample of unlabelled, native 7S RNPs were 
included as a marker. The marker lane was stained with 
ethidium bromide and viewed by UV illumination. 
RESULTS 
Sequence and structural requirements for nuclear transport 
of 58 rRNA. The sequence and structural requirements of 5S 
rRNA for nuclear transport in Xenopus oocytes were inves-
tigated by analyzing 31 mutant 5S rRNA molecules gener-
ated by in vitro transcription. Figure 1 shows the secondary 
structure of oocyte-type 5S rRNA and the locations of the 
mutations analyzed. With the exception of seven mutants, 
substitutions were located between nucleotides 11 and 108 in 
the region of the RNA molecule shown to provide the 
necessary sequence and conformational information re-
quired for nuclear transport (3). In our previous study, 
however, we did not investigate quantitative differences in 
nuclear transport. 
All mutant 5S rRNAs were stable 24 h after cytoplasmic 
microinjection (data not shown). Analysis of oocyte-type 55 
rRNA revealed that on average, 14% of the microinjected 
RNA was found in the nucleus after 18 h (Fig. 2, lanes 1 and 
2). These results were consistent with a previous study, 
which demonstrated that the total amount of labelled 5S 
rRNA found in the nucleus increases for up to 18 to 21 hand 
then remains constant (3). Presumably, this constant amount 
reflects steady-state levels of 5S rRNA molecules which 
have migrated into the nucleus and are being assembled into 
ribosomes. Nuclear transport of 5S rRNA thus represents a 
state of flux between the cytoplasm and nucleus, as opposed 
to a measure of nuclear import alone. The 31 mutant 5S 
rRNAs showed a variety of transport phenotypes. The 
intracellular distribution of five mutant RNAs is presented in 
Fig. 2. The most defective mutant, 16--21, showed a 75% 
reduction in nuclear transport relative to that of oocyte-type 
5S rRNA (lanes 3 and 4). Mutants 41-44 and 105-108 were 
less defective in nuclear transport, showing reductions of 67 
and 54%, respectively (compare lanes 5 and 6 and lanes 11 
and 12). In contrast, mutants .t.l63 and 67-70 had transport 
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characteristics similar to those for oocyte-type 5S rRNA 
(lanes 7 to 10). The data are summarized in Table l. 
Mutations within predicted helices II and V tend to have 
lower nuclear transport values if the mutations are helix 
breaking (HB in Table 1), than if the mutations are helix 
maintaining (HM). Nucleotide substitutions that alter either 
the 5' sequence of helix II or the sequence and structure of 
helix V resulted in a significant reduction (~50%) in nuclear 
transport. The loop mutants tested have block sequence 
substitutions in one loop which alter the sequence but 
maintain the single-stranded secondary structure (56). Nu-
cleotide substitutions that alter the 3' sequence of loop Cor 
the noncanonical base pairing in loop E (57, 72) resulted in a 
significant reduction in nuclear transport. The deletion of 
bulged nucleotides did not impair transport. In contrast, 
alteration of the hinge nucleotide at position 66 resulted in a 
57% reduction in nuclear transport, suggesting this nucle-
otide is located in a key region of the 5S rRNA. This is in line 
with a previous study showing that nucleotides in the hinge 
region of the 5S rRNA, the junction of the three helical 
domains, play a central role in determining the coaxial 
stacking interactions and tertiary structure of the RNA and 
are critical for TFIIIA recognition (8). In summary, specific 
structural elements of the 5S rRNA molecule have been 
shown to be important for nuclear transport, but no single 
region of 5S rRNA is solely responsible. 
TFIIIA has been implicated in mediating 5S rRNA nuclear 
export (31), but indirect evidence suggests that 7S RNPs are 
not import competent (3,44). In order to determine whether 
there is a correlation between wild-type TFIIIA binding 
affinity and wild-type nuclear transport, results on nuclear 
transport of the mutants are compared with data on their 
ability to bind TFIIIA in vitro from previous studies (7, 8, 56, 
74). In general, the two sets of data are comparable (Table 
1); there are, however, important exceptions. For example, 
mutants 10-13, 57-62, and G109 possess low binding affini-
ties for TFIIIA (17 to 40% of oocyte-type 5S rRNA), yet the 
measure of nuclear transport is closer to that of oocyte-type 
5S rRNA (63 to 77%). Furthermore, other mutants (e.g., 
96--101 and 14-15) with higher TFIIIA binding affinities (59 to 
85%) exhibit defective nuclear transport (36 to 49%). Since 
some of the structural requirements of 5S rRNA for nuclear 
transport and 7S RNP assembly differ, this suggests that 
TFIIIA binding is not a prerequisite for nuclear targeting. 
Nuclear import of 5S rRNA and mutant RNA molecules 
occurs by a mediated process. One possible explanation for 
oocyte-type and mutant 5S rRNAs entering the nucleus is 
that their small size allows for unrestricted entry. 5S rRNA 
is a 121-nucleotide molecule of approximately 41 kDa. The 
nuclear pore complex contains an aqueous channel of 9- to 
11-nm diameter which acts like a molecular sieve; this 
channel allows rapid, nonselective diffusion of molecules of 
approximately 20 to 40 kDa, while excluding larger cytoplas-
mic proteins (52). A truncated, 98-nucleotide 5S rRNA does 
not enter the nucleus (Fig. 2) (3), however, which implies 
that nuclear uptake of full-length 5S rRNA occurs by a 
mechanism other than unrestricted entry. Further, compar-
ing 5S rRNA and a globular protein may not be a valid 
comparison; the frictional ratio of naked 5S rRNA has been 
shown to be higher than that of 7S RNPs, suggesting that 5S 
rRNA is more elongated (17). 
Translocation across the nuclear envelope occurs by an 
energy-dependent process (2, 51, 55). Thus, sensitivity to 
ATP depletion is one criterion for distinguishing active 
transport from diffusion. We therefore tested the effect of 
cytoplasmic ATP depletion on 55 rRNA nuclear import. 
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FIG. L Secondary structure of X laevis oocyte-type 5S rRNA showing mutant nucleotide substitutions and deletions. (A) Single-strand substitution mutations. The bulged S 
nucleotides deleted (A at nucleotides 49 and 50 and C at nucleotide 63) are indicated by italicized letters. (B) Helix mutants. Only the relevant region of the 5S rRNA is shown. t" 
Nucleotide substitutions are indicated by outlined letters. 
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FIG. 2. Intracellular distribution of 32P-labelled oocyte-type or 
mutant 5S rRNA species following microinjection in X laevis 
oocytes. 32P-labelled oocyte-type or mutant 5S rRNA was microin-
jected into the cytoplasm of fully grown oocytes. After overnight 
(18-h) incubation, RNA was extracted from five pooled nuclear (N) 
and cytoplasmic (C) fractions and separated electrophoretic ally on 
denaturing 8% polyacrylamide gels containing 8 M urea. The num-
bers refer to those nucleotides in the oocyte-type 5S rRNA (oocyte) 
which have been substituted or deleted (Fig. 1). A truncated 5S 
rRNA molecule consisting of nucleotides 1 to 98 (control) which 
does not enter the nucleus was included as a control for isolation of 
nuclei free of cytoplasmic contamination. 
After injection of the ATP-hydrolyzing enzyme apyrase, 
ATP depletion was verified by a luciferase assay. At a final 
intracellular concentration of 100 D/ml, there was a rapid 
decline in ATP levels from 2 mM to 10 to 40 fLM. This 
decrease occurred within 30 min and remained low after 25 h 
of incubation (data not shown). As shown in Fig. 3, ATP 
depletion significantly inhibited nuclear import of oocyte-
type 5S rRNA (lane 4). The autoradiogram was deliberately 
overexposed to demonstrate the absence of detectable levels 
of labelled 5S rRNA in the nuclear fraction. 
Another criterion for signal-mediated import via the nu-
clear pore complex is sensitivity to the lectin WGA. WGA is 
known to inhibit active transport by binding to N-acetylglu-
cosamine (GlcNAc)-containing proteins present in the nu-
clear pore complex (25,26,65). Preinjection ofWGA signif-
icantly inhibited nuclear import of oocyte-type 5S rRNA 
(Fig. 4A, lane 4). To verify that inhibition of import resulted 
from WGA interacting with GlcNAc-containing glycopro-
teins, WGA was coinjected with GlcNAc. Figure 4A (lane 6) 
shows that the presence of 50 mM GlcNAc abolished WGA-
induced inhibition of import. The inhibitory effect of prein-
jected WGA on oocyte-type 5S rRNA was dose dependent 
(Fig. 4B), with 86% inhibition occurring at a concentration of 
0.1 mg/ml. To ensure that WGA was not acting by physically 
occluding the nuclear pores, small fluorescently labelled 
dextrans (10 kDa) were microinjected into the oocyte cyto-
plasm. After overnight incubation, oocytes were dissected, 
and the nuclei were viewed by fluorescence microscopy. 
Pre injection of WGA had no effect on nonselective diffusion 
of small dextrans, and large fluorescently labelled dextrans 
(150 kDa) were excluded from the nucleus (data not shown). 
Similar results have been obtained in cultured somatic cells 
(15, 25). 
An additional criterion for mediated transport is exclusion 
of nuclear proteins from the nucleus in chilled cells. Nuclear 
accumulation of large and small karyophilic proteins is 
inhibited by chilling, which slows enzyme-mediated reac-
tions, whereas small proteins lacking nuclear localization 
signals may diffuse freely across the nuclear envelope, 
regardless of the temperature (10). Thus, 5S rRNA nuclear 
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import was tested for temperature dependence. Figure 5 
shows that the nuclear import of oocyte-type 5S rRNA was 
inhibited in chilled oocytes (lane 4). Chilling did not inhibit 
nonselective diffusion of a small fluorescent dextran into the 
nucleus (data not shown). 
To determine whether nuclear import of mutant 5S rRNAs 
occurs by a mediated process or by nonselective diffusion, 
loop C mutant 41-44 and loop E mutant 96-101 were tested, 
since these RNAs have reduced abilities to enter the nucleus 
relative to that of oocyte-type 5S rRNA (Table 1). Preinjec-
tion of WGA significantly inhibited nuclear import of both 
mutant 5S rRNAs, although mutant 41-44 was less sensitive. 
Data are summarized in Table 2. Nuclear import of mutants 
41-44 and 96--101 was also inhibited in chilled oocytes (Table 
2), although both mutants were less sensitive than oocyte-
type 5S rRNA. The possibility remains that nuclear entry of 
these mutants is partly diffusional; binding to an import 
receptor protein may be of low affinity or weakly tempera-
ture sensitive. Not all RNA-protein interactions, however, 
are temperature sensitive, because assembly of microin-
jected 5S rRNA into 7S RNPs (storage particles) does occur 
in chilled oocytes (data not shown). 
In summary, nuclear import of 5S rRNA is sensitive to 
general inhibitors of nuclear pore-mediated translocation, so 
import is likely accomplished by a pathway similar to that 
used by karyophilic proteins. 
5S rRNA is assembled into 60S ribosomal subunits in the 
nucleus. Although indirect evidence to date suggests that 
cytoplasmic 5S rRNA returns to the nucleus for ribosome 
incorporation (3, 18), a nuclear assembly site has not yet 
been demonstrated. To deduce the site of 5S rRNA assembly 
into 60S ribosomal subunits, labelled 5S rRNA was micro-
injected into the cytoplasm and subsequently immunopre-
cipitated from the nuclear versus cytoplasmic compartment. 
The anti-60S ribosomal subunit serum detects two major 
bands in extracts of 60S ribosomal subunits (Fig. 6A and B, 
lanes 3); one band is approximately 37 kDa, and the other is 
approximately 14 to 15 kDa. The 37-kDa band corresponds 
to ribosomal protein L2; the 14- to 15-kDa band is not as 
easily identified but migrates similarly to ribosomal proteins 
in the range of L17 to L20 (53). This antiserum also reacts 
slightly with an approximately 18-kDa band in extracts of 
40S ribosomal subunits (Fig. 6A and B, lanes 4). In the 7S 
fraction from a sucrose gradient, apart from the high-molec-
ular-mass bands which probably represent polysaccharides, 
there is no cross-reaction (Fig. 6A and B, lanes 2). This 
antiserum does not immunoprecipitate 7S RNPs (Fig. 6C, 
lane 2). Intact ribosomes are immunoprecipitated by the 
anti-60S serum; the immunoprecipitates contain proteins 
that react with anti-40S ribosomal subunit serum as revealed 
by immunoblotting and contain both 28S and 18S rRNA as 
revealed by Northern blot (RNA) analysis (data not shown). 
60S subunits containing labelled 5S rRNA were first 
faintly detectable in the nuclear fraction after 18 h but were 
not detectable in the cytoplasm (data not shown). After 48 h, 
labelled 5S rRNA was immunoprecipitated as 60S subunits 
from both the cytoplasmic fraction (Fig. 7, lane 2) and the 
nuclear fraction (lane 4), thus indicating a nuclear site of 
assembly, followed by export to the cytoplasm. 
In a previous study, 7S RNPs were detected only in the 
oocyte cytoplasm after microinjection of labelled 5S rRNA 
and immunoprecipitation with anti-TFIIIA antibodies (3). 
Since TFIIIA has been shown to bind nuclear 5S rRNA (31), 
we repeated these assays with a different antibody prepara-
tion to determine whether a small nuclear pool of 7S RNPs 
was present. The antibodies raised against TFIIIA react with 
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TABLE 1. Summary of mutant phenotypes 
Mutant Nuclear TFIIIAK. in Immunoprecipitation
d 
7SRNP 
designation" transport relative vitro" EMSA" to oocyles typeb Anti-7S Anti-60S 
Oocyte type 1.00 1.00 + + + 
Helix II 
14-15 (HB) 0.49 ± 0,03 (3) 0.85 ± 0.22 IR IR + 
64-65 (HB) 0.97 (1) 0.74 ± 0.24 + + 
14-15/64-65 (HM) 1.04 0.16 (3) 1.11 ± 0.32 IR + + 
16--21 (HB) 0.25 ± 0.05 (2) 0.32 ± 0.15 + IR ND 
57-62 (HB) 0.73 (1) 0.40 ± 0.15 + + + 
16--21/57-62 (HM) 1.88 (1) 1.09 ± 0.48 + + + 
Helix III 
27-32 (HB) 0.70 ± 0.23 (2) 0.75 ± 0.10 + + + 
45-52 (HB) 1.45 ± 0.34 (3) 0.76 ± 0.12 + + + 
Helix IV 
78-81 (HB) 0.99 (1) 0.88 ± 0.01 + + ND 
95-98 (HB) 0.86 (1) 0.78 ± 0.02 + IR + 
78-81195-98 (HM) 1.19 ± 0.46 (3) 0.86 ± 0.01 + + NO 
82-86 (HB) 1. 75 ± 0.02 (2) 0.81 ± 0.30 + + ND 
91-94 (HB) 0.85 ± 0.31 (4) 0.96 ± 0.18 + + + 
82-86/91-94 (HM) 1.38 ± 0.19 (2) 1.21 ± 0.35 + + NO 
Helix V 
67-70 (HB) 1.18 ± 0.44 (2) 0.75 ± 0.12 + + 
105-108 (HB) 0.46 ± 0.15 (4) 0.39 ± 0.06 + + ND 
67-70/105-108 (HM) 1.07 ± 0.34 (2) 0.71 ± 0.01 + IR + 
71-72 (HB) 0.44 ± 0.12 (3) 0.35 ± 0.21 + IR ND 
103-104 (HB) 0.48 ± 0.18 (3) 0.50 ± 0.23 + IR NO 
71-72/103-104 (lIM) 1.37 ± 0.43 (3) 1.18 ± 0.32 + + NO 
Loop A 
10-13 (SEQ) 0.63 ± 0.00 (2) 0.30 ± 0.01 
LoopB 
22--26 (SEQ) 1.18 (1) 1.00 ± 0.02 + + + 
LoopC 
33-39 (SEQ) 0.97 ± 0.25 (3) 1.00 ± 0.02 + + + 
41-44 (SEQ) 0.33 ± 0.06 (3) 0.40 ± 0.10 + + + 
LoopD 
87-90 (SEQ) 1.26 (1) 0.71 ± 0.10 + + + 
LoopE 
73-76 (SEQ) 1.60 ± 0.20 (2) 0.57 ± 0.02 + + 
96--101 (SEQ) 0.36 ± 0.04 (3) 0.59 ± 0.01 + 
Bulged nucleotides 
M9,50 (DEL) 0.76 ± 0.38 (2) 1.00 ± 0.02 + + 
M3 (DEL) 1.04 ± 0.40 (4) 1.00 ± 0.02 + + 
Hinge nucleotides 
C66 (SEQ) 0.43 ± 0.05 (2) 0.12 ± 0.01 + + + 
Gl09 (SEQ) 0.77 ± 0.02 (2) 0.17 ± 0.05 + + 
• The numbers in the designations refer to those nucleotides in 5S rRNA which have been substituted or deleted (Fig. 1). FIB, helix breaking; HM, helix 
maintaining; SEQ, sequence mutation; DEL, deletion. 
b Assays were performed as described in the legend to Fig. 2; nuclear transport was quantified by densitometry of suitable exposures of autoradiograms (within 
the linear range of signal intensity of the film), relative to the steady-state levels of oocyte-type 5S rRNA localized to the nucleus during each experiment. 
Experimental values are presented (mean ± standard deviation from the mean). Numbers in parentheses indicate the number of independent experiments 
performed. 
" In vitro binding data is summarized from references 7, 8, 56, 58, and 74. 
d Assays were performed as described in the legend to Fig. SA. Protein binding was quantified by qualitative estimation of relative amounts of bound and free 
RNA. JR, inconclusive results caused by RNA with low specific activity. 
e Electrophoretic mobility shift assays (EMSAs) were performed as described in the legend to Fig. 8e. NO, not determined. 
the relevant protein (Fig. 6C, lane 1); no cross-reaction was 
noted with any other protein by immunoblotting (70). Under 
similar conditions, in this present study 7S RNPs containing 
labelled 5S rRNA were detectable only in the cytoplasmic 
fraction from 10 oocytes incubated for 21 h after microinjec-
tion (data not shown). However, a small nuclear pool of 7S 
RNPs was revealed by increasing the incubation time after 
microinjection to 48 h, increasing the specific activity of the 
labelled 58 rRNA, and increasing the sample size to 20 
oocytes (Fig. 7, lane 3). 
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FIG. 3. Nuclear import of oocyte-type 5S rRNA is ATP depen-
dent. Oocytes were pre injected with a final intracellular concentra-
tion of 100 U of apyrase per ml (-ATP), or PBS as a control 
(+ ATP). After incubation for 30 min at 18°C, 32P_labelled oocyte-
type 5S rRNA was injected into the cytoplasm, and the oocytes 
were incubated for a further 6 h. The analysis for nuclear import was 
then performed as described in 2. C, cytoplasm; N, nucleus. 
Sequence and structural requirements of 5S rRNA for 60S 
ribosomal subunit assembly and 7S RNP assembly in vivo. 
Since the results above demonstrated that the first require-
ment for subunit assembly is nuclear targeting, it was of 
interest to ascertain which sequence and structural elements 
of 5S·rRNA are required for incorporation into 60S riboso-
mal subunits. Immunoprecipitation assays were thus per-
formed on microinjected oocytes with antibodies against 60S 
subunits. 
The results of several representative experiments are 
shown in Fig. SA, and the complete data are presented in 
Table 1. Of 31 mutants. only 4 were completely defective in 
ribosome incorporation. Of these four mutants, two had 
mutations in single-strand loop regions. mutants 96-101 (Fig. 
8A, lane 14) and 10-13 (lane 16), indicating that these regions 
of the molecule are important in recognition or binding of 5S 
rRNA with other ribosomal components. Comparable 
amounts of oocyte-type and mutant 5S rRNAs were detect-
able in the immunosupernatant fractions, demonstrating that 
the mutants were not degraded during the 4S-h incubation 
(Fig. SB). The simplest explanation for mutant 96-101 not 
being detected in ribosomes is that this results from impaired 
nuclear transport (Table 1). However. mutant 41-44 is 
equally defective in nuclear transport. yet it is found incor-
porated into 60S ribosomal subunits (lane 12). The other two 
defective mutants were M9,50 (lane 18) and .6.63 (lane 20), 
indicating that these bulged nucleotides are important for 5S 
rRNA incorporation into the 60S subunit. Results were 
inconclusive for six mutants (Table 1). The possibility that 
the absence of these labelled RNAs in 60S ribosomal sub-
units was due to the low specific activity of the RNA could 
not be ruled out. Despite repeated attempts to increase the 
specific activity, these particular mutant 5S rRNA gene 
constructs continued to provide poor templates for tran-
scription. 
In addition to assaying different mutant 5S rRNA mole-
cules for their incorporation into 60S subunits, immunopre-
cipitation of 7S RNPs was also performed with anti-TFIIIA 
antibodies. This qualitative analysis provided a comparison 
with the in vitro data previously obtained for TFIIIA binding 
to the mutant 5S rRNA molecules (summarized in Table 1). 
All but six mutant 5S rRNAs were found to be able to bind 
TFIIIA in the oocyte in an immunodetectable complex. One 
of these defective mutants, 10-13 (Fig. 8A, lane 15), corre-
sponds with the in vitro data; mutant 10-13 has a Ka of 0.30 
and is 20 times less effective in inhibiting TFIIIA binding 
than oocyte-type 5S rRNA is (56). Negative results with 
other mutants, however, were contradictory. For example, 
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FIG. 4. Nuclear import of oocyte-type 5S rRNA is inhibited by 
WGA. (A) Oocytes were preinjected with WGA at a final intracel-
lular concentration of 0.1 mg/ml or with WGA (0.1 mg/ml) and 50 
mMN-acetylglucosamine (WGA + GlcNAc). PBS was preinjected 
as a control. After incubation for 3 h, 32P-Iabelled oocyte-type 5S 
rRNA was injected into the cytoplasm and the oocytes were 
incubated for a further 18 h. The analysis fOT nuclear import was 
then performed as described in the legend to Fig. 2. C, cytoplasm; 
N, nucleus. (B) Dose-dependent inhibition of 5S rRNA nuclear 
import. Oocytes were preinjected with 50 nl of WGA at various 
concentrations. The final intracellular concentration of WGA is 
denoted on the x axis. The nuclear import of 32P-Iabelled 5S rRNA 
was assayed 18 h after injection. Import in the presence of WGA is 
expressed as a percentage of the import of 5S rRNA in control 
oocytes preinjected with PBS only (% Control). 
mutant 67-70 (Fig. 8A, lane 7) was not immunoprecipitated 
with anti-TFIIlA yet has an in vitro binding affinity of 0.75 
(74). To clarify these results, homogenates of microinjected 
oocytes were analyzed by electrophoretic mobility shift 
assays. As shown in Fig. 8C, mutant 67-70 (lane 5) clearly 
showed a band shift present at a position corresponding to 
that of 7S RNPs. Similarly, mutants 64-65, 73-76, 96-101, 
and GI09 which were not immunodetectable by anti-TFIIIA 
showed band shifts corresponding to 7S RNPs (Fig. 8A and 
C and Table 1). In contrast, consistent with the in vitro 
binding data and immunoprecipitation data, no band shift 
corresponding to 7S RNPs was detected with mutant 10-13 
(Fig. 8e, lane 8). The data are summarized in Table L 
The inconsistent anti-TFIIIA immunoprecipitation assay 
and electrophoretic mobility shift assay results described 
above can be explained by reasoning that for these mutant 
5S rRNA molecules, the 5S rRNA-TFIIIA complexes that 
are formed have different conformations which are not 
recognized by the anti-TFIIIA antibody or that the com-
plexes formed are not stable under the assay conditions. 
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FIG. 5. Effect of chilling on the nuclear import of oocyte-type 5S 
rRNA. 32P-labelled oocyte-type 5S rRNA was injected into the 
oocyte cytoplasm. After incubation for 18 h at either 18°C as a 
control or on ice (O°C), the analysis for nuclear import was per-
formed as described in the legend to Fig. 2. C, cytoplasm; N, 
nucleus. 
These observations raise a cautionary note toward relying 
solely on antigen-antibody interactions for the analysis of 
RNA-protein interactions. 
The potential formation of an RNA-protein complex not 
recognized by an antibody is not a likely consideration with 
the anti-60S ribosomal subunit antibody. 5S rRNAis thought 
to be buried in the 60S subunit (42), within the peptidyl 
transferase center, whereas the ribosomal proteins recog-
nized by this antibody (L2 and another in the range of L17 to 
L20) are not detected in this region (23, 63, 68). Given the 
apparent lack of direct cross-links between 5S rRNA and the 
ribosomal proteins recognized by the anti-60S antibody, it is 
unlikely that any conformational change resulting from in-
corporation of a mutant 5S rRNA molecule into the 60S 
subunit would be transmitted to these ribosomal proteins; 
A 
200-
116-
85-
66-
45-
29-
18-
14-
B 
MW 78608408 
2 3 4 
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TABLE 2. Summary of effects of WGA and chilling on nuclear 
import of oocyte-type and mutant 5S rRNA 
RNA 
Oocyte type 
41-44 
96-101 
WGA 
14.6 (±OA) 
42.0 (±3.4) 
17.0 (±1.6) 
% ControlG 
O·C 
4.1 (±2.1) 
43.0 (±3.0) 
22.0 
a Nuclear import of the designated 32P-labelled RNA (Fig. 1) was assayed in 
samples of five oocytes as described in the legend to Fig. 4A for WGA (fmal 
intracellular concentration of 0.2 mg/ml) and in tbe legend to Fig. 5 for 
chilling. Imporl was quantified by densitometry and expressed as a percentage 
(± standard deviation from the mean) of the amount of import in control 
oocytes (% Control). Tabulated results are from two samples, except for 
mutant 96--101 (DoC) for which one sample was used. 
thus, the recognition or binding of the anti-60S antibody to 
these epitopes would not be affected. 
In summary, specific structural elements of the 5S rRNA 
molecule have been shown to be critical for ribosome 
incorporation. Deletion of bulged nucleotides and nucleotide 
substitutions that alter the sequence of loop A or the 
noncanonical base pairing in loop E (57, 72) abolish ribo-
some incorporation. Some of the structural elements of 5S 
rRNA required for ribosome incorporation differ from those 
elements required for nuclear transport. Further, some of 
the structural requirements of 5S rRNA for 7S RNP assem-
bly and for 60S ribosomal subunit assembly differ. 
DISCUSSION 
From the 5S rRNA mutants studied in this report, a 
picture emerges of complex and nonidentical structural 
features within the central domain of the RNA molecule that 
c 
FIG. 6. Control of antiserum specificity by irnmunoblotting and immunoprecipitation assays. Total protein from 7S fractions and from 
ribosomal subunits purified from Xenopus ovaries was fractionated by electrophoresis in 15% polyacrylamide gels containing 0.1% sodium 
dodecyl sulfate (SDS) and either stained with Coomassie blue (A) or transferred to Immobilon-P polyvinyJidene difluoride membranes and 
probed with anti-60S ribosomal subunit antiserum (B). The antigen-antibody complexes were revealed by treatment with 35S-labelled protein 
A and then autoradiography (48 h). The high-molecular-mass bands in lane 2 of panel B are probably polysaccharides. Lanes: MW, protein 
molecular mass markers (in kilodaltons); 7S, approximately 10 f,l-g of protein purified from the 7S region of a sucrose gradient; 60S, 
approximately 3 f,l-g of protein from 60S ribosomal subunits purified by sucrose gradient centrifugation; 40S, approximately 1 f,l-g of protein 
from 40S ribosomal subunits purified by sucrose gradient centrifugation. (C) 7S RNPs purified from immature Xenopus ovaries were incubated 
with protein A-Sepharose-antibody complexes in an immunoprecipitation assay. Proteins were recovered and separated electrophoretically 
on 12% polyacrylamide gels eontaining 0.1% SDS and then silver stained. Lanes: anti-7S, immunoprecipitation with anti-TFIIIA; anti-60S, 
immunoprecipitation with anti-60S ribosomal subunit; control, mock immunoprecipitation with anti-60S antiserum, but without 7S RNPs; 
1F1IIA, TFIIIA protein from 7S RNPs. 
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FIG. 7. Intracellular localization of microinjected 5S rRNA in 
60S ribosomal subunits and 7S RNPs. Labelled 5S rRNA was 
microinjected into the cytoplasm of oocytes. After incubation for 48 
h, 20 oocytes were manually fractionated into cytoplasmic (C) and 
nuclear (N) compartments. Homogenates from each compartment 
were incubated with protein A-Sepharose-antibody complexes in an 
immunoprecipitation assay. Labelled RNAs were recovered and 
separated electrophoretically on 8% polyacrylamide gels containing 
8 M urea. Lanes: 7S, immunoprecipitation with anti-TFIIIA; 60S, 
immunoprecipitation with anti-60S ribosomal subunit. 
are required for nuclear transport, assembly into 7S RNPs 
(storage particles) and assembly into 60S ribosomal subunits 
(Fig. 9). 5S rRNA is assembled into 60S ribosomal subunits 
in the nucleus; thus, the first requirement for subunit assem-
bly is nuclear targeting. However, some of the structural 
elements of 5S rRNA required for ribosome incOrporation 
differ from those elements required for nuclear transport 
(Fig. 9). Differences in the requirements for nuclear trans-
port and TFIIlA binding suggest that TFIIIA binding is not 
a prerequisite for nuclear targeting of 5S rRNA. 
Subcellular trafficking of 5S rRNA. Since 5S rRNA can be 
easily and specifically dissociated from intact ribosomes or 
subunits as a 5S rRNA-L5 complex (3), it was thought that 
the 5S rRNA might be added as a surface component to 
partially assembled subunits, hence a cytoplasmic site of 
integration of stored 5S rRNA seemed plausible. However, 
results presented here indicate that cytoplasmically stored 
5S rRNA returns to the nucleus for assembly into the large 
60S subunit. This conclusion is consistent with a recent 
study in Saccharomyces cerevisiae, which suggests that 5S 
rRNA is crucial to an early step in subunit assembly (69). 
Thus, analysis of intracellular distribution reflects the 
steady-state levels of 5S rRNA molecules reached after 
overnight incubation (3); 5S rRNA is released from storage, 
migrates into the nucleus, is assembled into ribosomes, and 
then is exported to the cytoplasm. Since ribosome assembly 
continues for a protracted period of time in Xenopus 
oocytes, only a small fraction of microinjected 5S rRNA 
would be expected to appear in the nucleus at any given time 
or be incorporated into nascent ribosomes. The latter is 
reflected in the small fraction of labelled 5S rRNA found in 
60S subunits compared with 7S RNPs (storage particles). 
Interestingly, a number of mutants accumulated in the 
nucleus to a greater degree than oocyte-type 5S rRNA, for 
example, nuclear accumulation of mutant 16-21/57-62 was 
nearly twice that of oocyte-type 5S rRNA. It is not clear 
whether this distribution represents enhanced nuclear im-
port or whether the increased nuclear accumulation of some 
mutants is due to a defect in another function, such as 
nuclear export. 
Mediated nuclear import of 5S rRNA. Nuclear import of 5S 
rRNA is inhibited by cytoplasmic ATP depletion, WGA, and 
chilling. Similarly, nuclear protein import (2, 51, 55), export 
of ribosomal subunits (6), and mRNA export (16) require 
metabolic energy in vivo. The concentration of WGA re-
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FIG. 8. Assembly mutant 5S rRNAs into 60S ribosomal sub-
units and 7S RNPs. (A) 32P-labelled oocyte-type or mutant 5S rRNA 
was microinjected into the oocyte cytoplasm. After 48 h, homoge-
nates of whole oocytes were analyzed by immunoprecipitation assay 
as described in the legend to Fig. 7. Labelled RNAs were recovered 
and separated electrophoretically on 8% polyacrylamide gels con-
taining 8 M urea. The numbers in the mutant designations refer to 
those nueleotides in oocyte-type 5S rRNA (oocyte) which have been 
substituted or deleted (Fig. 1). Lanes: 7S, immunoprecipitation with 
anti-TFIIIA; 60S, immunoprecipitation with anti-60S ribosomal 
subunit. (B) Labelled RNAs recovered from immunosupernatant 
fractions, from the anti-60S immunoprecipitation assays in panel A. 
Lane 1, oocytc-type RNA; lane 2, mutant 67-70; lane 3, mutant 
96-101; lane 4, mutant 10-13; lane 5, mutant A49,50; lane 6, mutant 
A63. (C) Electrophoretic gel mobility shift assays of mutant 5S 
rRNAs. Labelled oocyte-type or mutant 5S rRNA was injected into 
the oocyte cytoplasm. After 48 h, homogenates were electrophore-
sed on nondenaturing 6% polyacrylamide gels containing 0.1% 
Triton X-IOO. The location of 7S RNPs was determined by running 
an additional lane of unlabelled, purified 7S RNPs; this lane was 
stained with ethidium bromide and visualized by UV illumination 
(not Shown). The arrows indicate a band shift that may represent the 
5S rRNA-ribosomai j.rotein L5 complex, but this has yet to be 
confirmed. Marker, 3 P-labelled 5S rRNA. Lanes 1 to 4 and lanes 5 
to 8 represent experiments in which samples were electrophoresed 
for different lengths of time. 
quired to inhibit 5S rRNA nuclear import is comparable to 
the concentration of WGA shown to inhibit the nuclear 
import of U6 small nuclear RNA, but 20 times less than the 
concentration required to inhibit nuclear import of U1 small 
nuclear RNA to a similar degree (see Fig. 3 in reference 48). 
These results correlate with studies on nuclear export of 5S 
rRNA and 5S rRNA-containing RNPs. Approximately 60% 
inhibition of ribosomal subunit export can be achieved when 
WGA is injected into the nucleus at a final concentration of 
0.5 mg/ml (6), and export of 5S rRNA newly synthesized 
from microinjected cloned genes is significantly inhibited by 
preinjection of RL1, an antinucleoporin monoclonal anti-
body (24). The sensitivity of 5S rRNA to general inhibitors of 
nuclear transport suggests that 5S rRNA is targeted to 
oocyte nuclei by a receptor-mediated process. 
6828 ALLISON ET AL. MoL. CELL. BIOL. 
A AG III C U C G U 30 U 
® GC-C U G A ... .. .... 
5' 
I» •••••• 0 .. 
" 
CG G AC ~;:If;";;;;'~;";";'~A U A G ~ .... ~ 
~ ...... ~ 
3' UUUCGGAUGCUG 
120 
40 
v 
100 
IV 
A 
G 
U 
A 
C 
C 
Ueo 
G 
COG 
I A 
G-U 
C-G 
CoG 
00 A G ® 
GA 
1:::::::::::1 
c:::J 
Key 
nuclear import 
TFIIiA binding 
ribosome incorporation 
FIG. 9. Complex, nonidentical regions of 5S rRNA required for different functions. Shaded boxes indicate regions in which nucleotide 
substitution results in at least a 50% reduction in nuclear transport of 5S rRNA. Boxes outlined in bold indicate regions in which nucleo-
tide substitution results in at least a 50% reduction in TFIIIA binding affinity. Boxes outlined in dashed lines indicate regions in which 
nucleotide substitution abolishes incorporation of 5S rRNA into the 60S ribosomal subunit. 
Given the specificity of receptor-mediated processes, it 
seemed surprising that all mutants were capable of at least 
some degree of nuclear import. However, the results pre-
sented here are similar to an analysis of the nuclear export 
phenotypes of 30 different point mutants of human tRNA~et 
which revealed variable defects in transport; the percentage 
of microinjected tRNA exported to the cytoplasm ranged 
from 85 (wild type) to 34% (D stem mutant) (67). Glyceral-
dehyde-3-phosphate dehydrogenase binds two defective mu-
tants with lower affinity than that of wild-type tRNA, sug-
gesting that this protein may be involved in tRNA export 
(62). This comparison with tRNA export and a model for the 
tertiary structure of 5S rRNA provide some insight into 5S 
rRNA import. 5S rRNA has been proposed to adopt a 
Y-shaped structure in which the three helical domains are 
independent (13, 71), that is, the effect that a mutation has on 
the RNA structure is primarily restricted to the mutated loop 
(12, 40). If a protein involved in nuclear targeting makes 
numerous contacts with 5S rRNA, disruption of one small 
region may not disrupt binding in other regions, therefore 
potentially providing a stable complex that is still recognized 
by the transport machinery. Relatively small changes in 
complex stability may be masked at the saturating levels of 
RNA used in these experiments. 
Guddat et a1. (31) proposed that 5S rRNA nuclear export 
is mediated by either TFIIIA or L5 on the basis of studies 
showing that mutant RNA molecules that do not form 
immunodetectable complexes with these proteins are re-
tained in the nucleus. Results of this present study suggest 
that TFIlIA binding is not a prerequisite for nuclear import 
of 5S rRNA, consistent with earlier work suggesting that 7S 
RNP transport is unidirectional (3, 44). A small nuclear pool 
of 78 RNPs containing labelled 58 rRNA was detected after 
microinjection of labelled 58 rRNA into the oocyte cyto-
plasm, but it is likely that these 78 RNPs were assembled 
after nuclear entry. If 58 rRNA enters the nucleus in excess 
of the amount required for assembly into nascent 608 
ribosomal subunits, it may become associated with TFIIIA. 
Along these lines, it has been proposed that excess 58 rRNA 
may be targeted to the cytoplasm of mammalian somatic 
cells for degradation bound to a TFIIIA-like protein (39). 
Ribosomal protein L5 and 58 rRNA form a stable complex 
prior to assembly of ribosomal subunits (3, 11, 64, 73). 
Cytoplasmic exchange between TFIIIA and L5 for binding 
of 58 rRNA correlates with the mobilization of 5S rRNA 
from storage within the Xenopus oocyte cytoplasm (3), 
suggesting that L5 may mediate 58 rRNA nuclear targeting. 
Little is known about the sequence and structural require-
ments for L5 binding to 5S rRNA, although chemical pro-
tection assays (35) and immunoprecipitation assays (3) indi-
cate a binding domain similar to that of TFIIIA. Delineation 
of the sequence and structural requirements of 5S rRNA for 
L5 binding and correlation with data on subcellular localiza-
tion should provide further insight into the role of L5 in 
nuclear import and nucleolar targeting of 5S rRNA. The 
possibility remains that other proteins, such as carriers that 
shuttle between the cytoplasm and the nucleus (9, 36, 46, 
60), are involved in the subcellular trafficking of 58 rRNA. 
S8 rRNA structural elements required for ribosome assem-
bly. Loop structures, bulged nucleotides, and non-Watson-
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Crick base pairs of RNA have been shown to be of impor-
tance for specific protein recognition (4, 14, 54). Similarly, 
results presented here show that incorporation of 5S rRNA 
into ribosomes is abolished by deletion of bulged nuc1e-
otides, A at nucleotides 49 and 50 or C at nucleotide 63, and 
by nucleotide substitutions that alter the sequence of loop A 
or the noncanonical base pairing in loop E. These results 
correlate with results from other workers investigating pro-
karyotic 5S rRNA-protein interactions. Escherichia coli 5S 
rRNA has a structure similar to that of eukaryotic 5S rRNA, 
but E. coli 5S rRNA binds to three ribosomal proteins, L5, 
L18, and L25, rather than to one protein as in eukaryotes. A 
bulged nucleotide at position 65 in E. coli 5S rRNA, corre-
sponding to position 63 in eukaryotic 5S rRNA, is necessary 
for binding of L18 to the 5S rRNA (reviewed in reference 
29). 
Various regions of 58 rRNA have been postulated to be of 
importance for ribosome assembly and function (69; for a 
review, see reference 29). Complementary base pairing 
between nucleotide sequences at the 5' and 3' ends of mouse 
188 rRNA contained in the 40S ribosomal subunit and 
nucleotides 9 to 26 and 90 to 107 of 5S rRNA occurs in vitro 
(59). The functional significance of this stable interaction has 
yet to be determined. Interestingly, mutant 96-101 which has 
increased Watson-Crick base pairing in the loop E-helix IV 
region of 5S rRNA and mutant 10-13 which has an altered 
sequence in loop A were shown here to be defective in 
ribosome incorporation. These results indicate a correlation 
between the structural elements of the 58 rRNA molecule 
required for 60S ribosomal subunit assembly and the struc-
tural elements previously proposed to aid in formation of the 
80S ribosome by 58 rRNA-nucleic acid interactions. Protein 
recognition of the non canonical base pairing in loop E 
encompassing nucleotides 96 to 101 of the 58 rRNA mole-
cule (57, 72) may be of importance for 60S ribosomal subunit 
assembly, as well as RNA-RNA hybridization. 
58 rRNA represents an important model system for study 
of the regulated subcellular trafficking of RNA, because it 
involves many different components: shuttling of the 5S 
rRNA molecule across the nuclear envelope, a variety of 
RNA-protein interactions and exchanges, cytoplasmic local-
ization of the 58 rRNA in RNPs (storage particles), and 
nucleolar targeting. Continued study of the effects of muta-
tions by an in vitro binding assay (7, 8, 56, 74) and by the in 
vivo functional assays described here should help to further 
identify and clarify those sequence and structural elements 
of 5S rRNA required for some of its biological activities. 
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We studied the pathway of 58 ribosomal RNA (rRNA) 
during oogenesis in Xenopus from its storage in the cyto-
plasm to incorporation into ribosomes in the nucleus. Ribo-
nucleoprotein particle (RNP) assembly assays reveal strik· 
ing differences in the behavior of oocyte-type and somatic-
type 58 rRNA after microinjection into stage II, III, or IV 
oocytes or into the cytoplasm of stage V-VI oocytes. Mi-
croinjected oocyte-type 58 rRNA predominantly interacts 
with the 58 r RNA gene-specific transcription factor IlIA 
(TFIIIA) to form storage 78 RNPs. In contrast, microin-
jected somatic-type 58 rRNA predominantly interacts with 
ribosomal protein L5 to form 58 RNPs, which are precur-
sors to ribosome assembly. In addition, a greater amount of 
somatic-type 58 rRNA accumulates in the nucleus and is 
assembled into 608 ribosomal subunits. Thus, a slight 
difference in nucleotide sequence results in differential 
binding of 58 rRNA to TFIIIA and L5, specializing oocyte-
type for storage in the oocyte cytoplasm and somatic-type 
for rapid mobilization and ribosome assembly. When oo-
cyte-type and somatic-type 58 rRNA molecules were mi-
croinjected into the nucleus of stage V-VI oocytes in excess 
of other ribosomal components, the nucleocytoplasmic dis-
tribution of both types of RNA was similar, but the distinc-
tive protein associations were maintained. In contrast, the 
behavior of oocyte-type and somatic-type 58 rRNA grad-
ually synthesized in situ from microinjected cloned genes 
was similar, suggesting that nascent RNA is rapidly and di-
rectly recruited into ribosomes, thus bypassing an excur-
sion into the cytoplasm prior to ribosome assembly. © 1995 
Academic Presst Inc. 
INTRODUCTION 
Xenopus has two families of 58 ribosomal RNA 
(rRNA) genes, oocyte-type and somatic-type, which are 
under developmental control and produce 58 rRNAs 
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differing in six nucleotides (Wegnez et al., 1972; Ford and 
8outhern, 1973; reviewed by W olffe and Brown, 1988). 
The oocyte-type family of 58 rRNA genes, with approx-
imately 20,000 copies per haploid genome, is actively 
transcribed in the developing oocyte yielding large 
amounts of 58 rRNA for ribosome stockpiling, but is rel-
atively inactive during early embryogenesis and is 
switched off in somatic cells. In contrast, the somatic-
type family of 58 rRNA genes, with approximately 400 
copies per haploid genome, is transcribed throughout 
development, including in oocytes (Wormington and 
Brown, 1983). There has been widespread interest in the 
58 rRNA gene system as a model for differential gene 
regulation (e.g., Wormington et al., 1981; McConkey and 
Bogenhagen, 1988; Keller et al., 1990; reviewed by Wolffe 
and Brown, 1988), but less attention has been devoted 
to defining functional differences in the corresponding 
RNAs. 
Preribosomal particles containing 58, 188, 5.88, and 
288 rRNAs, and many of the ribosomal proteins, are as-
sembled in the nucleoli of somatic cells and are exported 
to the cytoplasm as 408 and 608 ribosomal subunits (re-
viewed by Hadjiolov, 1985). In previtellogenic (stages I 
to II; Dumont, 1972) Xenopus oocytes, however, 58 rRNA 
is synthesized before other components of ribosomes are 
available (Mairy and Denis, 1971) and stored in the cy-
toplasm as 78 ribonucleoprotein particles (RNPs) com-
plexed with the 58 rRNA gene-specific transcription fac-
tor UIA (TFIIIA) (Picard and Wegnez, 1979; Honda and 
Roeder, 1980; Pelham and Brown, 1980) or with other 
nonribosomal proteins and tRNA as 428 RNPs (Picard 
et al., 1980). Later in oogenesis (stages III to VI), when 
the synthesis of other ribosomal constituents is maxi-
mal, 58 rRNA becomes associated with ribosomal pro-
tein L5, forming 58 RNPs, and returns to the nucleus for 
incorporation into ribosomes in the amplified nucleoli 
(Allison et al., 1991, 1993). At this stage, newly synthe-
sized 58 rRNA may follow a shorter pathway for ribo-
some assembly. Nascent 58 rRNA first forms a transient 
association with the La protein (Guddat et al., 1990), 
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which may be involved in transcription termination 
(Gottlieb and Steitz, 1989). After La is replaced by L5, 5S 
rRNA may then migrate from the site of transcription 
directly to the nucleoli for incorporation into ribosomes, 
as is proposed for somatic cells (Steitz et aL, 1988). 
Since there are 50-fold more of the oocyte-type genes, 
oocyte-type predominates as the majorform of 5S rRNA 
in oocytes. Somatic-type 5S rRNA synthesized in 00-
cytes has been shown to be incorporated into RNPs im-
mediately after synthesis; however, only storage parti-
cles containing oocyte-type 5S rRNA appear to be con-
served over time. Somatic-type 5S rRNA has not been 
detected in the pool of RNPs or ribosomes stored for 
many months in the oocyte for use during embryogen-
esis (Denis and Wegnez, 1977). In this investigation, we 
asked whether the six nucleotide substitutions distin-
guishing the two types of 120 nucleotide RNA molecule 
make oocyte-type 5S rRNA better suited than somatic-
type 5S rRNA to the unusual way in which ribosomes 
are assembled during oogenesis. We tested whether so-
matic-type 5S rRNA is capable of following individual 
steps in the oocyte-type pathway of storage in the cyto-
plasm and subsequent return to the nucleus for assem-
bly into ribosomal subunits. 
First, in order to mimic the pathway followed by 
stored 5S rRNA during oogenesis, we microinjected in 
vitm-generated oocyte-type and somatic-type 5S rRNA 
into stage II, III, or IV oocytes or into the cytoplasm of 
stage V-VI oocytes. The results of RNP assembly assays 
reported here reveal striking differences in the behavior 
of the two types of RNA. Oocyte-type 5S rRNA predom-
inantly interacts with TFIIIA to form storage 7S RNPs, 
while somatic-type 5S rRNA predominantly interacts 
with L5 to form 5S RNPs, which are precursors to ribo-
some assembly. In addition, we show that twice as much 
somatic-type 5S rRNA accumulates in the nucleus and a 
greater amount is assembled into nascent 60S ribosomal 
subunits. Thus, the nucleotide substitutions distin-
guishing the two types of 5S rRNA result in differential 
binding to TFIIIA and L5 in vivo, specializing oocyte-
type for long-term storage in the oocyte cytoplasm and 
somatic-type for rapid mobilization and ribosome as-
sembly. Next, in order to track 5S rRNA originating in 
the nucleus in excess of other ribosomal components, we 
microinjected labeled oocyte-type and somatic-type 5S 
rRNA into the nucleus of stage V-VI oocytes. Under 
these conditions, the nucleocytoplasmic distribution of 
oocyte-type and somatic-type 5S rRNA was similar, but 
the distinctive protein associations were maintained. 
Finally, we compared injection of 5S rRNA into the nu-
cleus en masse with gradual synthesis in situ. When we 
injected cloned genes encoding the two types of RNA 
into oocyte nuclei, we found that the behavior of newly 
transcribed oocyte-type and somatic-type 5S rRNA was 
similar. This distribution most likely reflects a more 
rapid and direct recruitment of newly synthesized 5S 
rRNA into nascent ribosomes, thus bypassing an excur-
sion into the cytoplasm prior to ribosome assembly. 
MATERIALS AND METHODS 
PZasmids and Synthesis of 5S rRNA 
Internally labeled 5S r RNAs were produced by in VitTO 
transcription from pXlo-wt (oocyte-type) and pXls-wt 
(somatic-type) gene templates (generous gifts from P. J. 
Romaniuk, University of Victoria, Victoria, British 
Columbia, Canada). These 5S rRNA genes were con-
structed so that the T7 transcripts have 5' and 3' termini 
identical to those found in the natural 5S rRNA mole-
cules (Romaniuk et CtZ., 1987). Transcription reactions 
were performed using 50 U T7 RNA polymerase (Epi-
centre Technologies: Intermed Scientific Ltd., Auckland, 
New Zealand) and 50-100 /iCi [a-32PJGTP (3000 Cil 
mmole; Amersham Australia Pty. Ltd. or DuPont NEN: 
Life Technologies Ltd., Auckland, New Zealand) in a 20-
/il reaction containing transcription buffer (Epicentre), 
10 mM dithiothreitol, 40 U RNasin (Promega: Pacific Di-
agnostics I'ty. Ltd., Auckland, New Zealand), 200 liM 
CTI',ATP, and UTI', 40 /iMGTI', and l/igDNA template 
linearized with DraI (Boehringer Mannheim N. Z. Ltd., 
Auckland, New Zealand). The mixture was incubated for 
1 hI' at 37°C followed by treatment with 1 U RNase-free 
DNase (Boehringer Mannheim). Subsequently, 130 /il 
UB Blue (175 mMNaCI, 5 mMTris, pH 7.4, 5 mMEDTA, 
0.5% SDS, 0.05% methylene blue, 7 M urea) and 20 fig of 
glycogen (Boehringer Mannheim) were added. The sam-
ple was phenol/chloroform extracted and the RNA tran-
scripts were precipitated 15 min on ice with 2 vol etha-
nol. A second precipitation was carried out with 2.5 M 
ammonium acetate and 2 vol ethanol. The RNA pellet 
was resuspended in TE (10 mMTris-HCl, pH 7.6,1 mM 
EDTA) at 100,000 cpml/il and stored at -80°C. RNA 
concentration was quantified by DNA Quik STRIP 
(Eastman Chemical Co., New Haven, CT). 
In one experiment, we tested whether there was a re-
quirement for renaturation of in vit'ro-generated oocyte-
type and somatic-type 5S rRNA prior to microinjection. 
RNA samples were resuspended in 20 mMTris-HCI, pH 
7.6, 5 mM MgC12 , and 50 mkI KCl. The RNA was then 
renatured by heating to 65°C for 10 min, followed by 
slow (1 hr) cooling to room temperature. There was no 
difference in the behavior of microinjected renatured 5S 
rRNA, compared with 5S rRNA stored in TE; thus, this 
step was not carried out in subsequent experiments. 
Plasm ids encoding 5S rRNA genes for nuclear injec-
tions were obtained from A. H. Bakken (University of 
Washington, Seattle, W A): pXl08 contains four Xenopus 
laevis oocyte-type 5S rRNA gene repeats (described in 
Birkenmeier et al., 1978) and pJH17 contains one so-
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matic-type 5S rRNA gene repeat (constructed by J. Ha-
nas, University of Oklahoma Health Sciences Center). 
Microinjection 
Stage V-VI X laevi.c; oocytes were microinjected with 
20 nl RNA (2000 cpm/oocyte) into the cytoplasm or nu-
cleus using previously published procedures (Allison et 
al., 1993). A range of concentrations were tested; injec-
tions of 0.2 to 2 ng per oocyte yielded the same nucleocy-
toplasmic and RNP distribution. Where results of 
different treatments were being compared, an identical 
amount of oocyte-type and somatic-type 5S rRNA was 
injected for each treatment. To control nuclear injec-
tion, the technique of Jarmolowski et al. (1994) was fol-
lowed. Samples were mixed (1:1) with a 20-mg/ml solu-
tion of filter-sterilized blue dextran (2,000,000 molecular 
weight) (Sigma Chemical Co., St. Louis, MO). After dis-
section, only oocytes with blue nuclei were used. This 
procedure had no apparent effect on nuclear transport 
or RNP assembly. For analysis of newly synthesized 
RNA, 20 nl plasmid DNA (0.25 mg/ml) was microin-
jected into the nucleus together with [a-32P]GTP. The 
amount of RNA synthesized in .c;itu over 20 hr was esti-
mated to be approximately 0.1 to 0.2 ng, based on the 
amount of DNA injected and the rate of rRNA synthesis 
in oocytes (Gurdon and Melton, 1981). 
For injections of immature oocytes, oocytes were first 
separated into Dumont stages (Dumont, 1972) using the 
following criteria: late stage II, white/opaque, 300 ,urn; 
stage III, tan, 450 ,urn; stage IV, dark brown, distinct an-
imal hemisphere, 600 ,urn. Staged oocytes were immobi-
lized in culture dishes containing 0.7% agarose in 0-R2 
with depressions of the appropriate diameter and mi-
croinjected with 2 nl of in 1Jitro-generated RNA. 
Analysis of Nuclear Transport 
After microinjection and incubation in 0-R2 medium, 
nuclei were manually dissected from oocytes in 1 % TCA 
and collected for analysis (Allison et al., 1991). RNA was 
extracted from nuclear and cytoplasmic fractions ac-
cording to a procedure modified from Xie and Rothblum 
(1991). Three cytoplasms or nuclei (plus two carrier un-
injected oocytes) were homogenized on ice in 30,u1 0-R2 
by vigorously pipetting with a Gilson P200 Pipetman. 
Nine hundred seventy microliters of solution A (TE-sat-
urated phenol, solution B, and 2 MNaOAc, pH 4.0, in a 
ratio of 1:1:0.1, supplemented with 720 ,ul j3-mercapto-
ethanol per 100 ml of solution B) was immediately added 
to homogenates. Solution B consisted of 4 M guanidin-
ium thiocyanate and 25 mM sodium citrate (pH 7.0). One 
hundred microliters of chloroform/isoamyl alcohol (24: 
1) was added to each tube and the phases were mixed by 
vortexing briefly. The mixture was kept on ice for 30 min 
and the phases were separated by centrifuging at 9000g 
for 20 min. The upper aqueous phase was recovered and 
the RNA was precipitated at -20°C by addition of an 
equal volume of isopropanol. The RNA was analyzed by 
8% polyacrylamide/8 M urea gel electrophoresis as de-
scribed (Allison et a~, 1993). Dried gels were autoradio-
graphed on Amersham Hyperfilm-MP at -80°C. A 
Zeineh analytical hand-held scanning densitometer and 
Biomed Image Analysis software (Advanced American 
Biotechnology, Fullerton, CA) were used to quantify the 
intensity of bands on suitable exposures of autoradio-
grams (within the linear range of signal intensity of the 
film). In addition, samples were quantified prior to elec-
trophoresis in a Quick-Count QC-2000 bench top radio-
isotope counter (Bioscan, Inc., Washington, DC). 
A nalysis of RNP Formation 
Crude cellular lysates were prepared from samples of 
either three stage V-VI or five stage II, III, or IV mi-
croinjected oocytes as described in Allison et al. (1993). 
Samples were electrophoresed on 6% polyacrylamide/ 
0.1 % Triton X-100 gels in TBE with 0.1 % Triton X-100, 
followed by autoradiography and densitometric analy-
sis. A sample of unlabeled, native 7S RNPs (5S rRNA 
complexed with TFIIIA), purified from immature Xeno-
pus ovaries as described in Allison et al. (1991), were in-
cluded as a marker. The marker lane was stained with 
ethidium bromide and viewed by uv illumination. To 
prepare a marker for 5S rRNA complexed with ribo-
somal protein L5, native 5S RNPs were isolated from 
EDTA-treated ribosomes from Xenopus ovaries as de-
scribed in Allison et a~ (1991). An exchange reaction was 
then used to incorporate internally labeled 5S rRNA 
into the native RNPs, following the methods of Huber 
and Wool (1986). 32P-Iabeled oocyte-type 5S rRNA was 
incubated at 0-4°C for 1 hr in 20 ,ul of 25 mM EDTA, 
pH 7.0, containing approximately 5,ug of 5S RNPs. The 
exchange reaction was stopped by the addition of MgCl2 
to a final concentration of 25 mM. 
The protein components of labeled 5S rRNA -contain-
ing RNPs formed in situ were analyzed as follows. After 
incubation for 24 hr, five stage V oocytes microinjected 
with oocyte-type or somatic-type 5S rRNA were homog-
enized together with 60 uninjected stage III oocytes in 
order to supplement the pool of nonribosome bound 5S 
rRNA-containing RNPs. After separation of RNPs by 
non denaturing polyacrylamide gel electrophoresis, the 
0.75-mm gel was dried and an autoradiogram template 
was prepared. RNP bands were excised and gel slices 
were rehydrated with 30,ul sterile ddH20, removed from 
the filter paper backing, and transferred to a l.5-ml mi-
crocentrifuge tube on ice. Twenty microliters of sample 
buffer (2% SDS, 100 mM dithiothreitol, 60 mMTris, pH 
6.8, 0.01 % bromophenol blue) was added and the gel 
slices were heated at lOO°C for 5 min. Replicate gel 
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slices, permeated with sample buffer, were then trans-
ferred to the wells of a LO-mm-thick 12% polyacryl-
amide gel containing 0.1 % SDS. After electrophoresis 
for 8 hr at 10 V I em, half the gel was stained with 0.25 % 
Coomassie blue R250 to visualize proteins. To visualize 
RNA and proteins, the other half of the gel was silver 
stained with a Bio-Rad silver stain kit (Bio-Rad Labora-
tories Pty. Ltd., Auckland, New Zealand) according to 
the manufacturer's instructions. 
Antiser'Um and Immunoprecipitation Assays 
Anti-60S ribosomal subunit antiserum raised against 
Xenopus 60S ribosomal subunits was a generous gift 
from M. Ie Maire (CEA et CNRS, Gif-sur-Yvette, 
France). The antiserum is described and characterized 
in Viel et at. (1990) and Allison et al. (1993). 
Microinjected stage V-VI oocytes were incubated for 
45 hr at 18°C. Nuclei were isolated in 25 m111Tris-HCI, 
pH 8.0, 10% glycerol, 5 m111MgClz. and 2 mll1 dithiothre-
itol (Allison et ai., 1991). Cleared homogenates of 20 
nuclear and cytoplasmic fractions from microinjected 
oocytes were prepared as described in Allison et ai. 
(1991), and immunoprecipitation assays were carried 
out using 20,u.1 antiserum bound to protein A-Sepharose 
(Pharmacia LKB Biotechnology, Auckland, New Zea-
land). RNA was recovered from the immunoprecipitates 
and the immunosupernatants and resolved on 8% poly-
acrylamide/8 111 urea gels followed by autoradiography. 
Samples were quantified as described above for nuclear 
transport assays. 
For analysis of ribosome assembly during earlier 
stages of oogenesis, microinjected stage II, III, and IV 
oocytes were incubated for 24 hI' at 18°C. Immunopre-
cipitation assays were then carried out on cleared ho-
mogenates of 20 oocytes. 
RESULTS 
The Nuclear Import Kinetics of Oocyte-Type and 
Somatic-Type 5S rRNA Are DijJm'ent 
Nuclear import of oocyte-type 5S rRNA occurs by a 
temperature- and energy-dependent, nuclear pore-me-
diated process (Allison et al., 1993). Since the six so-
matic-specific nucleotide substitutions of 5S rRNA (Fig. 
1) are located between nucleotides 11 and 108, in the re-
gion of the molecule shown to provide the structural in-
formation required for nuclear transport (Allison et al., 
1991,1993), it was of interest to determine whether these 
substitutions alter the nuclear transport characteristics 
of 5S rRNA. To investigate nuclear import of the two 
types of RNA, we microinjected in vitro-generated oo-
cyte-type and somatic-type 5S rRNA into the cytoplasm 
of stage V-VI oocytes, thus mimicking the pathway fol-
lowed by stored 5S rRNA during oogenesis. A kinetic 
analysis of nuclear import of the two types of RNA re-
vealed that somatic-type 5S rRNA enters the nucleus 
more rapidly and accumulates to a greater extent than 
oocyte-type (Figs. 2A and 2B). At maximal levels, 35% 
of microinjected somatic-type 5S rRNA was found in the 
nucleus, while oocyte-type 5S rRNA reached levels of 
only 19%. This percentage of total RNA in the nucleus 
represents a state of flux between the cytoplasm and the 
nucleus; 5S rRNA migrates into the nucleus and then 
returns to the cytoplasm, presumably after assembly 
into ribosomal subunits (Allison et ai., 1991, 1993). Six 
additional experiments with oocytes from different 
frogs confirmed this pattern of distribution. On average, 
nuclear accumulation of somatic-type 5S rRNA after· 
approximately 20 hr incubation was twice that of oo-
cyte-type 5S rRNA (Table 1). The kinetics of oocyte-type 
5S rRNA transport shown here are comparable to our 
previous reports (Allison et at., 1991, 1993). 
To compare the nucleocytoplasmic distribution of cy-
toplasmically injected 5S rRNA with 5S rRNA originat-
ing in the nucleus in excess of other ribosomal compo-
nents, we next microinjected in vitro-generated 5S 
rRNA into oocyte nuclei. After 20 hr incubation both 
types of RNA were predominantly localized in the nu-
cleus (Fig. 2B; Table 1). On average, 62% of oocyte-type 
and 80% of somatic-type 5S rRNA were found in the nu-
cleus. 
Finally, to compare the nuclear export characteristics 
of 5S rRNA injected en masse into the nucleus with 
RNA gradually synthesized in situ, we introduced radio-
labeled 5S rRNA molecules by transcription from mi-
croinjected templates. After 3 hr incubation, 
slightly more newly synthesized somatic-type 5S rRNA 
was found in the cytoplasm, compared with oocyte-type 
5S rRNA (Fig. 2B). However, after 20 hr incubation, the 
nucleocytoplasmic distribution of the two types of RNA 
was similar (Fig. 2B; Table 1). On average, 68% of oo-
cyte-type and 60% of somatic-type 5S rRNA were found 
in the nucleus. During this incubation period a negligi-
ble amount of 5S rRNA was synthesized from endoge-
nous genes (Fig. 2C). 
In summary, we have shown that after microinjection 
into the oocyte cytoplasm, somatic-type 5S rRNA enters 
the nucleus more rapidly and accumulates to a greater 
extent than oocyte-type. These findings suggest that so-
matic-specific substitutions enhance nuclear import of 
5S rRNA. In contrast, the nuclear export characteristics 
of the two types of 5S rRNA are comparable. After 
nuclear microinjection, a greater percentage of both 
types of RNA was found in the nucleus when compared 
with their distribution after microinjection into the cy-
toplasm. These results suggest that the efficiency of ex-
port was low, possibly due to saturation of a specific 
event in export. However, the concentration dependence 
of 5SrRNA export is not a simple function (Jarmolowski 
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shown. Somatic-specific nucleotide substitutions are indicated at residue numbers 30, 47, 53,55,56, and 79. 
et al., 1994), and the percentage of total RNA in the nu-
cleus may also represent reimport of 5S rRNA. 
Oocyte-Type and Somatic-Type 5S'rRNA Bind 
Differentially to TJi'IIIA and L5 
Since the above experiments revealed significant 
differences in the nuclear import characteristics of oo-
cyte-type and somatic-type 5S rRNA, it was of interest 
to determine whether these differences could be corre-
lated with the protein associations formed upon intro-
duction of 5S rRNA into the oocyte cytoplasm or nu-
cleus. Although 5S rRNA-protein interactions in vivo 
have been analyzed previously (Guddat et aL, 1990; Alli-
son et al., 1991,1993), no systematic comparison has been 
made between the two types of RNA. 
To determine whether there are differences in protein 
binding of oocyte-type and somatic-type 5S rRNA, 
quantitative analysis of RNP formation was performed 
directly by electrophoresis of oocyte homogenates on 
nondenaturing gels. Association of 5S rRNA with the 
34-kDa protein L5 (Wormington, 1989) results in a 5S 
RNP complex of intermediate mobility, migrating be-
tween unbound 5S rRNA and RNA associated with the 
38.5-kDa protein 'fFIIIA (Ginsberg et al., 1984) (Fig. 3; 
cf. Fig. 2 in Sands and Bogenhagen, 1991). In an earlier 
study, the identity of this intermediate band had not 
been confirmed (Allison et al., 1993). We show here that 
this band migrates with the same mobility as native 5S 
RNPs, isolated from EDTA-treated ribosomes from 
Xenopus ovaries (Fig. 3B, lane 1). The identity of the pro-
tein component of these native, purified 5S RNPs has 
been confirmed by Western analysis using an antibody 
against L5 (data not shown). Bands from a gel similar to 
the one shown in Fig. 3B were excised and the compo-
nents electroeluted directly into an SDS-polyacryl-
amide gel. The single protein present in the 5S RNP 
band migrates with an apparent molecular weight of 34 
kDa (Fig. 3A, lane 3). 
Figure 3B shows a kinetic analysis of the RNP distri-
bution of oocyte-type and somatic-type 5S rRNA after 
microinjection into the cytoplasm of stage V-VI oocytes. 
Densitometric analysis of the final RNP distribution is 
presented in Table 1. Approximately 50% of protein-
bound oocyte-type 5S rRNA first appears as an RNP 
band migrating more slowly than the 7S RNP and 5S 
RNP bands (Fig. 3B, lanes 2 and 3). This transient com-
plex may represent association of 5S r RNA with p43, the 
43-kDa 5S rRNA-binding component of 42S RNPs (re-
viewed by Denis and Ie Maire, 1983; Sands and Bogenha-
gen, 1991). The concentration of 42S RNPs drops sharply 
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FIG. 2. Differential kinetics of somatic-type and oocyte-type 58 
rRNA nuclear transport. (A) Quantitation of nuclear accumulation af-
ter microinjection into the cytoplasm. Oocytes were microinjected 
with 32P-labeled oocyte-type or somatic-ty-pe 58 rRNA and incubated 
for the time intervals indicated. After manual dissection, RNA was 
extracted from three pooled nuclear and cytoplasmic fractions and 
subjected to denaturing electrophoresis. The percentage of radioactiv-
ity in the nucleus was quantified by densitometry on suitable 
exposures of autoradiograms (within the linear range of signal inten-
sity of the film). Each point is the mean of two to three groups of three 
oocytes. The error bars indicate the standard error of means. (B) Com-
parison of the nucleocytoplasmic distribution of oocyte-type and so-
matic-type 58 rRNA after microinjection of labeled RNA into the cy-
toplasm (autoradiogram exposure time, 5 hr), [a_32P]GTP and cloned 
genes (DNA) into the oocyte nucleus (exposure time, 25 hr), or labeled 
RNA into the nucleus (exposure time, 2 hr). RNA was isolated from 
both nuclear (N) and cytoplasmic (C) fractions after 3 or 20 hr incuba-
tion as indicated and analyzed by denaturing electrophoresis. 0, oo-
cyte-type 58 rRNA. 8, somatic-type 58 rRNA. (C) Analysis of the rel-
ative amount of 58 rRNA synthesized from endogenous genes during a 
20-hr incubation. [a_32P]GTP and either an oocyte-type 58 rRNA gene 
template (0) or buffer (TE) were microinjected into the oocyte nucleus. 
at the onset of vitel10genesis (Dixon and Ford, 1982; Viel 
et al., 1990); however, after micro injection into stage V-
VI oocytes detectable amounts of labeled 58 rRNA are 
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recovered by immunoprecipitation with anti-428 RNP 
antibodies (data not shown). Analysis of the proteins 
from this RNP band revealed a predominant protein mi-
grating with an apparent molecular weight of 43 kDa 
along with other minor species (Fig. 3A, lane 5). Twenty 
percent of somatic-type 58 rRNA was also present in 
this higher molecular weight complex, but approxi-
mately 45% of somatic-type immediately associated 
with L5 upon introduction into the oocyte cytoplasm 
(Fig. 3B, lanes 4 and 5). 
With increasing incubation time, the two types of 58 
rRNA formed stable complexes with either TFIIIA or 
L5 in a strikingly different pattern (Fig. 3B, cf. lanes 27 
and 28). Microinjected somatic-type 58 rRNA predomi-
nantly interacts with L5 to form 58 RNPs, which are 
precursors to ribosome assembly. In contrast, microin-
jected oocyte-type 58 rRNA predominantly interacts 
with TFIIIA to form storage 78 RNPs. Analysis of the 
relative RNP distribution in five batches of oocytes from 
different frogs revealed the same distinctive pattern, al-
though the absolute amounts of protein-bound 58 rRNA 
were variable (Table 1). Injecting one-tenth the amount 
of RNA also resulted in the same pattern of distribution 
(data not shown). Thus, there is a correlation between 
the predominant association of somatic-type 58 rRNA 
with L5 and its entering the nucleus more rapidly and 
accumulating to a greater extent than oocyte-type 58 
rRNA. These findings suggest that the somatic-specific 
substitutions enhance nuclear import of 58 rRNA by in-
creasing the affinity of the RNA molecule for L5, rather 
than by their direct interaction with other components 
of the nuclear transport machinery. 
To determine whether this distinctive pattern of RNP 
distribution was exhibited by 58 rRNA originating in 
the nucleus in excess of other ribosomal components, in 
vitro-generated 58 rRNA was microinjected into stage 
V-VI oocyte nuclei. A similar pattern was observed for 
somatic-type 58 rRNA, with the majority of the RNA 
associating with L5 to form preribosomal58 RNPs (Fig. 
3C, lane 3; Table 1). Oocyte-type 58 rRNA showed little 
association with L5, but also a decreased association 
with TFIIIA (Fig. 3C, lane 1; Table 1), most likely re-
flecting a smaller pool of TFIIIA in the nucleus than in 
the cytoplasm of stage V-VI oocytes. 
Finally, we investigated whether this distinctive pat-
tern of RNP distribution after nuclear injection en 
masse was exhibited by 58 rRNA gradually synthesized 
in situ. After microinjection of cloned genes into oocyte 
nuclei, a different pattern was revealed. Both types of 
newly synthesized RNA were associated to a greater ex-
tent with L5 than with TFIIIA (Fig. 3C, lanes 2 and 4; 
Table 1). 
Differential RNP Distribution throughout Oogenesis 
To investigate whether the differential RNP distribu-
tion observed in stage V-VI oocytes is solely a feature 
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TABLE 1 
SUMMARY OF THE DIFFERENTIAL NUCLEAR TRANSPORT AND RNP FORMATION OF OOCYTE-TypE 
AND SOMATIC-TYPE 5S RRNA IN STAGE V -VI Xenopus OOCYTES 
8ite of injection and Amount of RNA in the nucleus Storage7S Preribosomal 
type of 58 rRNA relative to oocyte-type" RNPs(%)b 5S RNPs (%)b 
Cytoplasmic injection 
Oocyte-type 1.0 43.9 ± 8.2 (5) 8.7± 5.8 (5) 
Somatic-type 2.1 ± 0.4 (6) 8.0 ± 5.5 (5) 66.6 ± 18.5 (5) 
Nuclear injection (RNA) 
Oocyte-type 1.0 20.3 (1) 8.7 (1) 
Somatic-type 1.3 ± 0.1 (3) 15.1 4.4 (2) 70.0± 1.3 (2) 
Nuclear injection (DNA) 
Oocyte-type 1.0 9.4 ± 1.6 (4) 20.2± 2,5 (4) 
Somatic-type 0.9± 0.2 (4) 6,1 ± 1.2 (2) 18.9± 0.1 (2) 
a Nuclear transport after approximately 20 hr was analyzed as described in Fig. 2. Data are expressed in arbitrary units as the mean ± the 
standard deviation relative to tbe amount of oocyte-type 5S rRNA in tbe nucleus. The number of experimental repetitions is indicated in 
parentheses. 
b 7S RNP and 5S RNP formation after 45 hI' was analyzed by nondenaturing gel electrophoresis as described in Fig. 3, The percentage of bound 
RNA relative to free RNA was determined by densitometry. 
of postvitellogenic oocytes, we analyzed the behavior of 
oocyte-type and somatic-type 5S rRNA after microin-
jection into previtellogenic to midvitel10genic oocytes 
(stages II, III, and IV). For this analysis the nucleus or 
cytoplasm could not be specifically targeted for microin-
jection, because the animal and vegetal hemispheres are 
undifferentiated in stage II and III oocytes, and the 
stage IV oocyte nucleus may not be displaced toward the 
animal pole (Dumont, 1972). As in fully grown oocytes, 
in stages II, III, and IV, microinjected oocyte-type 5S 
rRNA associated to a greater extent with TFIIIA than 
with L5, while somatic-type predominantly associated 
with L5 (Fig. 4). In these immature oocytes, somatic-
type 5S rRNA that was associated with TFIIIA formed 
a complex of slightly altered mobility when compared 
with 7S RNPs containing oocyte-type 5S rRNA. Inter-
estingly, oocyte-type was predominantly associated 
with the putative p43-5S rRNA complex, i.e., the higher 
molecular weight complex migrating more slowly than 
the 7S RNP and 5S RNP bands (cf. Fig. 3B and Fig. 4). 
Approximately 40% of the labeled RNA was found in 
this complex in stage II oocytes, decreasing to 15% in 
stage IV. In summary, these results confirm that 
throughout oogenesis microinjected oocyte-type 5S 
rRNA predominantly forms storage RNPs, whereas so-
matic-type 5S rRNA predominantly forms preribosomal 
5SRNPs. 
Somatic-Type 5S dlNA Is Assembled into Ribosome.<>, 
Having determined that somatic-type 5S rRNA is as-
sembled into preribosomal 5S RNPs, we next addressed 
the question of whether microinjected somatic-type 5S 
rRNA can be assembled into oocyte ribosomes. 60S ribo-
somal subunits are not resolvable by the conditions of 
electrophoresis described above, so ribosome assembly 
in stage II to VI oocytes was analyzed by immunoprecip-
itation with anti-60S ribosomal subunit antibodies. 
Densitometric analysis of the amount of somatic-type 
5S rRNA immunoprecipitated as 60S ribosomal sub-
units, relative to oocyte-type 5S rRNA, is summarized in 
Table 2. Throughout oogenesis, differential assembly of 
the two types of micro injected RNA into ribosomes was 
observed. In previtellogenic, vitellogenic, and postvitel-
logenic oocytes a greater amount of somatic-type 5S 
rRNA was assembled into 60S ribosomal subunits when 
compared with oocyte-type 5S rRNA. 
Approximately three times more somatic-type than 
oocyte-type 5S rRNA was found in 60S ribosomal sub-
units in stage II and III oocytes, and approximately four 
times more was found in stage IV oocytes (Table 2). In 
stage V-VI oocytes, the distribution of 60S ribosomal 
subunits between the nucleus and cytoplasm was ana-
lyzed by manual dissection of nuclear and cytoplasmic 
fractions, followed by immunoprecipitation. Figure 5 
shows the nucleocytoplasmic distribution of oocyte-type 
and somatic-type 5S rRNA in 60S ribosomal subunits 
after introduction of RNA into either the cytoplasm or 
the nucleus. After cytoplasmic microinjection, approxi-
mately seven times more somatic-type 5S rRNA than 
oocyte-type 5S rRNA was found assembled into nascent 
60S subunits (Fig. 5; Table 2). Even more striking was 
the difference in ribosome assembly after nuclear 
microinjection of RNA in excess of other ribosomal com-
ponents. Nearly 30 times more somatic-type than oo-
cyte-type 5S rRNA was found assembled into nascent 
60S ribosomal subunits (Fig. 5; Table 2). 60S ribosomal 
subunits containing either oocyte-type or somatic-type 
5S rRNA were primarily immunoprecipitated from the 
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FIG. 3. Differential assembly of oocyte-type and somatic-type 58 rRNA into 78 RNPs and 58 RNPs. (A) Analysis of the components from 58 
rRNA-containing RNPs. A 12% 8D8-polyacrylamide gel stained with Coomassie blue shows the proteins present in bands excised from a gel 
similar to the one shown in E. Lanes: M, protein molecular mass markers (in kilodaltons); RNA, components of the unbound 58 rRNA band 
electroeluted directly into the protein gel; 58, components of the 58 RNP band; 78, components of the 78 RNP band; HMW, components of the 
higher molecular weight RNP band which may represent a p43-58 rRNA complex (see text). The ribosomal protein L5 band at 34 kDa and the 
TFIIIA band at 38.5 kDa are shown by arrowheads. When a replicate gel was silver stained, an additional band was revealed in each lane, 
corresponding to 58 rRNA (data not shown). (E) 32P-labeled oocyte-type or somatic-type 58 rRNA was injected into the oocyte cytoplasm. At 
the indicated times, cleared homogenates of three oocytes were subjected to nondenaturing gel electrophoresis. Duplicate samples were ana-
lyzed. The location of 78 RNPs was determined by running an additional lane of unlabeled, purified 78 RNPs; this lane was stained with ethidium 
bromide and visualized by uv illumination (not shown). 58, 58 RNPs isolated from Xenopus ovary ribosomes, labeled by an in Vit1'O exchange 
reaction with 32p_58 rRNA. 0, oocyte-type 58 rRNA. S, somatic-type 58 rRNA. HMW, higher molecular weight complex (see text). (C) Either 
labeled 58 rRNA (R) or [a_32P]GTP and cloned 5S r RNA genes (D) was microinjected into the oocyte nucleus. The RNP distribution was analyzed 
after 45 hr incubation as described in B. 
nucleus, in which subunit assembly occurs (Fig. 5). 
Longer exposures of the autoradiograms more clearly 
show the cytoplasmic pool of 608 ribosomal subunits 
(data not shown), In contrast, comparable amounts of 
oocyte-type and somatic-type 58 rRNA transcribed 
from microinjected gene templates were found in 608 
ribosomal subunits (Fig. 5; Table 2), suggesting that 
when gradually synthesized in situ both types of RNA 
are rapidly and directly recruited into ribosomes, thus 
bypassing an excursion into the cytoplasm for storage 
prior to ribosome assembly. 
DI8CU8SION 
5S rRNA Binding to TFIIIA or L5: Specialization/or 
Storage Versus Mobilization 
In this study, we described experiments designed to 
test whether somatic-type 58 rRNA is capable offollow-
ing the individual steps in the pathway taken by oocyte-
type 58 rRNA during oogenesis. We have shown that so-
matic-type 58 rRNA is indeed capable of RNP formation 
and nuclear transport; however, there are striking 
diff~rences between oocyte-type and somatic-type 58 
rRNA when the RNAs are introduced into the milieu of 
the oocyte cytoplasm or nucleus. We showed that mi-
croinjected oocyte-type and somatic-type 58 rRNA bind 
differentially to TFIIIA and L5 and that these differ-
ences in protein binding are correlated with the behav-
ior of the two types of RNA within the oocyte. In previ-
tellogenic, vitellogenic, and postvitellogenic oocytes, mi-
croinjected oocyte-type 58 rRNA is complexed in 
storage RNPs, whereas somatic-type 58 rRNA in asso-
ciation with L5 is rapidly mobilized and targeted to the 
nucleus for ribosome assembly. These results suggest 
that the six nucleotide substitutions of oocyte-type 58 
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FIG. 4. Differential RNP distribution of oocyte-type and somatic-
type 58 rRNA in previtellogenic and midvitellogenic oocytes. Labeled 
oocyte-type or somatic-type 5S rRNA was injected into stage II, III, or 
IV oocytes. Mter 24 hr incubation, cleared homogenates of five oocytes 
were electrophoresed on a nondenaturing gel. Duplicate samples were 
analyzed for 58 RNP and 78 RNP formation as described in Fig. 3. 0, 
oocyte-type 58 rRNA. S, somatic-type 5SrRNA. HMW, higher molec-
ular weight complex (see text). 
rRNA are indeed advantageous for the unusual storage 
pathway taken during oogenesis. 
Ribosomal protein L5 and 58 rRNA form a stable 
complex prior to assembly of ribosomal subunits in Xen-
opus oocytes; thus 58 rRNA must be exchanged from 
binding with TFIIIA to binding with L5 prior to local-
ization within the nucleolus and 608 ribosomal subunit 
assembly (Allison et al., 1991). 8ince oocyte-type 58 
rRNA rapidly forms storage 78 RNPs after microinjec-
tion into the cytoplasm, an additional step is required 
along the pathway to ribosome assembly. During stages 
I to III of oogenesis, TFIIIA reaches its highest concen-
tration, then decreases 10- to 20-fold during the later 
stages of oogenesis (8tages IV to VI) (Dixon and Ford, 
1982; Ginsberg et al., 1984). Thus, the majority of the in-
teractions of oocyte-type 58 rRNA with TFIIIA after cy-
toplasmic micro injection into stage V -VI oocytes prob-
ably reflect exchange of the labeled 58 rRNA for the en-
dogenous RNA in pre-existing 78 RNPs (Andersen and 
Delihas, 1986; Allison et al., 1991). 
In contrast to the behavior of oocyte-type 58 rRNA, 
microinjected somatic-type complexes with L5 and is 
readily available for nuclear import and ribosome as-
sembly. This finding that microinjected somatic-type 58 
rRNA predominantly associates with L5 rather than 
with TFIIIA was surprising, given that somatic-type 
binds to TFIIIA with approximately 1.7 times greater 
affinity than oocyte-type 58 rRNA in vitro (Romaniuk et 
al., 1987). However, it has been shown that somatic-type 
58 rRNA is incorporated less efficiently than oocyte-
type into new 78 RNPs in ovary homogenates (Denis and 
Ie Maire, 1983). Further, somatic-type 58 rRNA also 
binds with greater affinity to L5 than oocyte-type in vi-
tro (Q. You, W. Q. Zang, and P. J. Romaniuk, in prepara-
tion). Our observations suggest that somatic-type 58 
rRNA also binds to L5 with high affinity in vivo. Al-
though L5 and TFIIIA recognize a common binding site 
on 58 rRNA, these two proteins share no sequence sim-
ilarity and are subject to distinct developmental regula-
tion (Wormington, 1989). The synthesis of L5 becomes 
maximal in stage III oocytes, coordinated with expres-
sion of 188-5.88-288 rRNA and ribosome assembly 
(Wormington, 1989), Thus, the stages of oocytes used in 
our experiments have a relatively abundant pool of L5 
protein, some of which may be free to associate with ex-
ogenous 58 rRNA. Alternatively, microinjected 58 
rRNA may compete for L5 that is already bound to en-
dogenous 58 rRNA (Allison et aL, 1991) by an exchange 
reaction similar to that carried out in vitm (Fig. 3B; 
Huber and Wool, 1986). 
When introduced into the oocyte nucleus in excess to 
other ribosomal constituents, oocyte-type preferentially 
binds to TFIIIA to form 78 RNPs, some of which may be 
exported to the cytoplasm. TFIIIA plays a role in medi-
ating nuclear export of 58 rRNA (Guddat et al., 1990); 
however, once in the cytoplasm, 78 RNPs are retained as 
storage particles (Mattaj et aL, 1983; Allison et aL, 1991, 
1993). 8omatic-type 58 rRNA, on the other hand, prefer-
entially binds to L5 and thus is more rapidly assembled 
into ribosomes as the other ribosomal components be-
TABLE 2 
ASSEMBLY OF SOMATIC-TYPE 5S RRNA INTO 608 RIBOSOMAL 
SUBUNITS DURING OOGENESIS 
Stage of oogenesis 
Stage II 
Stage III 
Stage IV 
Stage V-VI 
Cytoplasmic injection 
Nuclear injection (RNA) 
Nuclear injection (DNA) 
60S subunit assembly relative 
to oocyte-type 5S r RNA« 
2.8 ± 0.8 (2) 
2.9 ± 0.1 (2) 
4.3 0.0 (2) 
7.0 ± 3.3 (4) 
29.8 ±4.7 (2) 
1.2 ± 0.6 (3) 
«Assembly of somatic-type 5S rRNA into 60S ribosomal subunits 
was analyzed by immunoprecipitation as described in Fig. 5, exeept 
assays were carried out on cleared homogenates of whole stage Il to IV 
oocytes. Data from densitometric analysis are expressed in arbitrary 
units as the mean ± the standard deviation relative to oocyte-type 5S 
rRNA, which was assigned a value of 1.0, after adjusting for any minor 
differences in the total amount of B2P-labeled RNA present in oocyte 
homogenates. The total amount of radioactivity expressed as the av-
erage counts per minute (cpm), recovered from RNA extracted from 
immunoprecipitates and immunosupernatants, was as follows. Stages 
II to IV: oocyte-type, 2260 cpm; somatic-type, 1620. Stage V-VI cy-
toplasmic injection: oocyte-type, 15,510 cpm; somatic-type, 20,350 
cpm. Nuclear injection (RNA): oocyte-type, 10,800 cpm; somatic-type, 
9010 cpm. Nuclear injection (DNA): oocyte-type, 1260; somatic-type, 
1750 cpm. The number of experimental repetitions is indicated in pa-
rentheses. 
FIG. 5. Assembly of somatic-type 58 rRNA into 60S ribosomal sub-
units. 32P-Iabeled oocyte-type or somatic-type 5S rRNA was micro in-
jected into the oocyte cytoplasm or nucleus, or gene templates (DNA) 
were injected with [a_32P]GTP into the nucleus. After 45 hr, oocytes 
were manually fractionated into cytoplasmic (C) and nuclear (N) com-
partments. Cleared homogenates from each compartment were incu-
bated with anti-60S ribosomal subunit antibodies bound to protein A-
Sepharose in immunoprecipitation assays. Labeled RNAs were recov-
ered and separated by denaturing polyacrylamide gel electrophoresis. 
0, oocyte-type 58 rRNA. 8, somatic-type 58 I'RNA. 
come available with time. In contrast, when gradually 
synthesized in situ, both types of RNA are primarily as-
sociated with L5, and comparable amounts are found in 
60S ribosomal subunits. Thus, nascent 5S rRNA can ap-
parently bypass an excursion into the cytoplasm prior 
to ribosome assembly and participate in ribosome bio-
genesis via the typical somatic cell pathway. This result 
concurs with an earlier study by Mairy and Denis (1972) 
showing that newly synthesized endogenous 5S rRNA is 
taken up by ribosomes in vitellogenic oocytes somewhat 
more rapidly than stored 5S rRNA. No distinction was 
made between oocyte-type and somatic-type 5S rRNA 
by these authors, since their study was carried out prior 
to the identification of the sequence heterogeneity of 5S 
rRNA. 
The recruitment of somatic-type 5S rRNA into stage 
II to VI oocyte ribosomes shown here corroborates ear-
lier reports that provided indirect evidence for incorpo-
ration of somatic cell-type 5S rRNA into oocyte ribo-
somes. Guddat et al. (1990) found partial recruitment in 
fully grown oocytes of newly transcribed Xenoplts so-
matic-type 5S rRNA into RNPs that sediment at about 
80S on glycerol gradients, and HeLa cell (human) 5S 
rRNA was shown to be correctly targeted to the nucleus 
and to the nucleoli in fully grown Xenopus oocytes indi-
cating incorporation into preribosomal particles (De-
Robertis et al., 1982). Five of the Xenopus 5S rRNA so-
matic-specific substitutions are conserved in human 5S 
rRNA (Garrett et al., 1991); thus these observations are 
not unexpected. 
Our study does not address the question of differential 
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stability over longer time periods or of functional activ-
ity. Ribosomes that contain somatic-type 5S rRNA may 
be suitable for short-term use in protein synthesis in the 
developing oocyte. Maternal ribosomes are stored many 
months in the oocyte and then after fertilization func-
tion in the synthesis of embryonic proteins until the 
swimming tadpole stage (Miller, 1974). Somatic-type 5S 
rRNA has not been detected in this pool of stored ribo-
somes, suggesting that perhaps the conformation of so-
matic-type 5S rRNA is different enough from that of oo-
cyte-type 5S rRNA to confer lower metabolic stability to 
ribosomes which take up somatic-type 5S rRNA (Denis 
and Wegnez, 1977). Although somatic-type and oocyte-
type 5S rRNAs adopt very similar conformations in 1Ji-
t1'O (Westhof et al., 1989), helices III and IV in somatic-
type are less stable than the same structures in oocyte-
type 5S rRNA (Romaniuk et al., 1988). 
The Pa,thway of 58 rRNA to the Ribosome 
Is the pathway followed by 5S rRNA for assembly into 
ribosomes in oocytes peculiar to these specialized cells 
or does some of the 5S rRNA in somatic cells follow a 
similar pathway? As in oocytes, L5 and 5S rRNA form a 
stable complex prior to assembly of ribosomal subunits 
in somatic cells (Steitz et al., 1988; Wormington, 1989). 
TFIIIA has the distinctive ability to bind specifically to 
both 5S rRNA genes and 5S rRNA of oocyte-type and 
somatic-type (Engelke et aI., 1980; Honda and Roeder, 
1980; Pelham and Brown, 1980; Kim et at., 1990; Pfaff et 
al., 1991; Theunissen et nt., 1992; Bogenhagen, 1993); how-
ever, it is not clear whether storage RNPs, analogous to 
those found in oocytes, form in somatic cells. In mam-
malian cells, excess 5S rRNA is thought to be targeted 
to the cytoplasm for degradation bound to a TFIIIA -like 
protein (Lagaye et a,l., 1988). Another recent report de-
scribes a pool of cytoplasmic 5S rRNA in rat liver pres-
ent in a large complex containing aminoacyl-tRNA syn-
thetases (Ogata et at., 1993). The significance of these 
complexes in vivo remains unknown. It seems unlikely 
that cytoplasmic 5S rRNA in somatic cells would return 
to the nucleus and be incorporated into nascent ribo-
somes, given that assembly of ribosomal components in 
somatic cells appears to require concurrent synthesis of 
all components (Craig and Perry, 1971; Miller, 1974). 
The somatic-type 5S rRNA sequence appears to be 
more closely related to ancestral 5S r RN A than oocyte-
type, and it is thought that the mutations which have 
accumulated in oocyte-type 5S rRNA are unlikely to be 
neutral (Ford and Southern, 1973). We conclude that the 
oocyte-specific nucleotide substitutions are indeed ad-
vantageous and result in distinct functional differences 
that specialize oocyte-type 5S rRNA for following a 
pathway of ribosome biogenesis that involves additional 
protein associations, bidirectional nuclear transport, 
and long-term storage in the cytoplasm. 
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